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Summary
Recent epidemiological evidences on very late opacities or cataract manifestation have led to a review
of the actual limit for the eye lens (150 mSv/year) for workers exposed to ionizing radiation. ICRP
118 recommends reducing the limit to 20 mSv per year. This drastic change in the dose limit has been
incorporated into the revised European and International Basic Safety Standards (European Commission
2013, International Atomic Energy Agency 2014) and it should be implemented in national legislation
of member states in 2018. Up to now, eye lens dose is not routinely measured and there are no general
international recommendations regarding procedures on how correctly estimate the dose to the eye lens.
The present work provides proposals regarding metrological, dosimetric and radiation protection needs
associated to the new limit. At first, a calibration procedure and an easy-to-use dosemeter for the eye
lens have been set-up to accurately measure eye lens doses in terms of H p(3) for photon radiation fields.
Secondly, a measurement campaign on phantom was performed in order to test several dosimetric systems
and to analyze the influence of the position of the eye lens dosemeter. The best position for an accurate
assessment of the eye lens dose is to locate the dosemeter as close as possible to the most exposed eye.
Measurements at four Spanish hospitals in real clinical conditions were performed in order to evaluate
whether the risk of exceeding the new recommended eye lens dose limit of 20 mSv per year is of real
concern. 24 physicians and 12 nurses were monitored. Results show that approximately 40% of the
monitored physicians and 25% of monitored nurses would exceed the new limit. The relation between
the eye lens equivalent dose H p(3) and other quantities, easier to measure such as H p(0.07) with an
unprotected whole body dosemeter situated at the chest or the KAP registered in the X-ray console
have been investigated. Results highlight that the relation between H p(3) and H p(10) or H p(0.07)
measured on the chest or collar with an unprotected whole body dosemeter is more reproducible than
the relationship between H p(3) and KAP, in particular in the case of nurses. Large uncertainties are
associated to the estimation of H p(3) through other quantities (such as KAP or whole body doses).
The relationship is dependent on the type of procedure, position of the monitored person and use of
protection means. Thus, this methodology is only recommended to monitor the staff exposed to eye
lens doses below 6 mSv or in order to identify which individuals are likely to require regular eye lens
monitoring. The recommended correction factor is H p(3) = 0.8 · H p(0.07)thorax. For individuals at risk,
the use of a dedicated eye lens dosemeter is strongly recommended. Monte Carlo simulations were carried
out in order to analyse the influence of several parameters on eye lens equivalent dose and to provide
recommendations on eye lens dose reduction and on the effectiveness of the protective glasses. This thesis
proposes simple precautions to reduce the dose, such as the positioning of the monitors away from the
X-rays. A rotation of the head of 30◦ or 45◦ away from the tube is shown to reduce eye lens dose by
approximately 50%, in particular at distances of 20 cm and 40 cm from the X-ray source. Furthermore,
a correction factor of 0.3 for wraparound-style lead glasses and a more conservative value of 0.5 for any
design of glasses is recommended. This correction should be applied when an eye lens dosemeter is used
on an unprotected region close to the eye, as the measurement of the eye lens equivalent dose does not
take into account the protection provided by the glasses. This proposal is in agreement with previously
published work and with the recommendations from ISO in 2015. Finally, this thesis highlights the need
of training to improve the use of the protection systems, in particular the ceiling suspended screen during
clinical practice.
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Resumen
Evidencias epidemiolo´gicas sobre la manifestacio´n precoz de cataratas u opacidades han comportado la
revisio´n del l´ımite anual de dosis equivalente al cristalino (150 mSv /an˜o) para los trabajadores expuestos
a la radiacio´n ionizante. ICRP 118 recomienda reducir dicho l´ımite a 20 mSv por an˜o, promediado en un
per´ıodo de 5 an˜os. Este cambio dra´stico en el l´ımite de dosis se ha incorporado en las Normas ba´sicas
de proteccio´n radiolo´gica europeas (Comisio´n Europea, 2014) e internacionales (IAEA, 2013) y debera´n
ser transpuestas a la legislacio´n nacional de los Estados miembros en 2018. Actualmente, no se lleva a
cabo el control dosime´trico de la dosis al cristalino y no se dispone de recomendaciones internacionales
consensuadas sobre co´mo llevar a cabo dicho control. Esta tesis presenta diversas propuestas para
cubrir las nuevas necesidades metrolo´gicas, dosime´tricas y de proteccio´n radiolo´gica en el a´mbito de
la cardiolog´ıa y radiolog´ıa intervencionista, asociadas al nuevo cambio legislativo. Se ha desarrollado y
puesto a punto un procedimiento para la calibracio´n de dos´ımetros personales de cristalino en unidades
de H p(3). Tambie´n se ha caracterizado el dos´ımetro de cristalino UPC-ELD de acuerdo con la norma
IEC 32687 (2012) para campos de radiacio´n foto´nica. Dicho dos´ımetro se ha utilizado en una campan˜a de
medidas en maniqu´ı antropomo´rfico para la validacio´n de diversos sistemas dosime´tricos y para analizar
la influencia de la posicio´n del dos´ımetro para la estimacio´n de la medida de la dosis equivalente en
cristalino. Se concluye que la posicio´n o´ptima del dos´ımetro de cristalino es sobre la oreja, en el lado
correspondiente al ojo ma´s expuesto, habitualmente el izquierdo. Se efectuaron mediciones en cuatro
hospitales espan˜oles utilizando el dosmetro UPC-ELD. Participaron 24 facultativos y 12 enfermeras. Los
resultados muestran que aproximadamente el 40% de los me´dicos y el 25% de las enfermeras superar´ıan el
nuevo l´ımite. Paralelamente se ha investigado la relacio´n entre H p(3) y otras magnitudes como H p(0.07)
determinado con un dos´ımetro de cuerpo entero situado a nivel de to´rax encima del delantal plomado
o el KAP registrado en la consola de rayos X. Los resultados ponen de manifiesto que la relacio´n entre
H p(3) y H p(10) o H p(0.07), medidas en el to´rax, es ma´s reproducible que la relacio´n entre H p(3) y
KAP, en particular en el caso de las enfermeras. La determinacio´n indirecta de la dosis en cristalino
presenta importantes incertidumbres puesto que la relacio´n entre las distintas magnitudes depende del
tipo de procedimiento, de la posicio´n de la persona y del uso de los sistemas de proteccio´n. Por ello,
esta metodolog´ıa so´lo se recomienda para la vigilancia individual, si es muy poco probable que la dosis
equivalente anual en el cristalino supere 6 mSv, o bien si el objetivo consiste en identificar los puestos
de trabajo que pueden requerir un control dosime´trico sistema´tico. El factor de correccio´n recomendado
para estimar H p(3) es: H p(3) = 0.8 · H p(0.07)thorax. Cuando no es improbable superar 6 mSv, se
recomienda el uso de un dos´ımetro espec´ıfico para el cristalino. Mediante simulaciones Monte Carlo se
analiza la influencia de varios para´metros en la dosis equivalente en cristalino y se determina la atenuacio´n
de distintos tipos de gafas protectoras. En base a los resultados de las simulaciones se propone situar
los monitores alejados del haz de rayos X y girar la cabeza de 30◦ a 45◦ en direccio´n opuesta al tubo de
rayos X. Dicha posicio´n reduce la dosis en cristalino aproximadamente el 50%, en particular a distancias
de 20 cm y 40 cm de la fuente de rayos X. Adema´s, se ha determinado un factor de correccio´n igual a 0.3
para las gafas de plomo de estilo envolvente y un valor ma´s conservador de 0.5 para otros disen˜os menos
ajustados. Por u´ltimo, esta tesis subraya la necesidad de mejorar la formacio´n sobre el correcto uso de
los sistemas de proteccio´n, en particular del blindaje de techo.
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Chapter 1
Basis and impact of the new eye lens
dose limit
The lens of the eye has long been known to be a radiosensitive tissue (ICRP, 2007; UNSCEAR, 2011).
Radiation exposure can cause opacities or cataracts, producing a loss of eye lens function. When opacities
occur, the light is scattered inside the eye and cannot normally pass and focus on the retina. Therefore,
vision is reduced and the image is perceived to be blurred. Up to now, radiation cataractogenesis is
considered to be a deterministic event (ICRP, 2000, 1991), and thus, opacities or cataracts may occur
when a threshold dose is exceeded. The threshold dose is defined as the dose resulting in a 1% incidence
of specified tissue or organ reactions.
In 2007, the International Commission of Radiological Protection, ICRP, (ICRP, 2007) approved the
revised Recommendations for a System of Radiological Protection which formally replaced the previous
Recommendations issued in 1991 such as Publication 60 (ICRP, 1991). The new recommendations
maintained the major concepts of the previous ones, but updated some of the data and developed
additional guidance on the control of exposure from radiation sources. In particular, ICRP retained
estimates of thresholds for tissue effects in the adult human lens from ICRP 1984, Publication 41 (ICRP,
1984), and the equivalent dose limit for the eye given in Publication 60 (ICRP, 1991). However, they also
recognized that further information was needed and that revised judgements may be required as regards
these data. In these documents, thresholds of 2-10 Gy for acute dose and 8 Gy for chronic exposure were
set for visually disabling cataracts, while the threshold doses for induction of detectable opacities were
0.5-2.0 Gy and 5 Gy was applied for acute and protracted exposures.
Nevertheless, new recommendations were proposed in ICRP 118 (ICRP, 2012) based on several
epidemiological studies on specific groups of workers, especially on astronauts (Chylack et al., 2009),
interventional cardiology and radiology (IC/IR) workers (Vano et al., 2010; Junk et al., 2004), radiological
technologists (Chodick et al., 2008), atomic bomb survivors (Neriishi et al., 2007) and Chernobyl accident
liquidators (Worgul et al., 2007). Most of these studies presented very late manifestation of radio-induced
opacities, and results suggested that the threshold dose for loss of eye lens functionality may be lower than
previously considered in ICRP publications (ICRP, 2007, 1991). These human epidemiological studies, as
well as work with experimental radiation cataracts in animals (Worgul et al., 2002; Kleiman et al., 2007),
suggest that cataracts may occur following exposure to significantly lower doses of ionising radiation than
assumed previously. For cataracts in the eye lens induced by acute exposure, recent studies, where formal
estimates of threshold dose were made after long follow-up periods, indicate values of approximately 0.5
Gy with 90-95% confidence intervals including zero-dose. For chronic exposure over several to many
years, again much of the evidence refers to minor lens opacities. ICRP 118 considered the threshold
in absorbed dose for the lens of the eye to be 0.5 Gy based on these observations and it recommended
reducing the equivalent dose limit for the lens of the eye for workers from 150 mSv per year to 20 mSv
per year, averaged over a period of 5 years, with no single year exceeding 50 mSv (ICRP, 2012). This
drastic change in dose limit was incorporated into the revised European and International Basic Safety
Standards (EURATOM, 2014; IAEA, 2013). The Directive 2013/59 EURATOM is to be implemented
in national legislation of member states in 2018. This reduction of the occupational dose limit to 20
mSv·y−1 will have important implications for IC/IR workers, who represent the targeted population of
this study.
Several studies have been devoted to medical workers (Vano et al., 2010; Sim et al., 2010; Rehani et al.,
2011; Duran et al., 2011; Bouﬄer et al., 2012; Ciraj-Bjelac et al., 2012) and all of them suggested an
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increased risk of late adverse radiation effects, such as eye lens opacities, for this group of workers. In Vano
study (Vano et al., 2010), the risk of radiation cataracts after occupational exposure in interventional
cardiology personnel was evaluated. Slit-lamp examinations were performed both in interventional
cardiologists and a control group. Radiation exposure was estimated by using experimental data from
catheterization laboratories and data collected from questionnaires. 38% of interventional cardiologists
and 21% of exposed personnel, among nurses and technicians, had radiation-associated posterior lens
changes typically associated with ionizing radiation exposure, compared with 12% from the unexposed
population (control group). Median values of lens doses were estimated at 6.0 Sv for cardiologists and 1.5
Sv for associated medical personnel. These epidemiological studies and the consequent recommendation
by the ICRP to decrease the exposure limit for workers have emphasized the role of radiation protection
within the IC/IR framework and in eye lens dosimetry. An important difficulty is the fact that eye lens
dose is not routinely measured and there is no general international consensus regarding the best procedure
to correctly estimate the dose to the eye lens in practice. Before the eye lens dose limit reduction, whole
body monitoring was considered as being a reliable way to ensure that the dose limit to the eye lens
was not exceeded, but this is not always ensured with the new limit. As expected, implementation of
the limit reduction in European legislation implies a greater focus on individual supervisory control and
emphasis on the role of protection tools on occupational exposure at some workplaces. Consequently,
optimization of calibration procedures and measurement techniques for this specific tissue (eye lens) is
needed. Furthermore, an urgent need to educate radiation exposed professionals is suggested, in order to
reduce the likelihood of radio-induced cataracts.
This work will be focused on radiation protection within the field of medicine. The focus will especially
be on interventional cardiologists (IC) and radiologists (IR) who are among those groups who receive the
highest doses to the eyes. The procedures performed in IC/IR require the physician to stand close to the
patient, who represents the main source of scattered radiation. In fact, a photon source is focused on the
patient to follow the path of the catheter inside the blood vessels. The photon radiation is then scattered
by the patient itself to the operator. Furthermore, the number of IC/IR procedures has increased rapidly
in the past few years because of the rapid development of imaging technology and advances in digital
imaging. Consequently, staff should be considered at risk of having cataracts when the cumulative dose
to the eye is considered throughout a number of working years (Vano et al., 2008).
Several studies have highlighted the need to perform eye lens dose monitoring. One of the largest studies
conducted so far on this subject was carried out within the framework of the ORAMED (Optimization
of RAdiation Protection for MEDical staff) project, funded by the European Union between 2008 and
2011(Vanhavere et al., 2012). The dose to the eye was measured through passive dosemeters located close
to both the left and right eye. Annual doses were estimated from eye lens dose measurements and annual
workload for each operator under study. For the operator with the highest workload, the estimated annual
eye lens dose was 49.3 mSv. This value largely exceeds the recommended new dose limit. Furthermore, it
was found that 45% of monitored operators in interventional cardiology and radiology had annual doses
above 3/10th of the new annual dose limit of 20 mSv and 24% even exceeded it. These results highlight
the need to perform systematic monitoring of the eye lens dose for these workers.
In most countries, whole body doses H p(10) and H p(0.07) are regularly measured in IC/IR with passive
whole body dosemeters located under the lead apron. However, in some hospitals it is common practice
to clip an additional dosemeter outside the lead apron and this is often used as an estimate of the dose
to the eyes (Carinou et al., 2014). A lack of standardized methods for eye lens dosimetry has led to the
need to define guidelines and provide international recommendations for calibration and measurements
of the eye lens dose. Additionally, the awareness of a major risk of eye lens opacities has led to the need
to establish measures to ensure the protection of exposed workers by optimizing the radiation protection
tools in IC/IR.
This thesis addresses the major issues of concern in relation to occupational exposure of the eye lens in
IC/IR by:
1. Defining the most appropriate operational quantity for eye lens monitoring
2. Designing a suitable eye lens dosemeter
3. Establishing a proper eye lens calibration procedure
4. Proposing a procedure for eye lens dose monitoring to be implemented in routine practice
These topics will be treated in greater detail in the following chapters.
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Chapter 2
Dose quantities
Radiation protection aims at preventing biological deterministic effects and at limiting stochastic effects
to values that may be considered acceptable for professionally exposed personnel and the public. In
practice, to ensure compliance with the basic principles of radiation protection so that individuals are
not exposed to unacceptable radiation risks, received dose is subject to limits established by law. National
and international authorities are responsible for defining these dose limits for people exposed to ionizing
radiation. These regulations are based on the recommendations of the International Commission of
Radiological Protection (ICRP) and the International Commission of Radiologic Units and Measurements
(ICRU). Figure 2.1 summarizes the relation between dose quantities of interest in radiation protection
for external dosimetry.
Figure 2.1: Relation between physical, operational and protection quantities for external dosimetry based
on ICRU 57 (ICRU, 1998) (adapted from Mattson and Soderberg: ”Dose Quantities and Units for
Radiation”, Chapter 2 of ”Radiation protection in nuclear medicine” Springer Verlag 2013)
ICRP and ICRU have both defined two types of dose quantities for radiation protection applications:
protection quantities and operational quantities. Protection quantities defined in ICRP 103 (ICRP, 2007)
are the equivalent dose in an organ or tissue, H T , and the effective dose, E. The equivalent dose, HT , is
defined by:
HT =
∑
R
wRDTR (2.1)
where DTR is the average absorbed dose in the volume of a specified organ or tissue T, wR is the
radiation weighting factor for radiation R. The sum is performed over all types of radiation involved. The
unit of H T is J·kg−1 and has the special name of sievert (Sv = J · kg−1).
The effective dose is defined by a weighted sum of tissue equivalent doses as:
17
E =
∑
T
wTHT (2.2)
where HT is the equivalent dose in tissue or organ T and wT is the tissue weighting factor for tissue
T. The wT values are chosen to represent the contributions of individual organs and tissues to overall
radiation detriment from stochastic effects. The unit of E is sievert.
HT and E are defined to ensure that the occurrence of adverse stochastic effects is kept below an acceptable
level as well as to prevent tissue reactions. Limits of these quantities are established in national legislation
following ICRP recommendations. Table 2.1 shows the dose limits applicable at present in Spain and
those that will be implemented from 2018 for occupational exposure. The first limits are derived from
ICRP 60, while the new limits correspond to ICRP 103 and 118 recommendations (ICRP, 1991, 2007,
2012).
Dose quantity
Limit in 2017 Limit after February 2018
(RD783, 2001) (Implementation Directive 2013/59)
E
100 mSv in a consecutive five-year 20 mSv in any single year.
period subject to a maximum E of In special situations, a higher E up to
50 mSv in any single year. 50 mSv may be authorised.
Hlens 150 mSv/year
20 mSv per year, averaged over
5 years, with no single year
exceeding 50 mSv.
Hskin
500 mSv/year 500 mSv/year
This limit shall apply to the dose This limit shall apply to the dose
averaged over 1 cm2. averaged over 1 cm2.
Hextremities 500 mSv/year 500 mSv/year
Table 2.1: Comparison of dose limits for occupational exposure between 2016 and after the
implementation of the 2013/59 Directive EURATOM (EURATOM, 2014)
Protection quantities, as they are defined, are not measurable in practice. Therefore, operational
quantities are used for the assessment of effective dose or mean equivalent dose in tissues or organs.
These quantities aim to provide a conservative estimate for the value of the protection quantities related
to an exposure. Operational quantities for area and individual monitoring of external exposure were
introduced by ICRU in 1992 (ICRU, 1992). These quantities are related to physical quantities (see
Figure 2.1) that can be reproduced in radiation metrology laboratories through conversion coefficients
and the definition of appropriate phantoms. The joint ICRP and ICRU publication (ICRP, 1996; ICRU,
1998) includes a complete set of conversion coefficients to calculate the operational quantities from fluence
and air kerma.
Within the framework of this thesis we are mainly interested in the operational quantity for individual
monitoring of external exposure, which is the personal dose equivalent, H p(d). H p(d) is the dose
equivalent in ICRU (soft) tissue at a depth d below a specified point of the human body. This position
is normally taken to be where the individual dosemeter is worn. To monitor skin dose a depth d of
0.07mm is recommended, while 10mm is used for organ dose monitoring. Notations of these quantities
are respectively H p(0.07) and H p(10). H p(10) is used for the assessment of effective dose, and is usually
measured with a whole body dosemeter, worn on the anterior part of the chest. For the assessment of
skin and extremities (hands and feet) dose, H p(0.07) is chosen. For the lens of the eye, a depth d of
3mm was proposed (ICRU, 1988, 1992), as the lens is covered by about 3mm of soft tissue. Although
H p(3) is recommended for eye lens monitoring, it is rarely measured in practice up to now. At a first
stage, there were proposals of employing H p(0.07) for eye lens dose monitoring. ICRP 103 (ICRP, 2007)
states that in practice H p(0.07) can be used when H p(3) measurements are not available. Also Behrens’
work (Behrens and Dietze, 2010) suggests that the use of a dosemeter calibrated in terms of H p(0.07)
on a slab phantom is appropriate in radiation fields where most of the dose comes from photons. Several
studies were initially carried out using skin dose H p(0.07) for eye lens dose monitoring (Vanhavere et al.,
2012; Domienik et al., 2012). However, nowadays, it is generally agreed that the use of the dedicated
operational quantity H p(3) for eye lens dose monitoring is optimum. However, possible ways of obtaining
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H p(3) values still create debates within the radiation protection scientific community. H p(3) can be
assessed either directly or indirectly. Both methods have been used so far, and they will be detailed in
the following chapter.
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Chapter 3
Possible approaches to eye dose
assessment
The IAEA TecDoc No. 1731 ’Implications for occupational radiation protection of the new dose limit for
the lens of the eye’ provides advice to ensure appropriate individual monitoring of the eye lens (IAEA,
2013). Likewise, in 2015, the International Standard, ISO-15382, ’Radiological protection Procedures
for monitoring the dose to the lens of the eye, the skin and the extremities’, provides guidance on how
and when monitoring of the eye lens should be done, for all the different types of workplace fields (ISO,
2015).
Both documents state that the most accurate method for monitoring the equivalent dose to the lens of the
eye, Hlens, is to measure the personal dose equivalent at 3 mm depth, H p(3), with a dosemeter worn as
close as possible to the eye and calibrated on a phantom that is representative of the head. Nevertheless,
they also recognize that this procedure may be difficult to implement in practice and thus they indicate
that other methods may also be used such as evaluating H p(3) through H p(10) or H p(0.07) both measured
with dosemeters worn on the trunk or using other quantities such as the dose area product (DAP) or
kerma area product (KAP)1. In particular, in the case of photon radiation fields, recommendations are
given on the appropriate position of the dosemeter and quantity to be used in order to accurately assess
the eye lens dose, depending on the energy and the direction of the radiation field, the geometry and
the use of protection means. The IAEA Tecdoc (IAEA, 2013) states that, when protective equipment
such as the ceiling shield is employed, the monitoring near the eyes is necessary. However, dosemeters
calibrated in terms of H p(0.07) may be used. If the mean energy field is above 40 keV and the radiation
is coming mainly from the front or the person is moving in the radiation field, also H p(10) quantity
may be employed. Furthermore, when homogeneous radiation fields are present, the eye lens monitoring
with dosemeters worn on the trunk may be performed. However, there is still a lack of international ISO
and IEC standards related to the calibration procedures of eye lens dosemeters, for a proper radiation
protection policy for the eye lens dose monitoring and for the assessment of the performance criteria of
active personal dosemeters and area monitors.
3.1 Direct measurement of eye lens dose: suitable eye lens
dosemeters
In order to ensure appropriate individual monitoring, the eye lens dosemeters should comply with
internationally agreed-upon performance requirements. These requirements should be stated in
standards of the International Electrotechnical Commission (IEC) and the International Organization
for Standardization (ISO). At present, only IEC 62387 (IEC, 2012) provides performance requirements
for passive photon dosemeters to measure H p(3). The dosemeters used for monitoring the eye lens are
generally based on passive techniques and are made of thermoluminscent materials.
Ideally, the dosemeters should be designed to be type-tested and calibrated in terms of H p(3). However,
previous works, such as Behrens (Behrens et al., 2012), demonstrated that dosemeters calibrated
in terms of H p(0.07) and placed on the head may deliver the correct estimation of the Hlens for
photon irradiation. Few passive dosemeters are available for the measurement of H p(3). One of the
first prototypes designed as a passive eye lens dosemeter was proposed within the framework of the
1Within the framework of this thesis the term KAP will be preferably used throughout. The two quantities are indistinctly
used in interventional radiology and although the concept is not the same, the numerical value is.
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ORAMED project. It is based on a LiF:Mg,Cu,P thermoluminescent detector placed in a hemispherical
specifically designed holder to measure H p(3) (Bilski et al., 2011). This dosemeter is now produced by
Radcard (Krakow,Poland,http://www.radcard.pl/) and distributed by RadPro International GmbH,
https://www.radpro-int.com/, under the trade name EYE-DTM . It should be located as close as
possible to the most exposed eye lens. A head band can be provided to hold the dosemeter.
Since 2012 several other designs have been proposed. In 2014, the first intercomparison exercise for
eye lens dosimetry was organized by EURADOS at a European level (Clairand et al., 2016). In this
exercise, 20 services participated from 15 European countries with 12 different types of dosemeters. For
active dosemeters, currently no international standard is available for the quantity H p(3). The use of
active personal dosemeters has been recommended for operational monitoring of medical staff in IC/IR
(Struelens et al., 2011). However, electronic devices can be used for eye lens dose assessment if they
are optimized in terms of H p(3) with respect to energy and angular dependence, or if the quantity they
are optimized for provides an adequate estimate of the dose to the eye lens. Very few active dosemeters
specific for eye lens dose assessment are manufactured. However, whole body active personal dosemeters
have been used for the evaluation of the eye lens doses in some specific studies (Sanchez et al., 2014;
Vano et al., 2015). The advantage with respect to passive dosimetry is that active dosemeters provide
a real-time estimation of the dose. On the other hand, the main limitations to their application in this
field are their size and cost. In this case, small semi-conductor detectors clipped onto spectacles would
be a suitable approach to eye lens dose measurements for active dosimetry when lead glasses are worn
(Antic et al., 2013).
3.2 Assessment of eye lens dose from other quantities
The use of a specific personal dosemeter for the assessment of eye lens dose introduces several challenges.
Firstly, the eye lens dosemeter should be properly calibrated in terms of H p(3). Secondly, it is an extra
dosemeter for the practitioners that should be worn as close as possible to the region of the eye. This
might be neither practical nor comfortable. This has led to alternative issues being investigated in the
past few years from several studies. Two main approaches have been analyzed:
• Assessment of eye lens dose from routinely measured whole body doses
• Assessment of eye lens dose from kerma-area product (KAP) values.
Whole body quantities are not defined for the estimate of eye lens dose, but there is the possibility
to obtain H p(3) through dosemeters calibrated in terms of H p(10) and H p(0.07), by applying proper
correction factors. In 2000, ICRP publication 85 (ICRP, 2000) recommended wearing an additional
dosemeter at collar level and above the thyroid protective collar in order to have an indication of eye
dose. Indeed, the use of a second whole body dosemeter on an unprotected part of the body, is a
well-established procedure recommended by ICRP for interventional procedures and it consists of the
use of two passive dosemeters, one below the lead apron at the level of the chest and another on the
protective apron at a collar or chest level. The aim is to use a combination of the measurements from the
two dosemeters to assess the effective dose. Several studies then investigated the relation between eye
lens dose and dose at the collar. One of the most renowned studies is Clerinx et al. work which suggested
the application of a factor of 0.75 to convert the dose reading H p(0.07) from a dosemeter worn on an
unprotected part of the collar to eye lens dose (Clerinx et al., 2008). The calculations were performed
through Monte Carlo simulation. This correction factor has been put forth again by Martin in his review
on dose indicator values (KAP or H p(0.07)) that could be used to predict doses to the eye lens (Martin,
2011). However the estimate of eye lens dose provided by a collar dosemeter depends on multiple factors
related to the specific irradiation configuration, such as the position of the tube and of the operator and
the use of protection tools. These issues were highlighted by an extensive measurement campaign on
phantoms, performed within the European study ELDO to estimate correction factors to eye lens dose
from whole body doses measured above the protection lead collar or apron (Farah et al., 2013). Several
projections and access routes for mono-tube and biplane-systems were considered. No shielding was used
during the tests. The estimation of the eye lens dose from dosemeters worn on the collar, chest or waist
was studied. It was shown that H p(3) measured at the left eye correlates best with H p(10) measured
on the left side of the collar, above the protective wear. The collar represents the wearing position
closest to the eyes, so that the thyroid dosemeter is exposed to a similarly scattered X-ray field to the
eye lens dosemeter. The suggested correction factor to obtain H p(3)lefteye from H p(10)leftcollar was
3.36. This factor differs considerably from data found in the literature. Carinou et al.’s review (Carinou
et al., 2015) collects the main published results on the relation between whole body doses and eye lens
dose and it underlined the fact that the relation between these quantities is strictly situation-dependent.
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In most of the cases the doses measured in the thyroid and chest region are higher than the eye lens
doses, but this does not represent a general rule. Correction factors varying from 0.44 to 1.45 have been
gathered for interventional cardiology procedures only. Data on the distributions of ratio of eye lens and
thyroid dose from 17 studies reviewed from 1991 to 2011 by Martin (Martin, 2011) show that correction
factor vary from 0.24 to 1.25, with mean value of 0.63. Attention should be focused on the fact that
studies performed on phantoms or with Monte Carlo simulation do not take into account the protection
provided by protective tools in the room, which are usually used in clinical practice. Although the use of
correction factors and doses measured by whole body dosemeters worn on the collar or chest represents a
tempting strategy for the assessment of the eye lens dose, care should be taken and, probably, no general
rules can be drawn in order to have a standard procedure of estimating eye lens dose through whole
body dosemeters. Further studies should be undertaken to reduce the uncertainty of the dose estimate
(keeping in mind the fact that the main objective is to determine whether or not dose limits are reached).
Since staff exposure is mainly associated with radiation scattered by the patient, the use of KAP values
and a proper correction factor as a first estimate of H p(3) has been proposed (Vano et al., 2009). KAP
is automatically recorded during interventional procedures, as it is required by present regulation and is
considered to be a reliable quantity for the assessment of patient doses during fluoroscopic procedures. In
Antic et al.’s study (Antic et al., 2013), ocular lens doses were measured with an active personal dosemeter
calibrated in terms of H p(3). Estimated mean H p(3) per unit KAP for first operator, second operator
or nurse and radiographer were 0.94 µSv Gy−1cm−2, 0.34 µSv Gy−1cm−2 and 0.16 µSv Gy−1cm−2,
respectively. This study highlights the fact that information on location of the staff within the room
should be provided in order to apply the proper correction factor. Martin’s review showed correction
factors from 0.29 to 1.9 µSv Gy−1cm−2, with mean and median values of 0.79 and 0.43 (and third quartile
of 1.0) (Martin, 2011). At first, he proposed to use the maximum KAP-to-eye lens dose correction factor
of 1.9, to ensure the worst case to be assessed, but in order to avoid too conservative results, he suggested
that the use of the third quartile value of 1.0 µSv Gy−1cm−2 would be more appropriate. This value is in
agreement with mean H p(3)/KAP of 0.94 for first operator from Antic’s work and with 1.0 µSv Gy
−1cm−2
obtained during the ORAMED campaign for deriving eye lens dose estimate from DAP (Vanhavere et al.,
2011). However, the correlation between eye lens dose and KAP is of concern. The most important factor
contributing to the variation of these correction factors is the use of shields.
The advantage of these two indirect methods to estimate H p(3) is that they are based on dose quantities
which can be more easily measured and recorded than having to wear a specific additional dosemeter
close to the eyes. The main limitation is that the relation depends on too many parameters of influence
(Carinou et al., 2011; Donadille et al., 2011). Therefore, the use of correction factors to derive H p(3) leads
to a degradation of the accuracy of the eye lens dose estimate with respect to the direct measurement
of H p(3). Thus, in our opinion, as it is also pointed out by most authors (ISO, 2015), the indirect
evaluation of H p(3) can be proposed for guidance in risk assessment in order to identify those individuals
who may exceed the 20 mSv limit and for planning an initial protocol for dose monitoring, but this
method cannot be applied to all routine cases. In many epidemiological studies on eye lens exposure,
dosimetric measurements are poor or inexistent, thus improving our knowledge about the relation between
the different dose quantities is of interest for retrospective dosimetry.
3.3 Radiation protection tools in interventional cardiology and
radiology
IEC 61331 specifies the protective devices to be used against diagnostic medical X-rays (IEC, 2014). The
lead apron must be worn by all the people present in the room where X-rays are used. The level of
protection provided by the apron depends on the voltage applied to the tube: the larger the patient, the
higher the kV set by the fluoroscopy machine. Higher voltages mean greater penetration of the X-ray
beam. In order to protect the operator from backscattered radiation, the higher the lead thickness the
better. On the other hand, the weight of the apron is of concern. For this reason, lead aprons with
thicknesses equal to 0.5 mmPb at the front reach a good compromise between protection and comfort
(ICRP, 2010). Apart from body protection, radiological protection for the eyes is essential for IC/IR
physicians (ICRP, 2013). This protection is provided by the ceiling suspended screen. This shield
should be located between the operator and the radiation sources (the primary and the scattered) and
should provide protection to the upper part of the body, including the head, if well-positioned. However,
sometimes, the use of this shield is not practical and it interferes with the operator’s ability to perform
the procedure (ICRP, 2013). In these cases, lead glasses should be worn. Several studies have shown
that the effectiveness of lead glasses can be largely reduced, when they do not fit the operator’s head
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properly, and scattered radiation passes through the lens of the glasses and the operator’s head. For
highest effectiveness, the protective eyewear should have side protection or a wraparound design. Even in
this case, radiation to the eyes is reduced by only a factor of two or three (Moore et al., 1980; Thornton
et al., 2010; Koukorava et al., 2014).
The use of protection introduces some difficulties when evaluating the eye lens dose. When the dose is
directly measured by an eye lens dosemeter, if lead glasses are used, the positioning of the dosemeter
is of concern, as it can be located on an unprotected part in order to avoid discomfort. In this case
a correction factor should be applied to take into account the protection provided by the glasses (ISO,
2015). Otherwise, the eye lens dosemeter may be located under the protection. If eye lens dose is assessed
by means of other quantities, such as whole body quantities, the fact that whole body dosemeters may
be exposed to a different radiation field than to the head, as they may be protected by room protection
tools, should be taken into account. In fact, eye lens dose may be underestimated in this case.
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Chapter 4
Calibration procedure for eye lens
dosemeters
Although, there is common agreement on using H p(3) as the operational quantity for eye lens dosimetry,
no calibration phantom and no conversion coefficients hpK (3) have been officially decided upon and
published in the ISO standards for the calibration of personal dosemeters. Behrens and Hupe state that
in photon radiation fields, especially X-ray fields, both quantities H p(0.07) and H p(3) are suitable for
monitoring exposure of the eye lens if the dosemeters are calibrated on the ISO slab phantom (ISO, 1999)
for simulating the backscattering properties of the head (Behrens and Hupe, 2015). However, the urgency
in defining a more rigorous method for calibration and measurement of eye lens dose has raised attention
in order to find a more suitable phantom for eye lens dosimetry.
Within the ORAMED project, this topic was discussed in depth, and a new phantom was proposed.
In fact, a dosemeter calibrated in terms of H p(3) requires a proper calibration phantom that is able to
reproduce the characteristics of the part of the body where the dosemeter should be worn (the head in
the case of eye lens dosimetry). A cylindrical phantom of ICRU tissue, with height and diameter of 20
cm was defined (Gualdrini et al., 2011). Data show that a reasonable approximation of the backscattered
properties of the head is ensured with the proposed cylindrical phantom. For calibration purposes, a
practical phantom with the same outer dimension as the ICRU cylindrical phantom but with PMMA
walls 0.5-mm-thick and filled with water was proposed. In 2015 Behrens and Hupe (Behrens and Hupe,
2015) conducted a study comparing the angular response of an EYE-D dosemeter by irradiating it on a
slab, a cylinder and on a human-like Alderson phantom. It turned out that the response for the three
phantoms is nearly equal for angles of radiation incidence up to 45◦ and deviates only at larger angles
of incidence. For calibration purposes, usually performed at 0◦ radiation incidence, the use of both the
slab and the cylinder phantoms provide equivalent results. However, it was shown that for large angles of
incidence the responses on the cylinder and the Alderson phantoms are quite similar, whereas the response
on the slab significantly deviates from that of the Alderson phantom. Conversion coefficients hpK (3) are
needed to establish the equivalent dose H p(3) from the measurement of air kerma with a reference
instrument. Up to now, international organizations have not proposed specific conversion coefficients
for the eye lens, but some sets of hpK (3) can be found in the literature. Grosswendth (Grosswendt,
1990) calculated hpK (3) for monoenergetic beams and for several angles of impinging radiation on the
phantom surface. Calculations were performed on several phantoms, but not for the phantom recently
recommended by ORAMED. Daures et al (Daures et al., 2011) and Gualdrini et al. (Gualdrini et al., 2013)
determined the air kerma to H p(3) conversion coefficients by Monte Carlo simulation for monoenergetic
photons from 10 keV to 10 MeV in the suggested cylindrical phantom. Penelope (Salvat et al., 2006)
and MCNP (Pelowitz, 2005) codes were used and the results compared. The simulations were carried
out both in kerma approximation mode and transporting electrons. The geometry simulated consisted
of the proposed ICRU cylindrical phantom and a sensitive volume centered at a depth of 3mm inside
the phantom. The results of the two papers showed very good agreement, with a statistical uncertainty
of approximately 0.06% for kerma approximation mode. The uncertainty increases to 0.4% when the
transport of electrons is considered. It is shown that the kerma approximation is appropriate for energies
up to 1 MeV. The ORAMED study also included a short set of conversion coefficients calculated on the
cylindrical phantom with Monte Carlo simulation for a few RQR (IEC, 2005) and N (ISO, 1996) series
(Vanhavere et al., 2012).
Behrens (Behrens, 2011, 2012a) calculated H p(3) conversion coefficients for ISO 4037-1 photon spectra
(ISO, 1996) using conversion coefficients from mono-energetic beams by using interpolation techniques.
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Coefficients were calculated both for a square and a cylindrical phantom. This set of conversion coefficients
was included as informative data in IEC Standard 62387 (IEC, 2012). Table 4.1 summarizes the hpK (3)
found in the literature for non-mono energetic spectra.
hpK (d)slab hpK (3)cylinder
d = 0.07mm d = 10mm d = 3mm d = 3mm
N (ISO 4037-1) ISO 4037-3 ISO 4037-3
Behrens (2011)
Behrens (2012a)
IEC (2012)
RQR (IEC 61267) None None None
few RQR-
Daures et al. (2011)
Table 4.1: hpK (3) available in the literature for non-mono energetic spectra
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Chapter 5
Aims and outlines
Part I of this thesis highlights the main challenges derived from the new eye lens dose limit, in particular
in the case of interventional radiologists and cardiologists. The main scope of this work is to contribute
to having better knowledge on the assessment of eye lens monitoring for medical staff. The study includes
both experimental dose measurements and Monte Carlo simulation of different scenarios of interest in
order to improve our understanding of the potential risk of eye lens exposure during interventional
procedures. The project has been developed at the Institut de Te`cniques Energe`tiques of the Universitat
Polite`cnica de Catalunya in collaboration with the Hospital Cl´ınico San Carlos of Madrid and with
partial funding support of the Consejo de Seguridad Nuclear, the Spanish Nuclear regulator. Within this
framework, this thesis provides answers regarding:
1. Metrological needs: new conversion factors are calculated and a calibration procedure for eye lens
dosemeters has been set up.
2. Dosimetric needs: an eye lens dosemeter is characterized to be able to accurately measure eye lens
doses for photon radiation.
3. Radiation protection needs: this is the main objective of the study and it includes the following
features:
• Measurement campaigns in phantoms were first planned to help in the design of the survey
in hospitals. The aims were to test several dosimetric systems and to analyze the influence of
the position of the eye lens dosemeter.
• Measurements were then organized at several hospitals. This part aimed at identifying workers
that will require eye lens dose monitoring and estimate annual eye lens doses.
• Simulation calculations were carried out to analyze the influence of several parameters on eye
lens dose to study the effectiveness of the protection systems available in operating rooms for
eye lens dose reduction, to compare different techniques for the assessment of eye lens dose, to
identify and if possible overcome the difficulties of adequately measuring eye lens dose.
The results of the study will become a calibration procedure of eye lens doses at the Calibration
and Dosimetry Laboratory of the INTE-UPC, which will be available for authorized personal dosimetry
services. It will also inform of the eye lens dose levels and will aim to set up a procedure to identify
potentially high lens exposure practices. In addition, it will provide a practical and sufficiently accurate
solution for the regular monitoring of the eye lens in these workers as well as a procedure to estimate
eye-lens doses by other parameters when monitoring is not needed. Finally, last but not least, it will
provide information on the effectiveness of several radiation protection means, in order to reduce worker
dose.
Part III gathers the main methods used for the development of the thesis. On one hand, for the
experimental determination of the doses, an accurate dosimetry protocol needs to be defined. INTE-UPC
is provided with both thermoluminescent and calibration laboratories for external dosimetry. This
institute has great experience in this field and is the reason why thermoluminescent detectors were
employed during this project. On the other hand, the Monte Carlo method yields very accurate
dose calculations and provide a valid method of dose calculation for dosimetry purposes. However,
experimental measurements are still fundamental for the benchmarking of Monte Carlo results, and the
large demand in computing time is still currently prohibitive for routine use of Monte Carlo in clinics.
Multiple tools are also necessary for handling and analysis of the data, such as SPSS and Matlab. It
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is followed by Part IV which includes specific chapters corresponding to the results of the main studied
topics. Most of these studies have been presented in international or national scientific meetings and
published in peer-review journals. They are included in Appendix A. Part V presents a general discussion
on the results and proposes answers to the identified needs. Finally, Part VI summarizes the main
conclusions.
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Chapter 6
Operational thermoluminescent
dosimetry
Thermoluminescent (TL) detectors are largely employed in operational dosimetry and TL dosimetry
represents the most frequent type of personnel radiation exposure monitoring. TL detectors are suitable
for measurements in interventional cardiology and radiology. Some of the advantages of these detectors
are their small size, the possibility of re-use and affordable cost. The first part of this chapter will be
devoted to the characterization and calibration of thermoluminscent dosemeters (TLDs). The second
part will describe the eye lens dosemeter developed by the UPC within the framework of this study.
6.1 Definition of a thermoluminescent dosimetric system
Thermoluminescent means emitting light when heated. A TL detector is a crystal which has the capability
of emitting visible light when it heats up after being exposed to ionizing radiation. The amount of light
emitted is dependent upon the absorbed radiation energy. Materials exhibiting thermoluminescence in
response to ionizing radiation include lithium fluoride (LiF). The main characteristic of this material is
the presence of one or more impurities inside the crystal which produce trap states for energetic electrons.
In fact, as the radiation interacts with the crystal, electrons are freed and jump to higher energy states,
leaving holes of positive charge. The electrons travel through the solid in the conduction band and may
be trapped due to the impurities in the crystal. When the TL material is heated, the electrons drop
back to their ground state, releasing a photon of energy equal to the energy difference between the trap
state and the ground state. This extra energy is released in the form of light. The light intensity can be
measured and related to the amount of energy initially absorbed during exposure.
A thermoluminescent dosimetric system consists of several parts:
• The detector, sometimes also called dosemeter, i.e. the LiF:Mg,Cu,P crystal.
• A TL holder, where the TL detector will be located. The whole system of holder and detector is
the TL dosemeter (TLD).
• A TL reader consisting of a heating element, a photomultiplier tube and an electronic network.
The reader heats the exposed detectors and provides the signal stored in the detector in
terms of electric charge (Coulomb). The INTE-UPC dosimetry laboratory is provided with the
HARSHAW-BICRON 5500 reader.
• Ovens used for thermal treatments of the dosemeters (annealing procedures). These treatments
are necessary both in the preliminary stage of characterization of the batch, and before each
measurement to restore the initial stage of the dosemeter after usage.
• Appropriate algorithms to convert the TL signal (response provided by the reader) to dose values.
6.1.1 Thermoluminescent detector
In this work, dose measurements in photon radiation fields were performed using TLDs containing LiF
crystals, doped with magnesium, copper and phosphor (LiF:Mg,Cu,P). The LiF: Mg, Cu, P material was
chosen due to its high sensitivity and flat response with energy. Furthermore, as it is an approximately
tissue-equivalent material, it responds in a similar way as human tissue would respond.
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LiF:Mg,Cu,P TL detectors manufactured by Conqueror Electronics Technology Co. Ltd.(Beijing. China,
http://www.cet-cns.com/index.htm) under the trade name TLD-2000C were used. They are circular
pellets of 4.5mm diameter and are 0.8mm thick, with a density of 2.65 g/cm3.
6.1.2 TLD holder
To obtain a good measurement of the operational quantity of interest, the design of the TLD includes
the definition of a casing or holder for the thermoluminescent detectors. The holder contains one or
more filters of specified thickness and material, depending on the operational quantity H p(d) to be
measured. These filters can be used to differentiate between skin and organ doses, in the case of whole
body dosimetry.
Two types of TLD holders are used in this study for eye lens dose monitoring. On one hand, the EYE-D
dosemeter described in Part I was employed. Although this dosemeter provided an accurate measurement
of H p(3), it had some limitations. It has to be located close to the eye, on an operator head band or
on the lateral eyepiece of the operator’s glasses. Some operators, however, did not wear a head band or
glasses and thus could not wear it or in other cases found it cumbersome.
The need to find a compromise between placing the eye lens dosemeter (ELD) as near as possible to the
most exposed eye and at the same time avoiding discomfort of the worker, have led us to considering
defining a simple casing. The ELD designed at the INTE laboratories consists of two TL detectors
sealed in small plastic bags of opaque polyethylene, with density thickness of 11 mgcm−2 (Figure 6.1).
Henceforth, this ELD would be referred to as the UPC-ELD. The UPC-ELD dosemeter has been optimized
to respond in terms of H p(3).
Figure 6.1: The TL detectors and the UPC-ELD
In addition, for whole body dosimetry, the standard badge of the Universitat Politecnica de Catalunya
(UPC) personal dosimetry service was used. This service has been accredited by the Spanish Accreditation
body (ENAC) according to ISO 17025. The UPC whole body dosemeter (UPC-WBD) contains two
detectors for H p(0.07) and two for H p(10), located in the upper and lower part of the dosemeter,
respectively, and the holder material is made of PVC. The same pellets employed in the UPC-ELD
dosemeter were used as detectors for the UPC-WBD.
6.1.3 HARSHAW-BICRON 5500 reader
The Harshaw-Bicron 5500 reader includes a nitrogen heating system to heat the dosemeter. The emitted
luminescence is then amplified by a photomultiplier tube (PMT). The PMT consists of two electrodes,
a photocathode and an anode, in a vacuum tube, in the absence of external light. The photocathode
generates electrons as a result of impinging light and the electric signal is amplified by the photomultiplier
and collected at the anode. The reading process of TLDs proceeds as follows at the INTE laboratory
(Ginjaume et al., 1999)
1. The dosemeters are placed in a reading wheel inside the HARSHAW-BICRON 5500 reader
(Figure 6.2). The reading wheels accommodate up to 50 TL chips.
2. They are submitted to a preheating cycle for 10 seconds at 160◦C. The light emission that occurs
during this phase is not taken into account for the output signal.
3. Data acquisition then starts for 26.6s. TLDs are heated at 4◦C/s until the temperature reaches
250◦C. In Figure 6.3 the profile of the temperature cycle during data acquisition is shown in red.
The blue curve represents the plot of the light intensity emitted by the TLD; this curve is called
the glow-curve.
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Figure 6.2: HARSHAW reader and wheel at the start of the reading process
Figure 6.3: Signal from a TL detector
The time-temperature profile, the PMT noise range, the reference light range and the gain are
handled by the user, on a separate computer, through the operational software Thermo ScientificTM
WinREMSTM . A cooler for the PMT is needed to maintain gain stability and low noise within the PMT
itself. To ensure the entire light signal derives from the TLDs (and not from external light sources), a
photodiode is included in the system and measures the light within the tube when it is not reading: if
the light signal exceeds the PMT noise limits, set by the user at 90pC, the reader stops and the user
may decide to continue the reading or repeat it. The reference light is a parameter used to verify the
stability of the system and is usually given by a light emission diode. These two parameters are measured
periodically by the system. The user sets their frequency; in general, every 10 readings. Finally, the gain
of the PMT is determined by the voltage applied to the PMT itself and determines the amplification of
the electric signal inside the tube. For low dose irradiation, a high gain is needed. A PMT can produce
an amplification of the signal by a factor of 106 or more. In all performed readings the gain was set to
high. To guarantee the reliability of the system, both sensitivity and quality controls are necessary. The
typical cycle time reading per detector is 40 seconds.
6.1.4 PTW-THELDO oven
At the INTE-UPC dosimetry laboratory a PTW-THELDO oven is available. The user controls the oven
thanks to a program interface called THELDO. During the heating cycle, the hot air stream is circulated
by a built-in fan to ensure equal temperature distribution throughout the oven volume. The oven is used
to perform annealing of the LiF:Mg,Cu,P detectors, which consists of submitting them to a well-defined
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heating cycle. The annealing treatment at the INTE laboratory for LiF:Mg,Cu,P is set to a temperature
of 240◦ for 10 minutes, as suggested by the manufacturer. This heating cycle is used in the initial
characterization of the batch and prior to each irradiation.
The characterization of the batch starts with several annealing cycles: the treatment at 240◦ for 10
minutes is repeated 3 times. The aim is to reduce the possibility of variations in dosemeter performance
during its usage, overall in terms of sensitivity. The process of annealing must be as reproducible and
homogeneous as possible to guarantee all the detectors are submitted to the same treatment.
After the three annealing cycles, in order to ensure the batch homogeneity, the whole batch has to be
irradiated using a calibrated gamma source, under the appropriate electron equilibrium conditions. The
gamma source used was a Cs-137 source. Electronic equilibrium is ensured by locating the dosemeters in
a plastic holder during irradiation. After irradiation, the detectors are read. The detectors which do not
comply with tolerance limits, set at 10% of the mean response of the whole batch, were rejected.
TLDs may be re-used after a controlled heating treatment. An annealing cycle of 240◦ for 10 minutes is
carried out prior to the irradiation of the detectors to completely erase all the information stored from
any previous exposure to radiation. The aim of this annealing cycle is to recombine all electron-hole pairs
and restore the original condition of the TLDs.
6.2 Read-out of dosemeters and determination of the dose for
personal monitoring
After a designated monitoring period during which the dosemeters have been exposed to radiation,
the TLDs are collected and read with the TLD reader. To correctly assign a specific reading to the
person exposed to radiation and wearing that particular TLD, each detector was identified by a number.
Background TLDs during the monitoring period have to be kept for each measurement. Once the TLDs
exposed to the radiation are read, the background signal is subtracted from the measured TLD signals.
However, the output from the reader is not immediately usable for radiation protection purposes. A
personal dosimetry service, as in the case of the INTE facility, must provide results in terms of personal
dose equivalent H p(d). H p(d) is defined as the product between the reading L of a single TLD in
terms of electric charge and the calibration factor Ncal. The calibration factor is determined in reference
conditions. In addition, other factors have to be taken into account, as shown in (6.1).
Hp(d) = (Lifi− < B >)Ncal εcal
εt
(6.1)
Li represents the reading for a dosemeter i at time t. The individual calibration factor, fi, is a
term that takes into account the response of a single dosemeter with respect to the whole batch (see
subsection 6.2.1). < B > is the background, obtained as the average value of readings from multiple
dosemeters not exposed to the radiation field under investigation. Ncal is the energy calibration factor
and ε is the efficiency of the system at the moment of the energy calibration (εcal) and at time t of
measurement (εt). The ratio of efficiencies takes into account the stability of the response in time of the
whole batch with respect to the response obtained when the energy calibration was performed.
6.2.1 Individual calibration factors and efficiency
To determine the response of a single detector with respect to the whole set, individual calibration
factors fi were calculated for each TLD. The individual calibration factors are determined by irradiating
all detectors with a Cs-137 source, at a value of air kerma of 3 mGy. After irradiation, the chips were
read and the fi factors, for each chip, were calculated as fi =< M > /Mi. Mi is the reading of detector
i and < M > is the mean of all Mi readings. This process was carried out 6 times from mid-2013 to
early-2016, in order to control the stability of the batch.
As stated previously, the parameter used to quantify the stability of the whole batch through time is the
ratio of the efficiencies εt and εcal. The efficiency εcal is calculated as εt =< Mt > /D, where D is the
given dose of 3 mGy and < Mt > is the mean value of the batch read at time t. The differences in ratios
between the first calibration and the following 5 calibrations are within 1%, thus no correction factors
for the efficiencies were introduced during this thesis.
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6.2.2 Energy calibration factors: energy beam selection
As previously mentioned, the reader output Li is given in terms of electric charge (Coulomb), consequently
it is necessary to estimate an energy calibration factor Ncal to convert the unit of charge to the H p(d)dose
unit (Sievert). As the name itself indicates, energy calibration factors are energy dependent. Therefore,
some energy beams have been selected for calibration. The main radiation qualities of interest for
occupational monitoring are the X-ray narrow (N) series defined in ISO 4037-1 (ISO, 1996). The INTE
calibration laboratory is accredited by the Spanish National Accreditation Authority to reproduce N
qualities. However, since ISO narrow radiation spectra are slightly distant from the energy domain used
in IC/IR, additional less filtered radiation beams which can better approximate the field conditions for
IC/IR procedures were also considered in this study. RQR qualities defined in IEC 61267 IEC (2005) were
also used for energy calibration. Nowadays, it is a common practice to use these radiation qualities for
calibration purposes in radiology workplaces. Ncal values were calculated for radiation qualities: RQR5,
RQR6, RQR7, RQR8, RQR9, N60, N80, N100, N120. The characteristics of these beams are presented in
Table 6.1: radiation quality code, tube voltage, mean energy, first and second value layer and the added
filtration used in the laboratory to reproduce the reference qualities.
Radiation quality Tube voltage (kV) < E > (keV) HVL Added filtration (mm)
Al Cu Sn
N60 60 48 1st- 0.239 mmCu 4 0.6
2nd- 0.269 mmCu
N80 80 65 1st- 0.591 mmCu 4 2
2nd- 0.640 mmCu
N100 100 83 1st- 1.118 mmCu 4 5
2nd- 1.187 mmCu
N120 120 100 1st- 1.714 mmCu 4 5 1
2nd- 1.782 mmCu
RQR5 70 38 1st- 2.41 mmAl 2.5
2nd- 3.45 mmAl
RQR6 80 41 1st- 3.03 mmAl 3
2nd- 4.38 mmAl
RQR7 90 44 1st- 3.42 mmAl 3
2nd- 5.06 mmAl
RQR8 100 48 1st- 3.83 mmAl 3
2nd- 5.73 mmAl
RQR9 120 56 1st- 5.0 mmAl 3.5
2nd- 7.30 mmAl
Table 6.1: Characteristics of beam qualities chosen for eye lens dose calibration
6.2.3 Calibration phantom
As mentioned in the introduction, the need for calibrating eye lens dosemeters is very recent, thus ISO
4037-3 (ISO, 1999) does not define any phantom for this purpose. For eye lens dosimetry, the head-shaped
phantom recommended within the ORAMED project (Figure 6.4) would simulate the human head and
the relative backscattered radiation behavior better than the slab phantom. Because of the lack of a
recommended phantom in the standards, and taking into account the recent recommendation in the
scientific literature (Gualdrini et al., 2011), (Behrens, 2012b), this cylindrical water filled phantom with
PMMA walls was acquired by the INTE laboratories to carry out the present study. This phantom was
also chosen for the two EURADOS eye lens intercomparisons (Clairand et al., 2016).
6.3 Characterization of the dosimetry system according to IEC
62387:2012
600 TLD-2000C were acquired by the INTE. 300 pellets were used for calibration and measurement
purposes. The remaining TLDs were used to verify that the whole set complies with the IEC 62387 (IEC,
2012) international standard. IEC 62387 specifies the performance requirements of a dosimetry system,
including the detectors, the holder and additional equipment, and the corresponding methods to check
that these requirements are met.
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Figure 6.4: Monte Carlo model of the head phantom for eye lens dose calibration (Gualdrini et al., 2011)
According to IEC 62387, the dosimetry system has to comply with several radiation performance
requirements, namely repeatability (coefficient of variation), linearity, overload characteristics and
reusability, the variation of the relative response due to a change of radiation energy and angle of
incidence and over-response to the case of radiation incidence from the side (IEC, 2012). Secondly,
other tests are required to check the environmental performance of the dosemeters: the stability of the
response with respect to ambient temperature and relative humidity, both for the dosemeter and the
reader, the relative response of the dosemeter due to a change in light exposure, dose build-up, fading,
self-irradiation, response to natural radiation, the stability of the reader with respect to a change in light
exposure and primary power supply. Furthermore, electromagnetic compatibility (low EM disturbances)
and mechanical performance (the dosemeter should be able to withstand drops from a height of 1.0 meter)
requirements of the dosimetry system are needed. The requirements are fulfilled when the results are
within the tolerance limits established by the IEC.
The eye lens dosemeter described in section 6.1 was developed for this thesis. Complete characterization
of the dosemeter following the IEC 62387 standard for photon radiation was performed by C. Cagua in
her Master’s thesis (Cagua and Ginjaume, 2016). Details are beyond the scope of this work and are not
provided.
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Monte Carlo calculation for
dosimetric purposes
Measurements in real clinical settings present high variability because they depend on numerous
parameters. A method broadly used to investigate the influence of individual parameters in personal
monitoring is Monte Carlo (MC) simulation of radiation transport. The information provided by MC data
helps to understand the results obtained from measurements, where the influence of a single parameter
cannot be determined because of high variability of several factors.
7.1 MC simulation: basic concepts
Radiation interactions are stochastic events and so is the transport process, therefore multiple random
variables are involved, such as the position, energy and direction of the particles. A random variable
is characterized by a probability distribution function (PDF) that is determined by interaction models
(differential cross sections). Once the PDFs are known, a random track of a particle (history) can be
generated by numerical sampling of random variables, according to their PDF.
The statistical sampling process is based on the selection of random numbers. When a history of a
certain particle is generated, a number between 0 and 1 is selected randomly (random-number generator)
to determine what kind of interaction (if any) takes place, based on the physics and probabilities governing
the processes (i.e. their PDF), to determine the outcome of the particles life at each step. The number of
histories necessary to adequately describe a phenomenon is usually quite large: if it is large enough, the
average over the simulated histories provides reliable quantitative information of the simulated process.
7.2 Use of PENELOPE and MCNPX
In this work the main general-purpose Monte Carlo codes used are PENELOPE and MCNPX.
PENELOPE stands for PENetration and Energy Loss of Positrons and Electrons in matter (Salvat et al.,
2006). It was developed at the Universitat de Barcelona and it is freely distributed by the OECD-NEA
Data Bank (Paris). It simulates all kinds of interactions, except nuclear reactions, in the energy range
from 50 eV to 1 GeV. The general-purpose main program for PENELOPE is called PENEasy and it has
been employed for the development of this thesis (Sempau et al., 2011). It provides the user with a set of
source models, tallies and variance reduction techniques that are called from a modular code. PENEasy,
like PENELOPE, is both free and open software. MCNPX stands for Monte Carlo N-Particle eXtended
and is a general-purpose Monte Carlo code developed at Los Alamos (Pelowitz, 2005). MCNPX can be
used for neutron, photon, electron, or coupled neutron/photon/electron transport. Energy ranges are
from 10−11 to 20 MeV for neutrons with data up to 150 MeV for some nuclides, 1 keV to 1 GeV for
electrons, and 1 keV to 100 GeV for photons. In MCNPX, similarly to PENELOPE/PENEasy, a txt
input file interfaces the user to the Fortran program in which MCNPX is coded. MCNPX is neither an
open source program nor is it free.
Similar features can be given for both codes. The user creates an input file that is subsequently read
by the MC codes. The input file contains information about:
a) The geometry specification: the three dimensional geometry is defined by cells of specific materials,
bounded by quadratic surfaces defined by the user
b) The description of the source: position, type and energy of the particle, ...
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c) The type of output (or tallies) desired
d) Any variance reduction techniques used to improve the efficiency of the calculation.
The MCNPX code allows the performance of a MC simulation to be improved by using parallel
computing to speed up the calculation. Therefore, in this thesis, its use was preferred when complex
geometries were modeled. MCNPX simulations were performed for the sensitivity analysis of parameters
of influence in eye lens doses. In this case a realistic clinical scenario was modeled. The simplified IC/IR
scenario defined within the framework of the European projects ORAMED (Vanhavere et al., 2011) and
ELDO (Koukorava et al., 2014) was adopted. In these simulations, both the patient and the operator,
who stands on the right of the patient, were represented by two modified anthropomorphic ORNL-MIRD
phantoms (Snyder et al., 1978), as shown in Figure 7.1. The patient is in the supine position. Quadratic
surfaces are employed to define all the bodies. Three materials have been used for human tissue: bone,
soft tissue and air for the lungs. Very thin tally volumes of 4 · 10−3mm thickness were introduced at
a depth of 3 mm in the soft tissue of the eye to calculate the personal dose equivalent H p(3). An
hemispherical tally volume of soft tissue and volume of 0.16 cm3 was defined close to the left eye, at
the left lateral position, which realistically represents the position where the dosemeter can be used for
the measurement of the dose to the left eye. The code implemented during the ELDO project was used
as a basis and modified according to the requirements of this thesis. H p(d) was calculated by energy
deposition tally F6. F6 gives the energy deposited averaged over a cell, in MeV/g. SD cards are used
together with the tallies to specify the mass of the tally volumes. The photon p MODE (F6 : p) was used,
namely secondary particles were not included on the MODE card, as electrons generated during photon
collisions, are not tracked and their energies are deposited locally at the point of the interaction (the
so-called kerma approximation). This approximation is suitable for the selected beams as they are low
energetic. In a cell where most of the electrons lose all of their energy before exiting from the cell itself
represent a good approximation and is the case for this study. Otherwise, if these generated electrons
can carry significant energy into the neighboring cells, the use of the F6 : p tally for this cell can result
in a large overestimation of the deposited energy (kerma is larger than absorbed dose at high energy).
Figure 7.1: IC/IR scenario implemented in MCNPX. Section at plane x=50
The PENELOPE code was used during the preliminary phase. To easily describe a process, an
example of how PENELOPE works is given henceforth. When a history is generated, after the first event
occurs the particle may be, for instance, scattered. The angle of scattering is then selected randomly from
the physics of the scattering distribution (PDF). A secondary particle may be generated and followed
(or not) for later analysis. When the particle reaches a certain energy threshold, the particle history is
complete. These energy thresholds, called absorption energies (Eabs), are defined by the user. When
the particle reaches an energy below Eabs, its interactions are no longer simulated and it is absorbed
in the material. Simulations with PENELOPE were used for calibration purposes for the calculation
of conversion coefficients hpK (d). The aim was to have results as reliable as possible. Therefore, all
secondary particles generated by a history are tracked. For this reason, Eabs are set at the value of
1 keV, which represents the minimum resolution of the energy beam. On the other hand, following
secondary particles slows down the simulation. If a high precision of the simulation is not required, the
local absorption of the secondary particles (if any) generated from primary photons can be applied by
increasing the Eabs for electrons and positrons to the maximum value of the beam energy spectrum.
The quantities of interest requested by the user are tallied. The requested PENELOPE output was the
energy deposited in the detection material. This quantity was then divided by the mass of the scoring
volume to obtain the absorbed dose.
40
CHAPTER 7. MONTE CARLO CALCULATION FOR DOSIMETRIC PURPOSES
All interaction events in a photon history are simulated in chronological succession, until the photon
reaches an energy lower than Eabs and it is absorbed locally. As regards electron and positron tracks,
the simulation is performed by means of a mixed algorithm. Hard collisions are simulated in detail
and controlled by several parameters defined by the user: C1, C2, Wcc, Wcr. C1 and C2 control
the electron step length between consecutive hard elastic events (in perfectly elastic collisions there is
no loss of kinetic energy). C1 is the average angular deflection per step, C2 is the maximum average
fractional energy loss per step, Wcc and Wcr are the cut-off energy loss for hard inelastic collisions
and for hard bremsstrahlung emission, respectively. The simulation gets faster for large values of these
parameters (with 0 ≤C1,C2≤ 0.2). However, to ensure accuracy, these values should be small. Collision
by collision electron/positron simulation is achieved by setting C1, C2, Wcc equal to zero. In the case of
the simulations in this thesis, for C1 and C2 parameters a value of 0.02 is adequate and recommended
and is then used for calculation of conversion coefficients. Wcc, and Wcr are set to 1% and 0.1% of the
mean energy of the source beam, respectively.
The performed simulations are characterized by a low probability of scoring contributions to the quantity
of interest. This is generally due to the small scoring volume and, in some cases, to the fact that the
scoring volume is not irradiated by the primary source, but by the scattered radiation from bodies between
the source and the detector. However,two warnings must be issued. Firstly, in PENELOPE, a parameter
called maximum step length has to be defined. If the medium where the energy deposition has to be
calculated is extended, setting this parameter is not needed; otherwise, for critical geometries, i.e. with
thin bodies, it is reasonable to set this to one tenth of the thickness of the body. This is to ensure that
the number of hard collisions within the body is at least 10. In all performed simulations this precaution
has been implemented. Secondly, low probability of scoring leads to large statistical uncertainties. To
reduce the uncertainty, larger simulation times are required. Therefore, variance reduction techniques
are applied to speed up the simulation and, indeed, improve its efficiency.
7.3 Variance reduction techniques in PENELOPE and in
MCNPX
In both codes variance reduction techniques are implemented.
In PENELOPE three techniques are available: particle splitting, Russian roulette and interaction forcing.
Particle splitting is implemented to increase the likelihood of having a contribution by a particle when it
approaches the region of interest. The particle is split into NSPLIT particles; this number is set by the
user. Since an initial weight WGHT equal to one is given to primary particles, the generated particles
by the splitting will have weight WGHT/NSPLIT. Russian roulette should be used when a particle goes
away from the region of interest and is not likely to contribute, thus it is killed with probability PKILL
and, if it survives, its weight is replaced by WGHT/(1-PKILL). Interaction forcing forces interactions to
occur. This is equivalent to increasing the inverse mean free path (the interaction probability per unit
path length). Therefore, to keep the simulation unbiased, a new weight WGHT2 is assigned to secondary
particles produced in forced interactions of a particle of weight WGHT. WGHT2 is equal to WGHT/F
where F is a factor higher than one and equal to the ratio between the mean free path of the real process
and the shorter mean free path defined for the interaction forcing. Particle splitting and interaction
forcing are used. After repeating the same test with different NSPLIT values, NSPLIT equal to 10 was
chosen because the highest efficiency of the simulation is achieved. Interaction forcing was employed
in very thin foil, where the interaction probabilities were very low. Notice that also the weight of the
deposited energy is decreased by the factor F when forced interactions occur.
In MCNPX the DXTRAN sphere method is the name of a technique for variance reduction. The DXTRAN
sphere is used when particles have a very limited chance of reaching a small region, the user can then
specify a sphere that encloses this region. Two spheres have to be defined, one inside the other: an outer
and an inner sphere. When a particle collides with the outer sphere, a splitting of the particle into two
occurs: a special DXTRAN particle and a no-DXTRAN particle are generated. The DXTRAN particle
is created and deterministically scattered towards the inner DXTRAN sphere. Its transport towards the
inner sphere is forced, but not the collision, and a new weight is assigned to it (a fraction of the weight
of the original particle). The no-DXTRAN particle continues its track with no change in its weight. The
bias introduced is then compensated by adding a condition that if the no-DXTRAN particle crosses the
inner DXTRAN sphere, it is killed. This method has been adopted by the user to calculate the dose in
small regions of interest, such as the operator’s eyes, where the interaction of scattered radiation from
the patient is unlikely to occur.
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The way to define the DXTRAN sphere for photons p is DXT:p x y z Ri Ro. x, y and z represent the
point where the spheres are centered, Ri and Ro are the inner and outer radius of the two spheres. To
avoid a massive loss of particles inside the spheres, it is important to set the difference between the inner
and outer radius equal to the mean free path in the tissue of the region of interest, for the specific energy
of the beam. In the cases analyzed, the mean energy of the beam is approximately 50 keV. For a photon
with this energy, in muscle soft tissue, the mean free path is 4.46 cm. An example of syntax of the DXT
sphere for the eye region is: DXT:P 11 31 88.1 10 14.46.
Another variance reduction technique in MCNPX is the importance of a particle. The default importance
for all particles is one. The importance has not been changed in the programs implemented for the present
study. Otherwise, if, for instance, the photon importance of cell 1 is 2, then a track will be split into two,
and each new track will have half the weight of the original one before splitting.
Unfortunately, in spite of variance reduction techniques, to reach an accurate and reliable result
for complex geometries, long calculation times are needed. The use of Monte Carlo calculation in
real time is not generally feasible in clinical practice, hence Monte Carlo simulations have found
their major application in research. As previously stated, they are very helpful in providing specific
information on isolated parameters difficult to derive from measurements with dosemeters, because of
the multi-parametric nature of clinical procedures. Thus, experimental measurements are essential for
dose assessment and still represent the main source of data available in the literature.
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X-ray spectra and data analysis
8.1 X-ray spectra definition
Most of the MC calculations require the definition of the radiation sources, which are X-ray beams. The
program XCOMP5 (Nowotny, Hofer, 1985) is used to generate the required X-ray spectra. At the INTE
facility, the X-ray-tube-anode angle is 18◦ and its inherent filtration is 7mm of Beryllium. Apart from
the intrinsic parameters of the tube, features of the generated beam are given by the user. For instance,
for generating an RQR5 beam, 2.5mm of aluminum is needed as added filtration and a peak voltage of
70 kV has to be entered. The program provides the fluence spectrum of the beam, for energy steps of
1 keV. In Figure 8.1 the fluence spectra of N60 to N120 and RQR qualities from 5 to 9 generated by
Xcomp5 and visualized by Matlab are presented.
(a) N qualities (b) RQR qualities
Figure 8.1: Spectra from XCOMP database (Nowotny and Hofer, 1985)
8.2 Data analysis tool
Statistical analysis of data was performed with SPSS Statistics (IBM, 2013). SPSS is a software package
used for logical batched and non-batched statistical analysis. In this work it has been used mainly to verify
the statistical significance of difference in mean values. SPSS has a user-friendly interface and the main
features are accessible by a pull-down menu. The most useful options used in this thesis were descriptive
statistics, bivariate statistics, such as the t-test, and graphics generation. The output can be captured
as data, text, or as graphic formats (i.e. box-plots). Matlab (MathWorks, 2000) numerical computing
environment and Microsoft Excel have also been used for algorithm development, data visualization, data
analysis, and numerical computation.
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Chapter 9
Determination of conversion
coefficients from air kerma to eye
lens equivalent dose
As stated in the introduction, the set of air kerma to H p(3) conversion coefficients hpK (3) available in
the literature is limited to certain qualities and phantoms. To overcome this problem, hpK (3) for the
cylindrical phantom for all RQR IEC-61267 (IEC, 2005) X-ray beams and for angles of incidence from
0◦ to 180◦ were calculated. The RQR2 to RQR9 IEC-61267 qualities were chosen because they provide a
better approximation of the radiation spectra found in practice in interventional cardiology and radiology
workplaces than ISO 4037-1 qualities and are often used in intercomparisons in this field. The study also
discusses the influence of different approaches used in the literature for the calculation of conversion
coefficients. The simulation study to obtain the conversion coefficients was initially performed using both
PENELOPE (Salvat et al., 2006) and MCNPX (Pelowitz, 2005) MC codes.
The kerma-to-personal dose equivalent H p(3) conversion coefficient is defined as the ratio of the quantities
H p(3) and the air kerma K a:
hpK (3) = Hp(3)/Ka (9.1)
The air kerma K a and H p(3) in the cylindrical ICRU tissue phantom were calculated to obtain the
hpK (3, RQR, 0
◦)cyl conversion factors for normal incidence and for the radiation qualities RQR. Although
K a and H p(3) are obtained per unit fluence, i.e. K a/φ and H p(3)/φ, they are referred to as K a and
H p(3) for simplicity. In the set-up geometry the cylindrical phantom embedded in vacuum is irradiated
by a 20 cm × 20 cm collimated square beam, placed 1 m from the phantom front-face. To assess H p(3)
values, a 0.5−mm−thick sensitive volume was placed at 3 mm depth within the cylinder. Parallelepipeds
of 1 mm width, 0.5 mm thickness, and 5 cm height were used as scoring volumes for both MC codes. The
conversion coefficient depends on the energy, the directional distribution of the incident radiation and
the phantom used in the calibration. hpK (3, RQR,α)cyl values for different RQR radiation qualities and
angles α from 0 to 180◦ were assessed only using MCNPX. PENELOPE was employed to compare the
results only for normal incidence. The statistical uncertainty of the MC simulations was to within 0.1-1
% (1sd). It is worth mentioning that PENELOPE and MCNPX manage the simulation output process
in different ways.
The requested PENELOPE output for the calculation of H p(3) was the energy deposited in the detection
material. This quantity was then divided by the mass of the scoring volume to obtain the absorbed dose
at 3 mm depth. Cut-off energies were set to 1 keV for both electrons and positrons. On the other
hand, for the calculation of the air kerma, transport of secondary electrons and positrons was disregarded
by setting both cut-off energies equal to the maximum energy of the radiation spectrum, which is the
voltage applied to the X-ray tube. For the MCNPX calculations, energy deposition tally F6 was used,
employing the kerma approximation for both H p(3) and K a. hpK (3) coefficients obtained by PENELOPE
were calculated considering secondary electron transport, while hpK (3) obtained by MCNPX disregarded
secondary particles in order to evaluate the difference between the two approaches for these energies. The
codes show very similar outputs when identical geometries are run.
To find out if analytic calculations might also be a valid method for the calculation of hpK (3), conversion
coefficients were calculated for RQR qualities and for a varying angle of incidence from 0 to 180◦ by
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implementing the interpolation technique suggested by Behrens (Behrens, 2011). Conversion coefficients
for mono-energetic photon beams were taken from Gualdrini (Gualdrini et al., 2013). The following steps
were considered:
a) Firstly, the photon fluence spectra dφ/dE for the radiation qualities of interest were determined from
the XCOMP5 program (Nowotny and Hofer, 1985). The fluence per unit energy dφ/dEi is given for
integer values of energy from 1 keV to the voltage applied to the X-ray tube to generate the radiation
beam (Vmax), in steps of 1 keV.
b) Subsequently, the conversion coefficients hpK (3, RQR,α)cyl were calculated from hpK (3, Ei, α) for
mono-energetic photons for the ICRU cylindrical phantom by applying the following equation:
hpK (3, RQR,α)cyl =
Hp(3, RQR,α)cyl
Ka(RQR)
=
∑Vmax
i=1keV
dφ
dE i
hpK (3, Ei, α)Ei
µen(Ei)
ρ∑Vmax
i=1keV
dφ
dE i
Ei
µen(Ei)
ρ
(9.2)
The formula represents the ratio between the dose equivalent at 3 mm depth and K a, calculated for
the radiation quality of interest RQR. K a(RQR) is calculated from the photon fluence dφ/dEi and the
mass-energy absorption coefficients of air. The mass-energy absorption coefficients µen(Ei)/ρ for photons
in air are obtained by log-log interpolation (logarithmic both in energy and in values) from available values
(only for few energies) taken from Hubbell and Seltzer (1995) and folded with photon fluence and energies
Ei. The H p(3, RQR,α)cyl are calculated as the convolution of the conversion coefficients hpK (3, Ei, α)cyl
with photon fluence, energies Ei and µen(Ei)/ρ. hpK (3, Ei, α)cyl are obtained by using a cubic spline
interpolation at low energies (for energies between 10 keV and 40 keV and for angles larger than 90◦)
and a linear-logarithmic interpolation for the rest of energies and angles (linear in values and logarithmic
in energy). hpK (3, RQR,α)cyl are then calculated as the ratio between H p(3, RQR,α)cyl and K a(RQR)
for the specific RQR quality.
Results from MC calculations and interpolations are shown in Table 9.1. Only the coefficients for the
qualities of interest for the calibration and for normal incidence are shown. The set of conversion
coefficients obtained as mean values between MC codes (column 4) was then used for the set-up of a
calibration procedure for the UPC-ELD.
RQR qualities PENELOPE MCNPX MC average Interpolation
RQR5 1.281 1.270 1.276 1.276
RQR6 1.349 1.336 1.343 1.343
RQR7 1.384 1.368 1.376 1.376
RQR8 1.406 1.394 1.400 1.403
RQR9 1.461 1.456 1.459 1.462
Table 9.1: Conversion coefficients hpK (3, RQR, 0)cyl in Sv/Gy from MC and interpolation methods for
0◦ angle of incidence and RQR5 to RQR9 qualities
The difference between PENELOPE and MCNPX hpK (3, RQR, 0)cyl were below 1%. The statistical
uncertainty for both MC codes was within 1%, for one standard deviation. This result confirms the validity
of the kerma approximation used in the following calculations. In Table 9.2 all conversion coefficients
hpK (3, RQR,α)cyl calculated with MCNPX for RQR qualities and for angles of incidence from 0 to 180
◦
are listed.
The MCNPX output in Table 9.2 was compared to the values obtained by interpolation. For
all the considered incident angles, hpK (3, RQR,α)cyl differences were lower than 0.8%. This result
highlights the fact that the analytical method is both a good and quick estimation tool for the
calculation of conversion coefficients within the analyzed energy range, provided that conversion
coefficients for mono energetic photon beams are available. As suggested by Behrens (Behrens, 2011),
for angles larger than 90◦ an approximation with a cubic polynomial can better estimate conversion
coefficients at low energies from 10 up to 40 keV, and thus avoid unrealistic results. Indeed, in
this angle and energy range, the difference between analytical and simulated outputs is reduced
from a maximum of 7% (linear interpolation on a log-lin scale) to values within 0.8% (cubic spline
interpolation). Therefore, MC modelling has been considered the golden standard method even though
interpolation results lead to very good approximations when this technique has been chosen carefully.
Figure 9.1 shows an example of the two different interpolation techniques (linear and cubic) applied
at low energies for an incident angle of 105◦, for the RQR5 spectrum. If only linear interpolation
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EYE LENS EQUIVALENT DOSE
hpK (3, RQR,α)cyl
Angles RQR2 RQR3 RQR4 RQR5 RQR6 RQR7 RQR8 RQR9
0◦ 1.106 1.178 1.232 1.270 1.336 1.368 1.394 1.456
10◦ 1.099 1.172 1.226 1.268 1.337 1.369 1.396 1.455
15◦ 1.099 1.172 1.226 1.269 1.336 1.369 1.397 1.456
20◦ 1.094 1.167 1.221 1.262 1.329 1.363 1.390 1.449
30◦ 1.081 1.154 1.208 1.247 1.314 1.347 1.373 1.437
40◦ 1.060 1.140 1.186 1.228 1.295 1.330 1.358 1.418
45◦ 1.043 1.117 1.171 1.215 1.283 1.317 1.346 1.408
50◦ 1.019 1.093 1.149 1.195 1.263 1.296 1.324 1.388
60◦ 0.965 1.041 1.097 1.141 1.211 1.247 1.276 1.341
70◦ 0.883 0.945 1.016 1.055 1.128 1.166 1.197 1.265
75◦ 0.800 0.882 0.941 0.989 1.064 1.102 1.134 1.207
80◦ 0.705 0.787 0.859 0.902 0.981 1.020 1.052 1.128
90◦ 0.450 0.533 0.595 0.643 0.723 0.766 0.802 0.884
105◦ 0.131 0.186 0.232 0.269 0.330 0.365 0.396 0.467
120◦ 0.039 0.067 0.093 0.117 0.153 0.177 0.198 0.246
135◦ 0.015 0.030 0.046 0.062 0.086 0.102 0.117 0.151
150◦ 0.008 0.018 0.029 0.040 0.057 0.070 0.081 0.107
165◦ 0.005 0.013 0.022 0.031 0.046 0.056 0.066 0.088
180◦ 0.004 0.011 0.020 0.029 0.042 0.052 0.062 0.082
Table 9.2: hpK (3, RQR,α)cyl calculated with MCNPX for RQR qualities and for angles of incidence from
0◦ to 180◦
had been chosen, it would have led to an overestimation of the hpK (3, RQR, 105)cyl conversion coefficient.
Figure 9.1: Application of two different interpolation techniques to hpK (3) for RQR5 and 105
◦ angle of
incidence
The influence of RQR reproduced at different laboratories has also been studied. As opposed to ISO
4037-1 qualities, IEC-61267 does not specify the filtration needed to produce RQR beams. RQR qualities
are defined by the tube voltage and the nominal first half-value layer. In order to be reproduced, the
additional filtration has to be adjusted to obtain a ratio between air kerma (or air kerma rate) with and
without a filter of thickness equal to the nominal first half-value layer between 0.485 and 0.515. hpK (3)
were calculated for the RQR spectra generated at the Secondary Standard Laboratory at the Universitat
Polite`cnica de Catalunya (UPC) (Column 3 in Table 9.3), but to evaluate the influence of the filtration
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used by different laboratories, calculations were repeated for the RQR spectra used by the Metrology
Institute at the Physikalisch-Technische Bundesanstalt (PTB)in Germany. The information regarding
the spectra generated at PTB are provided in PTB calibration certificates (Column 4 in Table 9.3).
The inherent filtration for UPC and PTB beams is equal to 7 mmBe. In addition, results have also
been compared with hpK (3) coefficients calculated by the French National Metrology Laboratory CEA
LIST/LNE LNHB(5) for RQR7 and RQR9 nominal HVL values (Column 5, Table 9.3).
Tube voltage HVL (mmAl) Added filtration (mmAl)
(kV) UPC PTBa CEAb UPC PTB CEA
RQR2 40 1.41 1.42 2.5 2.49
RQR3 50 1.78 1.77 2.5 2.46
RQR4 60 2.11 2.19 2.5 2.68
RQR5 70 2.39 2.57 2.5 2.83
RQR6 80 3.01 3.01 3.0 2.99
RQR7 90 3.48 3.48 3.48 3.0 3.18 3.0
RQR8 100 3.86 3.96 3.0 3.36
RQR9 120 4.98 5.00 5.00 3.5 3.73 3.39
Table 9.3: HVL and added filtration for the different standard laboratories and RQR qualities.a Data
obtained from PTB calibration certificates (PTB, 2012). b CEA LIST/LNE LNHB (Vanhavere et al.,
2012)
Results showed good agreement. Differences were below 1.5% for angles smaller than 90◦ and between
1 and 7% for larger angles. The larger disagreement was found for RQR5 and RQR8 qualities, where
differences in added filtration are higher. The conversion coefficients given in Table 9.2 are calculated
for RQR qualities as defined in our laboratory. From the statement above, it has been verified that up
to an angle of incidence of 90◦ coefficients from Table 9.2 can be used by other laboratories to within
an uncertainty of 2% (one standard deviation). This is the same uncertainty stated in ISO 4037-3 for
ISO 4037-1 quality conversion coefficients. For larger angles of incidence specific conversion coefficients
should be determined.
In addition, data were also compared with the conversion coefficients published in Table 2.7 in the
ORAMED report (Vanhavere et al., 2012) for RQR7 and RQR9, for angles up to 90◦. In this case,
results agreed to within 0.6%.
Conversion coefficients shown in Table 9.1 and Table 9.2 were published in (Principi et al., 2015c) and
are used in this thesis for the characterization of UPC dosemeters when using RQR qualities. For ISO
N-qualities (Behrens, 2012a) are used.
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Chapter 10
Performance verification of the
UPC-ELD
10.1 Energy and angular response
10.1.1 Energy calibration and calculation of optimal energy calibration
factors
The average energy of the scattered radiation fields encountered in IC/IR ranges from 20 to 100 keV
(Eurados report ORAMED). Radiation qualities RQR5, RQR6, RQR7, RQR8, RQR9, N60, N80, N100
and N120 were chosen to study the energy response of the different dosimetric systems used in this thesis.
The characteristics of these beams are presented in Part III. 279 pellets were irradiated, and 10 detectors
were kept apart (not irradiated) for background radiation measurement. The calibration set-up for eye
lens dosimetry was based on the suggested cylindrical phantom (Gualdrini et al., 2011) and was carried
out for UPC-ELD and EYE-D holders. The UPC-WBD was irradiated using the ISO slab phantom
for the assessment of H p(10) and H p(0.07). Three UPC-ELDs and one EYE-D were irradiated on the
cylindrical phantom and two UPC-WBDs on the slab phantom, at each radiation quality. The energy
responses were determined through the energy calibration factors for the studied radiation beams. The
energy calibration factors are defined as the reference equivalent dose H p(d)ref divided by the measured
quantity MQ, for the specific beam quality Q.
Ncal(Q,Hp(d)) =
Hp(d)ref,Q
MQ
(10.1)
The reference equivalent dose at a depth d, in units of µSv, is given by:
Hp(d)ref,Q = Ka,refhpK (d, 0) (10.2)
Where K a,ref is the reference air kerma, measured by a secondary standard ionization chamber.
hpK (d,0) is the conversion coefficient from air kerma to equivalent dose at depth d, for the radiation
quality Q and for normal irradiation. The measured quantity is determined by using the equation:
MQ = Lifi− < B > (10.3)
Where Li is the reading of the dosemeter i, fi is the individual calibration factor for detector i, and
< B > is the mean reading of background detectors. It is given in units of electric charge (nC). Table 10.1
presents the energy calibration factors for each reference quality and for the different types of dosemeters.
The standard uncertainties of the energy calibration factors Ncal(Q,Hp(d))(k=1) are calculated
following the Guide to the expression of Uncertainty in Measurement (ISO/IEC, 2008). Details are given
in Appendix B.
In addition, Ncal(Q,Hp(d)) are represented in Figure 10.1 for WBD as a function of the ratio between
M(10) and M(0.07), where M(10) is the reading at 10mm depth, and M(0.07) at 0.07mm, in nC. This
ratio takes into account the penetration depth of the radiation. It is function of the radiation quality
and is used in the algorithm for H p(10) calculation.
Based on typical IC/IR beam characteristics, the energy calibration factor for the estimation of
H p(0.07) is calculated as the average of the energy calibration factors for radiation qualities RQR and
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Q Ncal(Q,Hp(0.07)) Ncal(Q,Hp(10)) Ncal(Q,Hp(3))UPC-ELD Ncal(Q,Hp(3))EYE-D
RQR5 6.08±0.16 16.15±0.43 5.40±0.14 5.70±0.24
RQR6 6.58±0.17 15.19±0.40 5.51±0.15 5.75±0.24
RQR7 6.38±0.17 13.23±0.37 5.58±0.15 5.91±0.25
RQR8 6.48±0.17 12.33±0.33 5.52±0.15 6.06±0.25
RQR9 6.36±0.17 10.67±0.28 5.90±0.16 6.06±0.25
N60 6.29±0.17 10.54±0.28 5.48±0.14 5.48±0.23
N80 6.87±0.18 8.64±0.23 6.40±0.17 6.46±0.27
N100 7.07±0.19 8.36±0.22 7.35±0.19 7.84±0.33
N120 7.95±0.21 8.94±0.24 7.82±0.21 8.13±0.34
Table 10.1: Energy calibration factors Ncal(Q,Hp(d))±u(Ncal(Q,Hp(d))) (k=1) for each reference quality
Q and at depth d, for the different types of dosemeters
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Figure 10.1: Ncal(Q,Hp(d)) vs. M(10)/M(0.07) ratio for H p(10) and H p(0.07)
N60 shown in Table 10.1:
Ncal(Hp(0.07))= 6.36 µSv/nC. The resulting uncertainty is u[Ncal(Hp(0.07))] = 4.8% (k=1) (see
Appendix B).
As regards the determination of H p(10), Ncal(Hp(10)) is clearly energy dependent. The calibration
factor is determined through a least square fitting as a function of M(10)/M(0.07): Ncal(Hp(10)) =
20.36 − 14.56 ·M(10)/M(0.07) in µSv/nC. The relative uncertainty in the range of interest associated
to the proposed algorithm is 0.8% (k=1). The combined uncertainty associated to Ncal(Hp(10)),
u[Ncal(Hp(10))]=4.3% (k=1) (see Appendix B).
For H p(3), the relative energy calibration factor normalized to
137Cs is given in Figure 10.2, for normal
incidence (α=0).
Maximum deviation of the energy calibration factors for RQR and N60 qualities with respect to
137Cs is around 10% for both dosemeters, whereas it increases up to 40% for N120 radiation quality.
UPC-ELD tends to lower values with respect to data from the EYE-D, although both dosemeters give
an energy response within the standard requirements. Based on these results, the energy calibration
factor to obtain H p(3) for unknown photon radiation fields typical to IC/IR is calculated as the average
of the calibration factors obtained for RQR5, RQR6, RQR7, RQR8, RQR9 and N60. This proposal
provides a deviation in this range with respect to 137Cs of 5%, calculated as the maximum deviation of
Ncal(Q,Hp(3)) with respect to Ncal(
137Cs), divided by Ncal(
137Cs).
The energy calibration factors are:
For EYE-D: Ncal(Hp(3)) = 5.83 µSv/nC, with an associated relative uncertainty in the range of interest
of 5.9% (k=1).
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Figure 10.2: Relative energy response of UPC-ELD and EYE-D to 137Cs
For UPC-ELD: Ncal(Hp(3)) = 5.57 µSv/nC, with an associated relative uncertainty in the range of
interest of 5.0% (k=1) (see Appendix B). The uncertainty of the EYE-D is larger than the uncertainty of
the UPC-ELD because, as it was decided not to use it in the measurement campaigns, a single detector
was used for the determination of Ncal(Q,Hp(d)).
When the eye-lens dosemeter is used together with a UPC-WBD dosemeter, the radiation quality can
be estimated using the ratio M(10)/M(0.07), and thus a more energy specific calibration factor is used,
as summarized in Table 10.1.
10.1.2 Angular response
Angular response was also evaluated for both UPC-ELD and EYE-D. In this case, irradiations were
limited to RQR6 and N60 qualities. The dosemeters were located at 0◦, 45◦ and 75◦ with respect to the
normal incidence of the beam to the frontal face of the phantom, along the horizontal axis.
The ideal angular response is achieved when the dosemeters fulfill the equation:
Ncal(Q,α)
Ncal(Q, 0)
=
KahpK (3, α)M(0)
KahpK (3, 0)M(α)
= 1 (10.4)
That is:
M(α)
M(0)
=
hpK (3, α)
hpK (3, 0)
(10.5)
Where M(α) is the dosemeter reading for an incident angle α, whilst M(0) is the reading at normal
incidence. It thus follows that the optimal angular response is achieved when the ratio between readings
at a certain angle α and for normal incidence is equal to the ratio between the conversion coefficients
hpK (3, α) and hpK (3, 0). Conversion coefficients for the cylindrical phantom for N60 quality were taken
from Behrens (Behrens, 2012a), while for RQR6 they were taken from Principi et al. (Principi et al.,
2015c).
Figure 10.3, presents the ratio of the readings of the two tested eye lens dosemeters at an angle α
compared with normal incidence for RQR6 and N60. In addition, the theoretical ratio, this is the ratio
of the conversion coefficients, is also represented.
Table 10.2 lists the angular response for the studied configurations and the deviation with respect to
the ideal angular response, which is unity.
In the case of the EYE-D, the largest deviation is 5% for 75◦ and RQR6, whilst for UPC-ELD
a deviation of 8% is observed for 75◦ and both N60 and RQR6 qualities. The performance of the
dosemeters was compared to the requirements of the IEC standard for passive photon dosimetry. The
IEC standard IEC 62387-1 (IEC, 2012) requires that the energy and angular response for any type of
passive photon dosimeters should be within 0.71 and 1.67 at any energy and angle. Both dosemeters
fulfill these requirements.
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Figure 10.3: Angular dependence for UPC-ELD and EYE-D relative to normal incidence
hpK (3, 45)M(0)
hpK (3, 0)M(45)
hpK (3, 75)M(0)
hpK (3, 0)M(75)
Deviation wrt ideal response
45◦ 75◦
N60 UPC-ELD 1.015 1.084 2% 8%
N60 EYE-D 1.006 1.026 1% 3%
RQR6 UPC-ELD 0.992 1.079 -1% 8%
RQR6 EYE-D 0.987 1.048 -1% 5%
Table 10.2: Angular response for UPC-ELD and EYE-D relative to normal incidence and deviation with
respect to the ideal angular response
10.2 Results of the UPC-ELD in the EURADOS 2014 eye lens
intercomparison
Intercomparison exercises dedicated to individual monitoring services are aimed at comparing results with
other participants and improving dosimetry systems. The final check of the performance of the UPC-ELD
system for photon fields typical from medical applications was obtained through the results obtained from
the first intercomparison exercise devoted to eye lens dosemeters, organized by EURADOS (Clairand
et al., 2016). 20 European individual monitoring services from 15 different countries participated in this
exercise. Nine individual monitoring services provided the EYE-D system, while the other participants
provided different systems of various designs. UPC-ELD was also tested during the intercomparison. The
dosemeters were located on the suggested cylindrical phantom for eye lens dose calibration (Gualdrini
et al., 2011). Figure 10.4 shows the different tested types of eye lens dosemeters. The irradiations were
carried out with several photon fields chosen to cover both the energy and angle ranges encountered in
medical workplace using the cylindrical phantom: S-Cs, ISO X-ray narrow series N40, N60, N80 and
RQR6 IEC diagnostic qualities. Finally, irradiations were performed with a realistic field representative
of the scattered field at the level of the operator in IC/IR. They correspond to a field with mean energy
of 42 keV and resolution of 52 keV, produced by a primary X-ray beam of 70 keV and a filtration of 4.5
mmAl + 0.2 mmCu, which corresponds to a mean energy of 48 keV and a resolution of 60 keV (Bordy
et al., 2007). For irradiations with 137Cs and RQR6, different ranges of doses in terms of personal dose
equivalent H p(3) were given. Furthermore, some irradiations were performed at different angles: at 0
◦,
45◦ and 75◦ for RQR6 and at 0◦ and 60◦ for S-Cs. Table 10.3 summarizes the experimental set-ups used
in the intercomparison.
UPC-ELDs were identified in the intercomparison with the code XAH.
Figure 10.5 shows the box plots with minimum, first quartile, median, third quartile and maximum
responses, R, for each participant, anonymously identified, resulting from the intercomparison exercise.
The response of a dosemeter was defined as the value of the dose measured by the participant and
corrected for background and transit dose, H p(3), divided by the reference value given by the irradiation
laboratory.
For the analysis of the global results, the performance limits according to the ISO 14146 standard,
commonly known as trumpet curves, were adopted:
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Figure 10.4: Tested types of dosemeters during EURADOS-2014 eye lens intercomparison
Set-up Radiation quality Number of irradiated dosemeters Range Hp(3) (mSv)
1 S-Cs; 0◦ 2 0.4 - 0.5
2 S-Cs; 0◦ 2 2.0 - 2.2
3 S-Cs; 60◦ 2 2.0 - 2.1
4 N-40; 0◦ 2 3.0 - 3.1
5 N-60; 0◦ 2 3.0 - 3.1
6 N-80; 0◦ 2 3.0 - 3.1
7 RQR6; 0◦ 2 2.6 - 2.7
8 RQR6; 45◦ 2 2.5 - 2.6
9 RQR6; 75◦ 2 2.1 - 2.2
10 Realistic field (Bordy et al., 2007) 2 0.9 - 1.0
Table 10.3: Experimental set-ups for the EURADOS-2014 eye lens intercomparison
Figure 10.5: Distribution of the response R for dosimetry systems from all participants (Clairand et al.,
2016).
1
F
(
1− 2H0
H0 +Hc
)
≤ R ≤ F
(
1 +
H0
2H0 +Hc
)
(10.6)
Hc is the conventional true value, R is the response, F is set equal to 1.5 following the recommendations
of the ICRP 75 report and H0 is the lower limit of the dose range for which the system has been approved
as mentioned in the ISO 14146 standard (ISO, 2000). For this IC, a value of H0 of 0.085 mSv was chosen
for all participants, assuming a lower limit of the dose range of 1mSv in a year, and a monthly issuing
frequency. For the UPC-ELD, the response R as a function of the reference doses Hc is displayed in
Figure 10.6 and the trumpet curves were built up according to the equation Equation 10.6.
Results show that the response provided by the UPC-ELD fulfills the ISO 14146 standard
requirements, as R remains within the trumpet curves for all configurations under study. In general,
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Figure 10.6: Response R as a function of reference doses Hc for the UPC-ELD
17 dosimetry systems out of the 20 participating provided 90% of their response in accordance with the
ISO 14146 standard requirements, which can be considered a globally satisfactory result for this first eye
lens IC. However, a relatively large variability is observed among participants, as the median of responses
ranges from 0.72 to 1.67. The results for the UPC-ELD are in all cases within the IEC 62387-1 and
ISO 14146 requirements. Thus, it can be concluded that it is a suitable system for eye lens dosimetry in
photon fields.
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Chapter 11
Measurements on phantom in a
realistic clinical set-up
The aim of this part of the study is to evaluate different possible approaches in order to have a good
estimate of the eye lens dose during interventional procedures. In particular, the influence of both the
type and the position of the dosemeter has been analysed. Before starting measurements on operators,
measurements on a phantom in a realistic clinical set-up were performed in order to:
• Determine the best position for the eye lens dosemeter (ELD), in other words where the recorded
dose is as close as possible to the dose of the most exposed eye/eye lens (since the ELD cannot be
placed directly on the eye of the operator)
• Compare the UPC-ELD with EYE-D measurements
• Determine the relation between eye lens dose with patient dose measured in terms of DAP or KAP,
in different configurations
• Determine the relation of eye lens dose with whole body quantities, i.e. H p(10) and H p(0.07)
measured with an unprotected WBD
• Determine whether the active personal dosemeter (DoseAware; Philips Medical System, The
Netherlands, http://www.healthcare.philips.com/) can provide a good enough estimate of eye
lens dose
Active personal dosemeters are very useful to optimize procedures and to improve awareness of
personnel exposure. Compared with passive systems, they provide an immediate feedback of the dose
received. However, previous works (Vanhavere et al., 2012) have highlighted some limitations when used
in pulsed radiation fields, in the energy and dose range characteristics of the monitored scattered fields.
In this preliminary study we considered it to be interesting to include the DoseAware active personal
dosemeter (APD) in order to validate its use in the medical campaigns. In fact, if electronic DoseAware
data are comparable with UPC-WBD measurements, they might possibly be used for providing real time
monitoring (the information collected is automatically stored in a centralized local data base).
The manufacturer claims linearity is ensured from 40 µSv·h−1 up to 300 mSv·h−1 and there is a 20%
variation in energy response between 33 keV and 100 keV and reports an angular dependence of more
than 30% for angles greater than 50◦. The energy responses of the dosemeters were previously checked at
a secondary standard calibration laboratory but no specific correction factor was used since the response
was within the manufacturer’s specification. Previous work (Chiriotti et al., 2011) showed differences
with UPC-WBD within 10%-15% in scattered radiation fields used in cardiology.
11.1 Experimental set-up
Measurements were carried out at San Carlos University Hospital in Madrid with a Philips Allura (http:
//www.healthcare.philips.com/) FD-10 X-ray system. Measurements were performed for low-dose
fluoroscopy mode (88-114 kV; HVL 8.0-10mmAl) and image acquisition mode (68-84 kV; HVL 3.5-4.0 mm
Al) and for two projections, Posterior-Anterior (PA) and Left-Lateral (LLAT) or Left-Anterior-Oblique
at 90◦ (LAO-90). When lateral irradiations are performed (LLAT) more penetrating beams are needed
and the voltage of the tube is increased. The beam resulted in a field size of 25cm2 at the level of the
patient’s back surface. Geometric schemes of the two configurations are presented in Figure 11.1, where
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both lateral and top views are presented for PA projection, and Figure 11.2 where a side view is given
for LLAT projection.
(a) PA - Lateral view (b) PA - Top view
Figure 11.1: PA projection
Figure 11.2: LLAT projection - Lateral view
The patient entrance surface air kerma K a was monitored by using a calibrated Radcal ionization
chamber model 20x6-60E connected to an electrometer model 20x26C (Radcal corp. Monrovia.
California. USA, http://www.radcal.com/). The main features of the performed experiments are listed
in Table 11.1.
Id. experiment Mode Added filtration voltage Radcal (mGy) Protection Projection
1 fluo 0.9mmCu+1mmAl 88 kV 45.5 No PA
2 cine – 68kV 77.6 No PA
3 cine – 68kV 245.0 CS, Apron,Collar PA
4 cine – 68kV 253.9 Glasses,Apron,Collar PA
5 fluo 0.9mmCu+1mmAl 88 kV 43.4 No PA
6 cine – 68 kV 92.2 No PA
7 fluo 0.9mmCu+1mmAl 88 kV 45.8 No PA
8 cine – 68 kV 94.5 No PA
9 fluo 0.9mmCu+1mmAl 114 kV 50.0 No LLAT
10 cine – 84 kV 368.24 No LLAT
Table 11.1: Main features of the performed experiments. CS stands for ceiling screen.
A 30·60·20 cm3 PMMA slab phantom on the treatment couch was used to simulate patient-scattered
radiation. The cardiologist was simulated by an anthropomorphic phantom model Rando (The Phantom
laboratory, Salem, NY, USA, http://www.phantomlab.com/), which was situated on the right-hand side
of the X-ray tube at a distance of 90 cm. The UPC-WBD was used as reference dosemeter for H p(0.07)
and H p(10) measurements. They were located on the chest (on the right and left side), on the left
shoulder and at the center of the collar of the Rando phantom. The three APDs were positioned on the
chest, at the top of the UPC-WBD, on the left side of the collar and below the UPC-WBD located on
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the shoulder.
The UPC-ELD batches were located:
• On the left eye (LE)
• On the right eye (RE)
• On the left lateral side of the head (LL), close to the left ear
• On the forehead or middle eye (ME), i.e. between the two eyes
The EYE-D was positioned on the left lateral side of the head. The EYE-D was used only for cases
1 and 2 in Table 11.1. The reference value for H p(3) was the measurement provided by the UPC-ELD
on the left eye. Figure 11.3 (a) clarifies the positioning of the dosemeters, while Figure 11.3 (b) shows
personal protection means (lead apron, glasses and protective collar) used in experiment 4.
(a) Without personal protections (b) With personal protections (Lead glasses, Collar protection,
Lead apron)
Figure 11.3: Positioning of the dosemeters (EYE-D, UPC-ELD, UPC-WBD, active dosemeters) on the
RANDO phantom
Measurements were carried out in two stages. For all cases, the table shielding below the couch was
correctly placed, as, in practice, is generally used by cardiologists. During the first set of measurements
(experiments 1 to 4), the attenuation because of the ceiling suspended screen and of the goggles was
evaluated by doing measurements both when they were used and when they were not. In spite of long
irradiations, when protection was properly used, measurements were close to the detection limit of the
dosemeters, so in the second stage of the study only the table shielding was used. For experiment 4,
when the goggles were used, the LL dosemeter was positioned on the internal side of the goggles, which is
below the lateral protection. A Thermo EPD MK2 electronic personal dosemeter (Thermo Scientific Inc..
US, http://www.thermoscientific.com/) was also used to monitor the scatter radiation in real time
Figure 11.3 (a). The reading of this dosemeter (50-70 µSv) was used to decide when to stop irradiation.
11.2 Optimal ELD positioning for eye lens dose measurement
H p(3) measured with the UPC-ELD situated on the LE is generally considered the best estimate of the
maximum eye lens dose and thus the other measurements are compared to it. In fact, values show that
the most exposed eye for the tested set-up (cardiologist on the left-hand side of the table, PA and LLAT
projections) is the left eye. In Table 11.2 the ratio between the dose measured at the LE, H p(3,LE), and
the doses measured in terms of H p(3) for the other positions, are shown.
59
11.3. DEPENDENCE OF EYE LENS DOSE WITH PATIENT DOSE (KAP)
Id. experiment 1 2 3 4
Mode LD Cine Cine Cine
Projection PA PA PA PA
Protection means CS Go
H p(3,LE)/H p(3,LL) 0.93 1.00 1.09 0.90
H p(3,LE)/H p(3,ME) 1.20 1.34 1.55 0.22
H p(3,LE)/H p(3,RE) 1.49 1.97
Table 11.2: LD: Low-Dose fluoroscopy; Cine: acquisition; CS: ceiling suspended screen; Go: goggles.
Ratio between H p(3,LE), and H p(3) for the other positions
The UPC dosemeter at the LL position provides a good estimate of the eye lens dose at the LE, while
the dosemeters located at the other positions tend to subestimate the dose. Especially, the reference
H p(3) measured on the LE is twice the H p(3) measured by the dosemeter on the right eye for the cine
mode. It is also shown that for the PA projection a dosemeter on the forehead (ME) would provide an
underestimate of more than 20% of the maximum dose to the eye lens, for this configuration. However,
when protection is used, different results may be expected. When the ceiling screen is employed (case
3) the eye lens dosemeter on LL position subestimates the dose measured on the LE. It depends on the
positioning of the ceiling screen in this specific case. Furthermore, ME dose is about four times higher
than LE dose when goggles are used. This is strictly depending on the model and fit of the goggles worn
(see Figure 11.3 (b)).
Table 11.3 summarizes all the ratios of H p(3,LL)/H p(3,LE) both for PA projection (cases 1, 2 and 5
to 8) and LLAT projection (case 9 and 10), collected during the whole study.
H p(3,LL)/H p(3,LE)
Projection Average±sd Range N
PA 1.08±0.05 1.14-0.98 6
LLAT 1.1±0.1 1.18-1.04 2
Table 11.3: H p(3,LL)/H p(3,LE) for PA (cases 1, 2 and 5 to 8) and LLAT (case 9 and 10)
11.3 Dependence of eye lens dose with patient dose (KAP)
Table 11.4 shows the estimated Hlens from H p(3,LE)UPC measurements and the associated standard
uncertainty, u, (k=1) for each set of measurements. Standard uncertainty u is calculated here taking into
account the standard deviation of the two detectors of each UPC-ELD and the standard deviation of the
background correction. Results show great variability for the H p(3)/KAP
1 ratios ranging from 0.1 when
CS is used (highest operator protection) to 6.2 for LLAT projection in fluo mode (highest peak voltage)
for set-up 10. The ratio between H p(3) and the KAP (if the radiation beam size is the same) is generally
higher in low-dose fluoroscopy mode than for image acquisition mode. Likewise, H p(3) is higher for the
LLAT projection than for the PA projection because the operator is closer to the X-ray tube (for the
implemented set-up) and because the beam is more energetic, thus it generates more backscatter.
Id. experiment 1 2 3 4 5 6 7 8 9 10
Mode LD Cine Cine Cine LD Cine LD Cine LD Cine
Projection PA PA PA PA PA PA PA PA LLAT LLAT
Protection means CS Go
KAP (Gy·cm2) 6.2 10.7 33.7 35.0 6.0 12.7 6.5 12.7 6.9 12.7
H p(3)±u (µSv) 20±1 18±2 3±0.6 7±0.6 25±1 27±1 34±3 30±1 43±3 49±6
Hp(3)
KAP
(µSv·Gy−1cm−2) 3.2 1.7 0.1 0.2 4.2 2.1 5.3 2.4 6.2 3.8
Table 11.4: Summary of the ten set of measurements’ conditions and the estimated Hlens and Hlens/KAP.
H p(3) measured by the UPC-ELD on the left eye of the Rando phantom was used as estimate of the
Hlens± combined standard uncertainty (k=1). CS: ceiling suspended screen; Go: goggles
1air kerma-area product (KAP) calculated from the Radcal K a measurement and the field area
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When the ceiling suspended screen was positioned between the X-ray tube and the Rando phantom
(experiment 3) H p(3) ranged between 1-3 µSv, values close to the detection limit of the dosemeters.
Therefore, it was verified that the screen, correctly positioned, provided very good protection for
the operator’s upper part. When goggles were used, but no ceiling suspended screen was employed
(experiment 4), for the same KAP, H p(3) to the left eye and to the side of the goggles was between
7-8 µSv, while on the external left side of the goggles (unprotected) H p(3) was of the order of 50 µSv.
As expected, due to the attenuation of the radiation by the protection, H p(3)/KAP is much lower for
experiments 3 and 4 compared with the other cases. From these results it can be concluded that KAP
will, in general, not be a good parameter for eye lens dose assessment. When used, it must be known
beforehand if protection is being used or not.
11.4 Relation of eye lens dose with whole body dose
A paired sample t-test verified that the mean value of the two quantities H p(10) and H p(0.07) can be
considered equal to within a 95% confidence interval of (-0.29 - 0.44), which means there is no statistical
difference between these two quantities (p=0.7 > 0.05=α.). Thus, the mean value of H p(10) and H p(0.07)
is calculated for each position and compared to H p(3,LE). Table 11.5 summarizes the influence of
UPC-WBDs position in estimating Hlens. It reports the ratio of the different dose measurements in the
selected body positions with H p(3) measured on the left eye. For this evaluation only TLD data were
used although similar conclusions could be derived from DoseAware measurements.
Projection Position
H p(d)position/H p(3,LE)
Average±sd Range N
PA (cases 1, 2, 5, 6, 7, 8)
Chest Left side 1.3±0.3 1.82-0.94 6
Left shoulder 1.9±0.3 2.45-1.61 6
Center of collar 0.9±0.2 1.26-0.78 6
LLAT (cases 9, 10)
Chest Left side 1.8±0.3 2.04-1.62 2
Left shoulder 2.5±0.6 2.91-2.10 2
Center of collar 1.0±0.2 1.19-0.86 2
Table 11.5: Ratios between H p(d) measured at various positions and H p(3) measured at the left eye, for
PA and LLAT projections
The best estimate of H p(3,LE) would be given by H p(10) or H p(0.07) measured by a WBD at a
certain position where the lowest spread of values is achieved. In the case of H p(d,collar)/H p(3,LE) the
standard deviation sd is equal to 0.2 both for PA and LLAT configurations and the value of the ratio is
close to unity. This implies that the whole body dose measured at collar level might be a good estimate of
the dose to the left eye. The left side of the chest seems to be a better position than the left shoulder which
shows a larger overestimate and a larger variability. However, none of the studied positions provide a
better estimate than H p(3) measured at the LL position, as previously shown in Table 11.2. In addition,
it must be kept in mind that these results do not include measurements performed when the ceiling
suspended screen or the lead glasses were used.
11.5 Comparison of whole body and eye lens doses from
different dosimetric systems
It was verified that there was no significant difference (p>0.05) between the UPC-WBD and DoseAware
performance for fluoroscopy and image acquisition mode measurements. Table 11.6 shows the mean
value, standard deviation and range of the ratio between H p(10) measured with DoseAware and with
UPC-WBD considering the different positions and experiments.
To compare the performance of UPC-ELD with standard EYE-D at the same position the ratio
H p(3,LE)UPC/H p(3,LL)EY E−D was also calculated. Because of the good estimate of H p(3) provided by
UPC-ELD, the EYE-D was not used in all experiments. Experiments 3 and 4 (where protection tools
were used) were not included in the calculations because readings were close to the dosemeter detection
limit.
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Average±sd Range N
H p(10)DoseAware/H p(10)UPC−WBD 1.02±0.21 1.35-0.65 24
H p(3)UPC−ELD/H p(3)EY E−D 1.07±0.13 1.28-0.94 8
Table 11.6: Comparison of a) H p(10) measurements with the electronic DoseAware detector and the
UPC-WBD b) H p(3) measurements with the EYE-D holder and the UPC-ELD
11.6 Recommendations for the hospital measurement protocol
The left lateral part of the head is shown to be the optimal site on which to locate the eye lens dosemeter.
In clinical practice, the positioning of the eye lens dosemeter is even more important than in phantom
studies because during the procedures, protection such as the ceiling suspended screen can be moved
and thus will protect only a part of the head/upper body. The eye lens dosemeter therefore has to be
positioned as close as possible to the area to be monitored (the left eye). Consequently, for this study,
the left lateral side will be the optimal position for performing eye lens dose measurements in hospital
campaigns. Details will be provided in section 11.7. Both UPC-ELD and EYE-D supply similar results,
but for simplicity in its use, only the UPC-ELD will be employed in measurements campaigns in hospitals.
As regards the best position to locate the WBDs to be correlated with the eye lens dose, both thyroid and
chest dosemeters provided acceptable results. However, after discussions with the staff to be monitored,
it was agreed to locate the dosemeter at chest level, on the left side of the apron (usually on the pocket
of the apron), as it is more comfortable for the operators to wear it on the thorax than the neck and it
prevents the need to use a different protocol for staff who do not wear thyroid protection.
It is also seen that the DoseAware electronic device responds satisfactorily in realistic fields in
interventional scattered field cardiology, for the studied configurations. When available, electronic devices
will be used together with the passive dosemeter. However, the mean value of H p(10) and H p(0.07) from
the UPC-WBD will be used as a reference for WB dose monitoring.
11.7 Preliminary measurements on physicians
The scope of this part of the study was to confirm that a TLD located on the left side of the head
estimates the maximum dose to the eye lens, as the left eye is the most exposed eye due to it being the
closest to the X-ray tube. Four physicians from Clinico San Carlos Hospital in Madrid participated in
this measurement campaign. Since all of them wore normal glasses, the ELDs were taped on the left
and right lateral eyepieces of the glasses. The monitoring period varied depending on the physicians’
workload, but was generally about two weeks. Data collected are summarized in Table 11.7. Physicians
were identified as phys a, b, c and d. In column 2 and 3 the performed procedures together with the
cumulated KAP during the follow-up period are presented. In column 4, 5 and 6 the dose measured at
the left lateral (LL) and the right lateral (RL) eyepiece of the glasses with the UPC-ELD and the ratio
H p(3,LL)/H p(3,RL) are shown, respectively.
Performed procedures KAP H p(3,LL) H p(3,RL) H p(3,LL)/H p(3,RL)
(Gy·cm2) (µSv) (µSv)
phys a 6 PTCA, 8 diagnostic, 1 Valvuloplasty 1107 653 188 3.5
phys b 8 PTCA, 2 diagnostic 452 140 57 2.5
phys c 5 PTCA, 9 diagnostic 532 378 101 3.7
phys d 1 PTCA, 3 Valvuloplasty 368 383 108 3.6
Table 11.7: Right and left eye lens dose monitoring in 4 physicians. PTCA stands for Percutaneous
transluminal coronary angioplasty
Data show the left eye received doses about 3 times higher than the right eye. Therefore, during the
following campaigns in IC/IR, H p(3) at the right eye will not be measured and only UPC-ELDs will be
used.
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Chapter 12
Measurement campaign in real
clinical conditions
The measurements described in this chapter were performed at four Spanish hospitals: Vall d’Hebron,
Clinico San Carlos, Princesa and Clinica Universidad de Navarra. In total, 24 physicians and 13 nurses
participated. A common protocol was employed for all measurement campaigns.
12.1 General features
According to the conclusions of the preliminary studies on phantom presented in chapter 11 a common
protocol was established to monitor medical staff during clinical procedures. All participants wore
UPC-ELDs and UPC-WBDs which were individually identified. The protocol followed was the same
for all campaigns. The UPC-ELDs were located on the external left side of normal glasses when worn by
the operators. When normal goggles were not worn by the worker, the dosemeter was fixed to the left
side of the cap. Two dosemeters were assigned to each operator when workers wore lead glasses in order
to test their efficiency in protecting the eyes in clinical conditions, . For (b)− and (c)− type glasses,
represented in Figure 12.1, one dosemeter was fixed to the left external lateral part of the eyewear, while
the other was located on the internal side of the lateral protection, beneath the shielding. In the case
of type (a) wraparound glasses, a dosemeter was situated on the external left eye piece, while the other
was located on the internal side of the left front glass, since there is no shield on this side, in a position
that did not produce visual impairment (Figure 12.1 (a), arrow). The left side was chosen because, as
verified in the preliminary tests, it is often the closest side to the X-ray tube and the dose measured is a
good estimate of the maximum eye dose. Uncertainties in H p(3), calculated following the Guide to the
Expression of Uncertainty in Measurement (ISO/IEC, 2008), are of the order of 6% (see Appendix B).
The lower detection limit of the dosemeters in the study is 10 µSv , at a confidence level of 95%. The
WBD for the estimation of the quantities H p(0.07) and H p(10) was located on the lead apron, on the
left side of the thorax.
Data for the estimation of attenuation of lead glasses were collected from six physicians from the
hemodynamic units of three of the four hospitals under study.
(a) Wraparound type lead glasses (b) Lead glasses with side protection(c) Lead glasses with side protection,
but with smaller frontal and lateral
lenses compared with type b glasses
Figure 12.1: Different types of lead glasses
In addition to the above-mentioned dosimeters, all participants wore their own dosemeter from the
official dosimetry service situated under the lead apron, for whole-body monitoring of effective dose.
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Measurements were conducted at the four above mentioned hospitals in Spain. The monitoring
period varied depending on the workload and availability of the participants. Preferably, at least two
measurements were performed for each participant to obtain more data and improve the statistics of the
results. The main features of the campaigns are summarized in Table 12.1.
Hospital Monitoring period Participants Frequency of dosemeter change
Vall d’Hebron 1 week 6 physicians 4 nurses Weekly
(phys 1 to 6; nurses 1 to 4)
Vall d’Hebron 1 week 8 physicians 2 nurses UPC-WBD Daily for phys;
(phys 1 to 4, 6 to 9; nurses 5 and 6) UPC-ELD after each procedure for phys;
WBD and ELD weekly for nurses
Vall d’Hebron 7 weeks 3 physicians 1 nurse Weekly
(phys 3, 9, 10 and nurse 6)
San Carlos 4 weeks 5 physicians Variable, as a function of physicians workload
La Princesa 5 weeks 5 physicians Variable, as a function of physicians workload
C.U.Navarra 5 weeks 4 physicians 7 nurses Weekly
Table 12.1: Monitoring period, number of participants and frequency of dosemeter change
Table 12.2 provides details about which medical field each monitored worker belonged to. P stands
for physicians and N for nurses.
Hospital Hemodynamic Vascular cardiology Endoscopy Electrophysiology
Vall dHebron 10 P, 6 N — — —
San Carlos 5 P — — —
La Princesa 2 P 2 P 1 P —
C.U.Navarra 2 P 2 N 1 P 1 N — 1 P 4 N
Table 12.2: Number and type of participants (P=physicians; N=nurses) depending on the field
12.2 Vall d’Hebron study
The measurements were performed at the Hemodynamic Department at the Vall d’Hebron Hospital in
Barcelona. The department is provided with three different operating rooms with three Philips Allura
X-ray systems: one FD10, one FD10/10 and one Clarity FD10. The total number of participants was
16. The monitoring was divided in three phases, as shown in Table 12.1.
• a first phase lasting one week in which WBD and ELD were changed weekly.
• a second period of one week in which ELDs were changed after each procedure and WBD daily (for
physicians); dosemeters were changed weekly for nurses. The aim of this phase was to analyze the
influence of the type of procedure on the eye lens dose.
• a third period lasting 7 weeks in which monitoring was performed on a weekly basis. It included
three physicians and one nurse. ELDs were changed weekly, both for physicians and nurses. Data
obtained in this third phase will be used to determine annual doses to the eye lens and correlation
with whole body measurements.
During the first two-week monitoring period, detailed data were collected for each procedure thanks
to a careful follow up of the operators’ work. Eye lens dose exposure was monitored for nine physicians
and six nurses. The number of procedures that were followed up was 43 during these first two weeks,
with a total of 60 sets of monitoring data from physicians and 43 sets from nurses. In most procedures
there were two operators and one nurse. This level of detail was not achieved during the third follow-up
(7-weeks period). In this case, the dosemeters were delivered to the workers and changed weekly, when
feasible, as the operators were already familiar with the use of the TLD batches after the first two-week
follow-up period. The number of procedures followed up during the 7-weeks-period was 228. The
main monitored procedures were coronary angiography (CA) and percutaneous transluminal coronary
angioplasty (PTCA). Patients were both adults and children, in the age range 4-80 years old. As
mentioned above, in this hospital only one physician wore lead glasses, whereas all other physicians used
both a lead apron and a thyroid collar. Only one nurse wore the thyroid protection. The frequency of the
usage of personal protective equipment for the 16 participants is shown in Figure 12.2 (a). Furthermore,
it was observed that ceiling suspended screens were frequently not appropriately positioned, or only used
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for a fraction of the time (Figure 12.2 (b)). Sometimes, the screen was not used at all, though available,
because it impeded the physician’s work. Meanwhile, the table shield available under the bed was always
employed.
(a) Use of personal protective equipment (b) Use (%) of the protective screen for the monitored
procedures during the first two-week period
Figure 12.2: Statistics of the use of protective equipment
12.2.1 Data collection
The information acquired during the first two-week monitoring period included:
1. Identification number of the operator
2. Whether the patient was pediatric or adult
3. Tube configuration (monoplane or biplane system)
4. Type of intervention (PTCA, valvuloplasties, )
5. Protection tools used (ceiling suspended screen, lead glasses, thyroid collar)
6. Position along the patient (1st, 2nd and 3rd operator position, according to Figure 12.3)
7. Catheter access route (femoral F or radial R access, on the left or right side)
8. Kerma area product (KAP)
9. Air kerma (Kair)
10. Fluoroscopy time (Tfluo)
11. Whether the operator leaves the room during image acquisition
12. Beginning and end time of the intervention
In Figure 12.3 sketch of a possible configuration is represented: two physicians are in the room, at
the 1st (the closest to the tube) and the 2nd position, while the nurse is at the 3rd position.
An example of the detailed dataset for each monitored procedure performed during the first two weeks
is given in Table 12.3 and Table 12.4.
Table 12.3 corresponds to the first week of monitoring, in which only weekly doses are available, whereas
in Table 12.4 values of eye lens doses per procedure are shown from the second week of follow-up. The
identification numbers of the physicians are listed in column 1. Details on: patient, whether adult or
pediatric; monoplane or biplane tube configuration; type of procedure; use of ceiling screen CS; position
of the physician; catheter access; KAP and air kerma values, the ’in-room’ percentage, which indicates
the fraction of time the monitored person was inside the operating room and time of fluoroscopy; are
given.
Table 12.3 provides measured dose values during the 1st-week follow-up in columns 12 to 14.
In Table 12.4 measured H p(3) per procedure from the second week are given in column 13 and daily
H p(0.07) and H p(10) are listed in columns 14 and 15. In column 16 H p(3) values normalized by KAP
are also indicated.
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Figure 12.3: Positioning of the operators along the patient table. A sketch of a possible configuration is
represented: two physicians are in the room, at the 1st (the closest to the tube) and the 2nd position,
while the nurse is at the 3rd position
ID Patient Tube Procedure Use of CS Position Access KAP mGycm2 K a mGy % In room Tfluo H p(3) µSv H p(0.07) µSv H p(10) µSv
[y=yes
n=no
p=partially]
phys 1
Adult Mono ACTP y 2nd right F 32049 329.066 100%
Adult Mono ACTP+Diagnostic y 1st right R 57%
Adult Mono Valvuloplasty n 1st right F 22972 204.05 100% 15’31”
Adult Mono Valvuloplasty n 1st left F 21824 188.66 58% 16’14”
Adult Mono Diagnostic y 2nd left F 11242 106 100% 15’52”
Adult Mono ACTP+Diagnostic y 2nd left F 161781 2129 100% 37’50”
phys 1 442 132 134
phys 2
Adult Mono Diagnostic y left R 56574 635 0% 11’04”
Adult Mono ACTP+Diagnostic p 2nd left R 185163 3153 100% 40’37”
Adult Mono ACTP+Diagnostic y 2nd right F 224914 3114.42 77% 29’16”
Adult Biplane Diagnostic y 1st left R 168996 997-front; 874-lat 22% 22’19”
Adult Biplane ACTP y 2nd left R 451557 1962-front; 3842-lat 100% 6’44”
Adult Mono ACTP+Diagnostic y 1st left R 45582 827.55 40% 11’14”
Adult Mono Diagnostic y 1st left F 25413 427.33 100% 6’32”
phys 2 485 197 186
phys 3
Pediatric Mono ACTP+Diagnostic y 1st left F 20978 214.4 100% 51’19”
Pediatric Mono ACTP n 1st right F 7158 123.99 100% 8’34”
Pediatric Biplane ACTP n 1st right F 130423 145-front; 1189-lat 100% 15’44”
Pediatric Biplane ACTP n 2nd right F 202161 190-front; 1704-lat 100% 23’35”
phys 3 1421 318 287
phys 4
Adult Mono Valvuloplasty n 2nd right F 22972 204.05 100% 15’31”
Adult Mono Valvuloplasty n 1st/2nd left F 21824 188.66 100% 16’14”
phys 4 62 12 1
phys 5
Adult Mono ACTP+Diagnostic y 1st/2nd right R 37%
Adult Mono ACTP+Diagnostic y 2nd left R 136292 1753.53 100% 13’19”
Adult Mono Diagnostic y 1st right R 4661 33.345 100% 2’19”
Adult Mono Diagnostic y 1st left R 44747 633.879 100% 4’51”
Adult Mono ACTP+Diagnostic y 1st left R 108034 1256.73 100% 13’
Adult Mono Diagnostic p 2nd left F 11242 106 100% 15’52”
Adult Mono ACTP+Diagnostic y 2nd left R 161781 2129 100% 37’50”
Adult Mono Diagnostic y 1st left R 17562 269 100% 6’12”
Adult Mono Diagnostic y 1st left F 12191 199.75 100% 2’7”
phys 5 404 173 171
phys 6
Adult Mono Diagnostic y 2nd right F 64509 742.65 50%
Adult Mono Diagnostic y 1st left R 56574 635 100% 11’04”
Adult Mono ACTP+Diagnostic y 2nd left R 185163 3153 75% 40’37”
Adult Mono Diagnostic p 1st/2nd left R 45582 827.55 100% 11’14”
phys 6 149 71 70
Table 12.3: Data sheet for physicians monitored during week 1. PTCA stands for Percutaneous
transluminal coronary angioplasty; F or R access means either femoral or radial artery access of the
catheter
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ID Patient Tube Procedure Use of CS Position Access KAP mGycm2 K a mGy % In room Tfluo H p(3) µSv H p(0.07) µSv H p(10) µSv H p(3)/KAP
[y=yes (µSv Gy−1cm−2)
n=no
p=partially]
phys 1
day 1 Adult Mono ACTP n 2nd right F 259884 760.86 100% 14’55” 189 0.7
Adult Biplane ACTP+Diagnostic y 1st right F 73143 310 ap; 558 lat 100% 5’54” 118 1.6
day 1 150 156
day 2 Adult Biplane ACTP y 1st right F 161407 458 ap; 1036 lat 100% 24’31” 460 2.9
Adult Biplane Valvuloplastia n 1st/2nd right F 394562 954 ap; 2076 lat 100% 39’20” 572 1.4
day 2 788 806
phys 2
day 1 Adult Mono Diagnostic y 2nd left R 52664 730 50% 19’13” 14 0.54
day 1 15 13
phys 3
day 1 Pediatric Mono Biopsia n 2nd Jugular 2164 34 50% 8’44” 13 6.1
Pediatric Biplane Diagnostic n 2nd right F 4375 33 ap; ? Lat 100% 13’31” 9 2.1
day 1 18 15
day 3 Pediatric Mono ACTP y 1st/2nd right F 98602 358.96 100% 23’09” 267 2.7
Pediatric Mono ACTP n 1st right F 9634 81.85 100% 15’09” 37 3.8
day 3 50 51
phys 4
day 4 Adult Mono ACTP n 1st/2nd left R 203681 3036 75% 30’45” 120 0.8
Adult Mono ACTP+Diagnostic y 1st/2nd right R 220695 3873 50% 19’54” 66 0.6
day 4 75 81
phys 6
day 2 Adult Mono Diagnostic p 1st/2nd left R 29932 480 100% 10’04” 53 1.8
Adult Mono Diagnostic y 1st left R 10255 159 100% 4’26” 20 2.0
Adult Biplane ACTP+Diagnostic y 1st left R 70
day 2 99 97
day 3 Adult Mono Diagnostic y 1st left R 42060 697 100% 5’56” 79 1.9
Adult Mono Diagnostic y 1st left R 21367 367 100% 6’25” 31 1.5
Adult Mono Diagnostic y 1st/2nd left R 52664 730 100% 19’13” 170 3.2
day 3 332 321
day 4 Adult Biplane ACTP n 1st/2nd right F 161407 458 ap; 1036 lat 100% 24’31” 21 0.1
Adult Mono ACTP+Diagnostic y 1st/2nd right R 220695 3873 50% 19’54” 50 0.4
day 4 63 65
phys 7
day 1 Adult Mono Diagnostic y 1st right R 9231 144 100% 8’31” 19 2.0
Adult Mono Diagnostic y 1st left R 12782 157 100% 4’09” 23 1.8
Adult Biplane ACTP+Diagnostic y 1st right R 102109 1496 100% 27’46” 73 0.7
day 1 49 46
day 2 Adult Mono Diagnostic p 1st left R 29932 480 50% 10’04” 8 0.5
Adult Mono ACTP+Diagnostic y 1st left R 157
day 2 29 32
day 4 Adult Biplane ACTP y 1st left R 73109 1238 100% 16’04” 77 1.0
Adult Mono ACTP+Diagnostic y 1st/2nd right R 220695 3873 50% 19’54” 97 0.9
day 4 83 91
phys 8
day 1 Pediatric Mono ACTP y 1st/2nd right F 98602 358.96 100% 23’09” 251 2.5
day 1 36 37
phys 9
day 2 Adult Mono ACTP n 1st right F 259884 760.86 100% 14’55” 782 3.0
day 2 47 52
day 3 Adult Mono Diagnostic y 1st left R 52664 730 25% 19’13” 28 0.5
Adult Mono ACTP y 1st right R 118959 1300 100% 15’49” 132 1.1
day 3 30 27
day 4 Adult Mono ACTP n 1st/2nd left R 203681 3036 100% 30’45” 231 1.1
day 4 34 37
Table 12.4: Data sheet for physicians monitored during week 2
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Two physicians and one nurse that had participated in the second week follow-up participated in a
third follow-up phase. An additional physician (phys 10), who was wearing lead glasses, wraparound
style joined in the study. Table 12.5 shows data of weekly measured eye lens doses, in this last phase.
ID Patient N Procedures KAP (Gycm2) H p(3) (µSv) H p(0.07) (µSv) H p(10) (µSv) H p(3)/KAP H p(3)/N
(µSv Gy−1cm−2) (µSv proc−1)
week 1
phys 3 Pediatric 3 62
phys 9 Adult 21 3294 2934 851 791 0.9 140
phys 10 Adult 5 1614 3608 683 738 2.2 722
nurse 6 13 1520 156 161 159 0.1 12
week 2
phys 3 Pediatric 2 107 664 1112 1188 4 133
phys 9 Adult 20 2924 1749 1326 1448 0.6 87
phys 10 Adult 2 1168 1395 310 301 1.2 698
nurse 6 10 787 89 110 88 0.1 9
week 3
phys 3 Pediatric 3 112
phys 9 Adult 18 1294 1416 225 230 1.1 79
phys 10 Adult 5 795 905 199 176 1.1 181
nurse 6 7 530 79 81 75 0.1 11
week 4+5
phys 3 Pediatric 2 30 711 5 168
phys 9 Adult 37 3669 1187 603 627 0.3 32
phys 10 Adult 8 2397 1596 621 572 0.7 199
nurse 6 17 1740 349 229 202 0.2 21
week 6+7
phys 3 Pediatric 3 208 841 4 280
phys 9 Adult 35 3271 1267 422 421 0.4 36
phys 10 Adult 8 2766 1517 482 486 0.5 190
nurse 6 9 756 66 63 55 0.1 7
Table 12.5: Data collected from the third follow-up period
H p(3) for phys 10 shown in Table 12.5 corresponds to the reading from the UPC-ELD worn on
the unprotected part of the glasses. Phys 3 (pediatric) did not change his dosemeter after week 1 and
week 3, thus the registered measurements of week 2 and week 4 represented the cumulative dose for two
consecutive weeks (weeks 1 and 2, and weeks 3 and 4). Hence, Hp(3) per unit KAP (column 9) and
H p(3) divided by the number of procedures (column 10) is obtained as the cumulative H p(3) in the two
consecutive weeks divided by the corresponding KAP or number of performed procedures during the
two-week monitored period, respectively.
12.2.2 Data analysis for the 1st and 2nd follow-up
Mean eye lens dose <H p(3)> per procedure (in µSv) obtained from the first week of monitoring (week 1)
and the second week of monitoring (week 2) are shown for each participant in Table 12.6. <H p(3)> was
obtained as the sum of all H p(3) per procedure and divided by the number of the monitored procedures
per person. H p(3), H p(0.07), H p(10) and KAP, cumulated during week 1 and 2, are also listed. Ratios
of H p(3)/H p(0.07) and H p(0.07)/H p(10) are given for further consideration. <H p(3)>, calculated over
two consecutive working weeks, shows high variability even for the same physician.
phys 1 phys 2 phys 3 phys 4 phys 5 phys 6 phys 7 phys 8 phys 9
<H p(3)> week 1 (µSv) 74 69 355 31 45 37
H p(3)cumulated week 1 (µSv) 442 485 1421 62 404 149
H p(0.07)cumulated week 1 (µSv) 132 197 318 12 173 71
H p(10)cumulated week 1 (µSv) 134 186 287 1 171 70
KAPcumulated (Gy cm
2) 343 891 361 45 563 273
H p(3)/H p(0.07) 3.3 2.5 4.5 5.3 2.3 2.1
H p(0.07)/H p(10) 1 1.1 1.1 8.7 1 1
H p(3)/KAP (µSv Gy
−1cm−2) 1.29 0.54 3.94 1.38 0.72 0.55
<H p(3)> week 2 (µSv) 335 14 81 93 62 65 251 130
H p(3)cumulated week 2 (µSv) 1339 14 326 185 494 453 251 1173
H p(0.07)cumulated week 2 (µSv) 938 15 68 75 494 161 36 111
H p(10)cumulated week 2 (µSv) 962 13 66 81 483 169 37 115
KAPcumulated (Gy cm
2) 889 26 114 263 482 370 99 596
H p(3)/H p(0.07) 1.4 0.9 4.8 2.5 1 2.8 7.1 10.6
H p(0.07)/H p(10) 1 1.1 1 0.9 1 1 1 1
H p(3)/KAP (µSv Gy
−1cm−2) 1.51 0.54 2.86 0.7 1.02 1.23 2.54 1.97
Table 12.6: H p(3) per procedure, cumulated H p(3), H p(0.07), H p(10), KAP and H p(3)/H p(0.07),
H p(0.07)/H p(10), H p(3)/KAP during week 1 and 2
Large differences in <H p(3)> between the two weeks were observed for most of the participants. Some
of the differences, in particular, the high <H p(3)> value of phys 1 second week and phys 3 first week,
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can be explained by analyzing the operations performed. During the second week phys 1 performed an
infrequent, lengthy procedure which entailed a recorded H p(3) higher than the cumulative eye lens dose
during the first week (572 µSv in one single procedure on day 2 of the second week vs. 442 µSv cumulated
during the first week). Thus this value is considered an outlier and disregarded for the estimation of annual
eye lens dose. As regards phys 3, in the first week he was the only physician in the room, while during
the second week he worked as the second position operator.
High variability in the H p(3)cumulated is also highlighted. This is associated with the weekly workload,
which is generally largely variable through the year, and also to the complexity of the procedures. Higher
H p(3) usually corresponds to lengthy procedures, which generally require large fluoroscopy times, hence
high KAP. The variation of KAP between the two weeks is about a factor of 3: 889 vs. 241 Gy cm2
and 361 vs. 114 Gy cm2 for phys 1 and phys 3 respectively. H p(10)cumulated and H p(0.07)cumulated are
also listed in Table 12.6. No statistical differences were observed between H p(10) and H p(0.07) (p =
0.54), except for phys 4 who presented an unexpected H p(0.07)/H p(10) ratio of 8.7. Accordingly, dose
values from phys 4 were disregarded when analyzing the relation between H p(3) and whole body doses.
Large differences are observed between H p(3)/H p(0.07) ratios, with values ranging from 0.9 to 10.6. The
range of variation of these values is broader than that obtained with measurements on phantoms. This
difference is associated with the fact that in clinical conditions more parameters vary simultaneously.
For instance, the large variability of <H p(3)> and H p(3)/H p(0.07) may be explained by the fact that
the use of radiation protection tools in routine practice is not always appropriate. The ceiling suspended
screen provides good protection, but it is not always well placed to protect the eyes. The box plot
in Figure 12.4 shows the distribution of KAP per procedure for all physicians, for the second week of
monitoring, when data from single procedures were available for both KAP and H p(3). Figure 12.5 also
provides the distribution of H p(3) normalized by the corresponding KAP for single procedures. When
KAP was not registered and when H p(3) values were below the detection limit of 10 µSv, data were
disregarded and not included in the figures. KAP can be defined as an indicator of the complexity
of the procedure, and is highly variable even for the same physician. Data for phys 3 show that even
though procedures do not require particularly large fluoroscopy time and KAP, high H p(3)/KAP ratios
are recorded. Phys 3 performs pediatric interventions and thus is usually closer to the tube because of
the small size of the patient. He also uses the biplane system more frequently and often does not employ
the ceiling suspended screen. This consequently leads to higher eye lens doses, even though the amount
of KAP is the same. Therefore, the length and complexity of the procedure may be indicated by the
KAP values, but there are other parameters that also affect the dose. Hence, from these preliminary
considerations, KAP cannot be considered to be an exhaustive indicator of the eye lens dose.
Figure 12.4: Box plot of the distribution of KAP per procedure for all physicians monitored during the
second week
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Figure 12.5: Box plot of the distribution of H p(3)/KAP per procedure for all physicians monitored during
the second week
12.2.2.1 Effect of the position of the operator, patient size and ceiling suspended screen
use on eye lens dose and access route
One of the main limitations in analyzing IC/IR personal monitoring data is the multi-parametric
dependence of dose on other factors, such as:
• The position of the operator with respect to the source or with respect to other operators in the
room.
• The use of protection tools, such as personal or shielding equipment installed in the room.
• The duration and difficulty of the intervention, which enlarge the fluoroscopy time (it also depends
on the experience of the operators).
• The intensity and characteristics of the radiation field.
Thus, the parameters influencing the dose vary simultaneously during a single procedure and there
is also variation among procedures. The non-static configuration of the operator and of the ceiling
suspended screens introduces variability. Some of these parameters have been taken into account for data
analysis.
Table 12.7 presents mean, standard deviation and range of H p(3)/KAP values per procedure for
physicians, and distinguishes between:
• Pediatric physicians and non-pediatric ones (lines 3 and 4)
• Radial, femoral and jugular access (lines 5 to 7)
• Physicians at the 1st or 2nd position (line 10).
To increase the number of data, values from week 1 and 2 were considered. The t-test was used
to verify that the differences found in the dataset presented in Table 12.7 have statistical significance.
Firstly, normality of the data distribution was proven. The Shapito-Wilk test was used to verify if the
distribution of the data is normal when the sample number was less than 50. If significance is greater than
0.05, then a Gaussian distribution can be assumed. In all cases, the condition of a normal distribution
was fulfilled, except for the operator at the second position. In this case, significance was below 0.05
(0.008) and the Mann-Whitney U test was used instead of the t-test.
The position of the operators in the room next to the patient plays an important role in understanding the
collected doses: generally, the closer they are to the source, the larger the dose. During this measurement
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campaign, two physicians and one nurse were usually inside the operating room during the intervention.
The presence of two physicians is determined by 1− the complexity of the procedure. In this case, two
experienced physicians are in the room; or 2− the training of physicians with only a few (or no) years of
experience. In this case, one inexperienced physician and one experienced physician are in the room, at
the 1st and 2nd position, respectively. The 1st position operator is the physician who stands closest to the
X-ray tube. The nurse is generally located at the patient’s feet (3rd position). Furthermore, apart from
the positioning with respect to the operators in the room, the location of the physician performing the
procedure depends on the size of the patient (whether pediatric or adult) and the preferred access route
(radial, femoral or jugular). Another limitation when evaluating the results is the use and positioning of
the room protection equipment, especially the ceiling suspended screen.
H p(3)/KAP (µSv Gy
−1cm−2)
Mean Max Min Sd N p (2-tallies)
patient
Pediatric 3.5 6.1 2.1 1.4 6 0.001
Non pediatric 1.3 3.2 0.1 0.8 29
access
Radial 1.3 3.2 0.5 0.7 18 0.023
Femoral 2.1 3.8 0.1 1.1 10
Jugular 6.1 1
H p(3)/KAP 1
st position/ H p(3)/KAP 2
nd position
Mean Max Min Sd N p (2-tallies)
1st/2nd 4 6.4 1.5 2.3 7 0.038
Table 12.7: Mean, maximum, minimum, standard deviation of H p(3)/KAP mean and number N of
samples for pediatric/non pediatric, different access and relative position
Data show a difference between eye lens dose for physicians working in pediatric units and those
who usually work with adults of a factor 2.7. The maximum H p(3)/KAP of 6.1 for pediatric patients
corresponds to an operation with jugular access. In this specific case, the physician had to stay very
close to the tube, and the presence of the screen would have disturbed his work. Sometimes, in the case
of pediatric intervention, the use of the protective screen is found cumbersome by the operators and is
indeed not used. This fact contributes to higher H p(3)/KAP. As regards the access route, although
data from the bibliography (Vanhavere et al., 2011) state that eye lens doses are usually lower when
catheter access is carried out on the femoral route rather than for radial access, due to the greater
distance from the source (even though when ceiling screen is present the difference is not statistically
significant); data from the present work show the opposite. The reason may lie in the fact that femoral
access is preferred by experienced physicians who, on the other hand, do not use protective screens as
often as inexperienced physicians do. The use of biplane system was preferred to monoplane tube by
Phys 1, who show high H p(3)/KAP . Furthermore, during this monitoring period, the radial route was
never used by pediatric physicians, who were physicians that received the highest eye lens dose levels per
unit KAP. In summary, we believe that our sample is too small to draw conclusions on the influence of
catheter access, and is an example of the difficulties encountered in generalizing observations from one
hospital to another.
The position of the operator, if two physicians are present in the operating room, also affects the dose.
On average, the operators at the 2nd position receive a dose to the eye lens that is 4 times lower than
the operators at the 1st position. This was found for all 7 monitored interventions where 1st and 2nd
operators were both present and monitored. During the second week follow-up, the whole interventional
procedure was witnessed by the author of this thesis and the use of the suspended shield was registered.
The distribution of H p(3)/KAP collected for single procedures is represented in Figure 12.6, data were
separated on whether the shield (suspended screen) was employed or not. H p(3) values lower than
10 µSv were disregarded for this analysis as they are close to the lower detection limit. Operators at
the first position and the second position together with nurses are analyzed separately, in the light of
previous results. As the nurse H p(3) values per procedure were not available, H p(3)/KAP were obtained
from weekly values. When the operators moved between the first and second position, the most frequent
position was chosen; if the time at the second and at the first position was the same, the value was
disregarded.
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Figure 12.6: Distribution of H p(3) per unit KAP for: operator at first position, shielded by the ceiling
suspended screen (1 shield); operator at first position, unshielded (1 no shield); operator at second
position, shielded (2 shield); operator at second position, unshielded (2 no shield); nurses, considered
as being independent of the shielding (nurse)
The distribution shows that nurses clearly receive the lowest doses, followed by the operator at the
second position. There is no clear trend for physicians at the second position. No differences are observed
whether the ceiling suspended screen was used or not (p = 0.8) for nurses or second position operators.
Operators at the first position that do not use room shielding are the ones that received the highest
amount of scattered radiation to the eyes, even though only two measurements are available. The t-test
proves that the difference between 1 s and 1 n is statistically significant (p = 0.01). Equal variances
are assumed for these tests, as the number of samples is small. Operators at the second position are
compared with the group of nurses, with the use of the screen being disregarded. A t-test analysis shows
that no statistical difference (or very weak significance) is seen between these two groups (nurses and the
operator at the second position, p = 0.05). The descriptive statistics are given in Table 12.8.
Position N Mean sd Median Min Max
H p(3)/KAP (µSv Gy
−1cm−2)
1 n 2 3.41 0.56 3.41 3.01 3.8
1 s 17 1.69 0.82 1.77 0.52 3.23
2 n 3 0.55 0.36 0.73 0.13 0.78
2 s 2 0.49 0.06 0.49 0.45 0.54
n 4 0.18 0.03 0.17 0.14 0.21
Table 12.8: Descriptive statistics depending on the position of the operators (1 or 2) and on the use or
not of the ceiling suspended screen ( s or n)
The database demonstrates a reduction of eye lens dose by a factor of 2.2 when the ceiling suspended
shield is used, obtained as (<H p(3)>1 noshield/KAP) /(<H p(3)>1 shield/KAP) for the operator at the
first position. The attenuation provided by the screen is not as high as expected, considering that an
attenuation factor of 17 was calculated for measurements on a phantom.
12.2.2.2 Estimation of annual eye lens dose
Annual eye lens doses were extrapolated from measured H p(3) and the annual workload for all monitored
physicians and nurses was provided by the hospital. Table 12.9 summarizes the mean measured H p(3)
per procedure (<H p(3)/N>) and the corresponding standard deviation (1 sd) for the nine physicians
during the follow-up period corresponding to the two weeks of monitoring. The estimated annual eye
lens dose is then obtained by multiplying <H p(3)/N> by the number Nyear of procedures performed in
one year.
Data show that four physicians out of nine exceeded the new recommended limit of 20 mSv y−1.
<H p(3)/N> ranges from 42 to 251 µSv procedure
−1, while the estimated annual doses range between
8 and 61 mSv y−1. Large variability of the measured H p(3)/N is observed, as previously assessed. The
standard deviation of H p(3)/N is of the order of 80%, even for the same physician. This variability is
mainly associated with the high KAP values recorded in some procedures, where a long fluoroscopy time
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<H p(3)/N> ± 1 sd (µSv) Nyear H p(3)year (mSv)
Phys 1 164±129 369 61
Phys 2 42±39 303 13
Phys 3 218±163 149 32
Phys 4 62±45 253 16
Phys 5 45±42 182 8
Phys 6 49±46 253 12
Phys 7 65±53 325 21
Phys 8 251±187 77 19
Phys 9 130±102 385 50
Table 12.9: Mean measured H p(3) per procedure ± 1 sd, number of procedures per year Nyear and
estimated annual dose for physicians based on the first follow-up
is required, and to the inappropriate use of shielding. Two values of H p(3) equal to 780 and 540 µSv
were removed to derive the annual dose, since they were considered to be outliers, and not considered
to be significant of standard procedures. If these values had been included, the estimated annual dose
would have increased up to 75 mSv for physician 1 and up to 113 mSv for physician 9. This highlights
the fact that a larger period of monitoring is needed for a more reliable estimate of the annual eye lens
dose. Table 12.10 presents the estimated annual eye lens dose for nurses. In this case, none of the nurses
exceeds the recommended 20 mSv y−1 and the range of variability among the different monitored nurses
is small.
H p(3)/N (µSv) Nyear H p(3)year (mSv)
Nurse 1 11 209 2
Nurse 2 18 193 3
Nurse 3 14 171 2
Nurse 4 22 105 2
Nurse 5 13 176 2
Nurse 6 24 171 4
Table 12.10: H p(3) divided by the number of procedures N, number of procedures per year and estimated
annual dose for nurses
12.2.3 Data analysis for the 3rd follow-up period
Previous data analysis highlights the influence of the chosen monitoring period in dose assessment. As
the workload varies from week to week, it is difficult to estimate annual doses if short monitoring periods
are used and it is possible to run into large over or underestimation of the annual eye lens dose. For
this reason, monitoring over a longer period of seven weeks was undertaken and annual doses obtained
from the third follow-up period are compared with previous results. Table 12.11 provides the mean and
standard deviation of H p(3) per procedure, number of procedures per year and estimated annual H p(3)
for the third follow-up period, which lasted for 7 consecutive weeks.
H p(3)/N ± 1 sd (µSv) Nyear H p(3)year (mSv)
Phys 3 171±83 149 25
Phys 9 65±44 385 25
Phys 10* 56±18 191 11
Nurse 6 13±5 171 2
Table 12.11: H p(3) divided by the number of procedures ± 1sd (third follow-up), number of procedures
per year and estimated annual dose values. *Phys 10 wore lead goggles, H p(3) was estimated by using
the dosemeter in the internal part
In this case, two physicians out of three exceed the 20 mSv y−1. The mean H p(3) per procedure for
phys 3 and 9 was lower than in the first two-week follow-up. The longer the measuring period, the more
reliable the estimation of annual H p(3). Table 12.11 highlights the fact that the standard deviations
associated with H p(3) per procedure for a weekly monitoring period are lower when compared with those
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in Table 12.9 for a shorter monitoring period. Results in Table 12.9 and Table 12.11 show that for all
monitored physicians the estimated annual eye lens dose exceeds 3/10th of the recommended limit of 20
mSv, which corresponds to 6 mSv. Thus, regular monitoring is highly recommended. This is not the case
for nurses, whose annual dose is always below 6 mSv.
The attenuation factor due to the use of lead goggles for phys 10 was estimated weekly, along the 7-week
period (3 data values available). The mean ratio between H p(3) measured of the external left earpiece
and behind the lead glass of the goggles is 3.5 and ranges from 2.5 to 4.8.
12.3 Measurement campaign at other Spanish hospitals
Eye lens doses and whole body doses were measured at other Spanish hospitals following the same protocol
as the one employed for the 3rd phase of the Vall d’Hebron study. In this case, data are not as detailed
as previously described for the first two-week follow-up. Dosemeters were delivered to the operators who
used and returned them after an established period of time, shown in Table 12.1. The main aims at this
point were: 1− The comparison of H p(3) with H p(0.07) or H p(10); 2− The comparison of H p(3) with
KAP; 3− the estimation of annual eye lens dose from data collected and annual workload.
12.3.1 Correlation with whole body quantities and KAP
One of the aims of this study was to determine whether the measured eye lens dose can be correlated
to whole body doses or KAP. All available weekly data from our database are used for this analysis.
Thus, data from single procedures from week 1 and week 2 follow-ups at Vall d’Hebron have been added
to obtain weekly data. Physicians and nurses were studied separately. WBD gave very close values of
H p(10) and H p(0.07) for the same measurement. No statistical differences were observed (p > 0.05).
Therefore, both quantities could be used to verify the correlation with H p(3). H p(0.07) was chosen.
Figure 12.7 represents H p(3) measured outside the lead glasses as a function of H p(0.07) measured on
the lead apron for physicians for each of the hospitals that participated in the study. A least square fit
was performed to derive the linear relationship between H p(0.07) and H p(3), without intercept. The
slope of the line was considered the best correction factor to assess H p(3) from H p(0.07) measurements.
The square of the Pearson coefficient (R2) is used to measure the strength of the linear relationship
between H p(3) and H p(0.07). The analysis of data from the Vall d’Hebron Hospital show statistically
significant differences between the eye lens dose for pediatric physicians and no- pediatric ones. Also
the position of the operator, whether at first or second position, entails differences in the exposure and
thus in the eye lens equivalent dose (see subsubsection 12.2.2.1). Thus, only data for physicians at first
position, excluding pediatric physicians, were considered for Vall d’Hebron hospital in this comparison.
The fitted equation and R2 are indicated in the figures.
Figure 12.8 represents H p(3) measured outside the lead glasses as a function of H p(0.07) measured on
the lead apron for nurses for the two hospitals where nurses were monitored. H p(3) better correlates
with H p(0.07) for nurses (R
2 = 0.8, 0.9) than for physicians (R2 = 0.7-0.9), while the ratio between
H p(3) and H p(0.07) was found to be close to one. In fact, for nurses, the trend in data is similar for
both hospitals. Correlations with KAP were also analysed. Figure 12.9 and Figure 12.10 show the
experimental data, the fitted equation and the R2. The correlation of H p(3) with respect to KAP
is, in general, worse than with H p(0.07). R
2 ranges between 0.5 and 0.7 for physicians and it is 0.5
for nurses. The ratio between H p(3)out and H p(0.07) and the ratio between H p(3)out and KAP are
listed in Table 12.12 and Table 12.13 for both physicians and nurses, respectively. Mean, maximum,
minimum, standard deviation sd and standard deviation of the mean sdx¯, median and N values are
tabulated for each ratio. The value N stands for the number of data values collected (not for participants).
Data from Table 12.12 for H p(3)out/H p(0.07) show variability of the mean ratios for physicians
at each hospital, within 11% and 35%. Except for H p(3)out/H p(0.07) for Navarra hospital which
presents the largest variability, there is a good consistency between the mean and the median. The
highest H p(3)/H p(0.07) is obtained for the Vall d’Hebron Hospital. Although we cannot explain this
difference between this hospital and data from other hospitals, the main discrepancy observed during
the measurement campaigns was the unusual and in some cases misplaced positioning of the ceiling
suspended screen at the Vall d’Hebron Hospital. This latter fact could mean that the thorax may
be better protected than the head and high H p(3)out/H p(0.07) ratios are justified. Furthermore, the
biplane system was employed in some cases. As regards H p(3)out/KAP ratios, the spread of values for
physicians ranges from 11 and 23% and mean values range from 0.6 to 1.9.
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Figure 12.7: Relation between H p(3) measured outside the lead glasses H p(3)out and H p(0.07) measured
on the lead apron for physicians for the four hospitals in the study
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Figure 12.8: Relation between H p(3) measured outside the lead glasses H p(3)out and H p(0.07) measured
on the lead apron for nurses, for the two hospital in the study
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Figure 12.9: Relation between H p(3) measured outside the lead glasses H p(3)out and KAP for all
physicians from the four hospitals under study
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Figure 12.10: Relation between H p(3) measured outside the lead glasses H p(3)out and KAP for nurses,
for the two hospital in the study
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Vall d’Hebron Navarra Princesa San Carlos
only no pediatric-1st operator
Hp(3)out
Hp(0.07)
Hp(3)out
KAP
Hp(3)out
Hp(0.07)
Hp(3)out
KAP
Hp(3)out
Hp(0.07)
Hp(3)out
KAP
Hp(3)out
Hp(0.07)
Hp(3)out
KAP
Mean 2.6 1.9 1.6 0.9 0.7 0.6 0.78 0.7
Max 6.8 3.8 6.0 1.8 1.1 1.1 0.96 1.0
Min 0.8 0.4 0.5 0.1 0.4 0.2 0.56 0.3
sd 1.7 0.9 1.7 0.6 0.3 0.3 0.18 0.3
sdx¯ (%) 15% 11% 35% 19% 11% 21% 12% 23%
Median 2.2 1.8 1.1 1.0 0.8 0.8 0.8 0.7
N 20 18 9 10 10 8 4 4
Table 12.12: Mean, maximum, minimum, standard deviations sd and sdx¯ (%), median and N values
of the ratios between H p(3)out and H p(0.07) and between H p(3)out (in µSv) and KAP (in Gycm
2) for
physicians
Vall d’Hebron Navarra
H p(3)out/H p(0.07) H p(3)out/KAP H p(3)out/H p(0.07) H p(3)out/KAP
Mean 1.27 0.42 1.26 0.48
Max 2.43 3.2 1.9 1.56
Min 0.81 0.08 0.7 0.04
sd 0.5 0.92 0.38 0.41
sdx¯ (%) 12% 66% 7% 20%
median 1.04 0.15 1.15 0.53
N 11 11 7 7
Table 12.13: Mean, maximum, minimum, standard deviations sd and sdx¯ (%), median and N values
of the ratios between H p(3)out and H p(0.07) and between H p(3)out (in µSv) and KAP (in Gycm
2) for
nurses
Nurses are exposed to a more homogeneous radiation field than physicians because of different proximities
to the source. Mean H p(3)out/H p(0.07) is close to unity, and a low spread of values is observed (7%
and 12% for Navarra and the Vall d’Hebron Hospitals, respectively). However, as regards the relation
between H p(3) and KAP, the variability is higher than with physician and the correlation worst, in
particular in the case of Vall d’Hebron. This is due to the fact that, in general, the increase in KAP is
related to an increase of complexity of the clinical procedure and this has higher impact on physicians’
doses than on nurses’.
12.3.2 Estimation of attenuation coefficients for lead glasses
The protection efficiency of the lead glasses was estimated as the correction factor (CF) defined as the
ratio of the dose to the eyes when lead glasses were used and when they were not:
CF =
Hp(3)in
Hp(3)out
(12.1)
Measured CF in real clinical conditions for types of lead glasses shown in Figure 12.1 are presented in
Table 12.14. The number of collected data values are shown in line 6. For the wraparound lead glasses
(Figure 12.1 (a)), the measured CF ranged between 0.21 and 0.41, with a mean value of 0.31. Meanwhile,
for the (b) and (c) models, the CF ranged from 0.25 to 0.72, with a mean value of 0.37. The highest
CF (0.72), which indicates the lowest protection efficiency, belongs to the (c) model that has the least
efficient protection design with smaller frontal and lateral lenses when compared to the other glasses. The
mean CF is about 0.5 (i.e. they halve the doses) for Type (c) glasses, while for the (a) and (b) models it
is approximately 0.3 (i.e. they reduce dose to 1/3).
12.3.3 Estimation of annual eye lens dose
The estimated annual dose is calculated for San Carlos, Navarra and Princesa Hospitals Table 12.15.
Values of H p(3)/N (µSv procedure
−1) are multiplied by the number of procedures per year Nyear to
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CF
Glasses model
Wrap around glasses Lateral shielding - large lenses Lateral shielding - small lenses
Figure 12.1 (a) Figure 12.1 (b) Figure 12.1 (c)
Mean 0.31 0.32 0.54
Min 0.21 0.25 0.36
Max 0.41 0.52 0.72
N 3 7 3
Table 12.14: Ratio of H p(3) values with and without lead glasses (CF) obtained in experimental
measurements. Mean, minimum, maximum and number N of data values collected for each model of
glasses are listed
obtain an estimation of the annual H p(3)year. When H p(3) data collected inside the protective glasses
are available, then the estimate of the H p(3)in,year is given. Values are given in Table 12.15 both for
physicians and for nurses. In the latter case, only nurses from the Navarra Hospital were monitored. Data
show that 8 physicians over 14 surpassed the recommended 20 mSv annual eye lens dose. Even though
physicians wore lead glasses, in two cases, the protection provided was not enough to reduce the dose
below 20 mSv (cases Pr 3, Nav 3), in some cases the dosemeter inside the goggles is probably located
on a part of the glasses to avoid disturbing the physician and is therefore not very well protected, the
attenuation factor might thus be highly underestimated. In the case of nurses, three nurses out of six
exceeded the 20 mSv y−1 limit, in contrast with what was observed in Vall d’Hebron Hospital.
H p(3)/N (µSv procedure
−1) Nyear H p(3)year (mSv)
Physicians
Pr 1* 5 200 1
Pr 2* 19 700 13
Pr 3* 33 700 23
Pr 4 46 300 14
Pr 5 92 300 28
Nav 1* 38 429 16
Nav 2 279 444 124
Nav 3* 58 566 30
Nav 4 11 908 10
SC 1 41 667 27
SC 2 14 625 9
SC 3 27 700 19
SC 4 77 417 32
SC 5 8 639 5
Nurses
Nav 1 72 665 48
Nav 2* 117 677 79
Nav 3 87 336 29
Nav 4 13 655 9
Nav 5* 19 267 5
Nav 6 5 752 4
Table 12.15: H p(3) is estimated by using the dosemeter in the internal part of the glasses (H p(3)in,year).
H p(3) divided by the number of performed procedures, number of procedures per year and estimated
annual doses calculated for physicians from the Princesa Hospital (Pr), Navarra (Nav), San Carlos (SC)
and nurses from the Navarra Hospital (Nav). *Physicians wearing lead goggles
78
Chapter 13
Analysis of variability through
Monte Carlo calculation
MC analysis allows the study of the influence of different parameters on eye lens exposure during an
interventional procedure. This part of the work, performed in collaboration with the EURADOS working
group 12 (Dosimetry in Medical Imaging), complements the experimental measurements and aims to
study the influence of operator position, height and body orientation on eye lens exposure by using
Monte Carlo simulations. The protection efficiency of lead glasses in real clinical conditions and the
relation between H p(3) and H p(10) measured at thorax level on the lead apron are also examined. More
specifically the following parameters were studied:
• The effect of operator position with respect to the patient when lead glasses are not worn;
• The influence of the presence of the image intensifier, tube voltage and operator height;
• The protection efficiency of lead glasses for different operator positions and body orientations with
respect to the patient;
• H p(10) on the left and the centre of the thorax and its comparison with H p(3).
The IC/IR scenario described in Part III was simulated, as defined within the framework of the
European projects ORAMED and ELDO. A first study was carried out in order to evaluate the influence
of operator position and body rotation on eye lens dose when lead glasses were not worn. The main aim of
this part was to investigate how the eye lens dose can be reduced by optimizing the relative position of the
operator with respect to the X-ray source. Several distances (0, 20, 40 and 70 cm) between the operator
and the X-ray source were considered together with the following operator body orientations: 0, 10, 30,
45 and 60 degrees, facing towards and away from the tube. A simplified sketch of the configurations is
illustrated in Figure 13.1. The selected distances represent the position of the operator for jugular access
(0 cm), radial access for pediatric (20 cm) and adult patients (40 cm) and femoral access (70 cm). A 90
kV peak-voltage X-ray beam with 3 mmAl added filtration was used. The reference operator height is
178 cm. Postero-Anterior projection and thorax irradiation were considered for these simulations.
Depending on the relative position of the operator, the image intensifier can provide attenuation of
the scattered radiation that reaches the operator’s eye. In order to investigate this, a 2 − mm−thick
cylindrical lead shell filled with air and an input window of 1.5mm aluminium were used to represent the
image intensifier. Simulations were repeated by replacing the lead and aluminium materials by air, for
the above-mentioned distances. Rotation of the operator with respect to the source was not considered.
For all the other cases, the image intensifier was simulated.
The effect of tube voltage on the operator eye lens was studied by repeating calculations for a 110 kV
peak voltage radiation beam with 3mm aluminium added filtration at distances of 0, 20, 40, 70 cm and
0◦ rotation. Eye lens dose values were compared against the beam with a lower voltage (90 kV). The
higher voltage is usually used for a larger patient. In order to study the influence of eye lens exposure for
an operator who is either shorter or taller than the reference operator, calculations for operator heights
of 158, 168 and 188 cm were also included. Simulations were performed for distances of 0, 20, 40, 70 cm
and 0◦ rotation. For the study of the efficiency of the lead glasses, the wraparound style was modelled
as defined in Koukorava et al. (2014) with 0.5mm lead and 7.5mm lens size. Two field dimensions were
studied resulting in a 30 and 20 cm diameter field at the level of the patient’s thorax, for Postero-Anterior
(PA) and Left-Lateral (LLAT) projections, respectively.
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Figure 13.1: Simplified geometry with some of the possible configurations of the clinical simulated
scenario. In this figure the operator is at 40 cm distance and 0◦ orientation (no rotation) and at 70
cm distance and rotated 45◦ away from the source (facing towards the image screen)
When using lead glasses, ISO 15382 (ISO, 2015) recommends the use of a dosemeter worn, preferably,
behind the lead part of the glasses. However, this option is usually not very practical as it is a bit
cumbersome. An alternative solution is to wear a dosemeter close to the eye on an unprotected part and
to apply a proper correction factor that takes into account the protection provided by the glasses. In this
study, the protection efficiency of the lead glasses was hence estimated as the correction factor (CF) as
defined in subsection 12.3.2. CF is the ratio of the dose to the eyes when lead glasses are used and when
they are not.
In order to study the relation between whole body dose, measured at the thorax above the lead apron,
and eye lens dose, two thin tally volumes were positioned on the apron, at the center (MT) and at the
left (LT) of the thorax. A 1 − cm−thick soft tissue layer was placed above each of them to estimate
H p(10) at the two positions. H p(10) was used as it was found from experimental measurements that no
statistical differences were observed when H p(0.07) was used. Furthermore, active dosemeters are usually
calibrated in terms of H p(10) and results can be compared with published data. The dose to the left eye
(LE) to calculate the personal dose equivalent H p(3) and to the left lateral position (LL), were compared
with doses at MT and LT.
Distances of 40 and 70 cm between the operator and the X-ray source were considered together with
operator body orientations of 0, 30 and 45 degrees, facing towards and away from the tube. Only radial
access (40 cm) and femoral access (70 cm) were considered for these simulations as they represent the
most common configurations in clinical practice. Postero-Anterior projection and thorax irradiation were
simulated. LLAT projection at 40 cm and 70 cm distance without rotation was also considered.
Energy deposition tally (F6 tally) in kerma approximation mode was used to determine the energy
deposition to the left eye (LE), to the left lateral position (LL), to the middle thorax (MT) and to the
left side of the thorax (LT). Correction factors from whole body dose, measured by dosemeters placed on
the lead apron, were used to extrapolate eye lens dose.
13.1 Results of the influence of operator position, height and
body orientation on eye lens dose
Table 13.1 shows the ratio of the left and right eye lens personal dose equivalent calculated using MC
simulations. Data were obtained for a PA projection for the operator at the different studied positions
in the configuration facing away from the tube (columns 2 to 5) and facing towards the tube (columns
6 to 8). The latter is quite an unlikely scenario in interventional cardiology and radiology practice. In
this case, the left eye is generally the most exposed, but the ratios between the two eyes is almost 1
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when the operator is facing towards the tube. The cumulative dose in the left and right eye is similar
and differences are sometimes within statistical uncertainty. The statistical uncertainty of the simulation
results was 1% (1 sd) in most cases, except for the cases of 45 and 60◦ rotation facing away from the
tube where the uncertainty was 3% (1 sd). Simulations were performed without lead glasses since the
aim of this part of the study was to evaluate the influence of operator position and rotation on left and
right eye lens dose when no protection is used.
At 0 cm distance (jugular access-typical position) and 0◦ and 10◦ rotation, there are no differences between
the left and right eye dose, while for larger angles the eye closest to the tube receives the greatest dose.
When the operator is looking away from the tube (Table 13.1, column 2), when the monitoring screen
is set to his/her right, the most exposed eye is the left one. In realistic clinical conditions, the operator
always turns towards the screen when hitting the X-ray pedal in order to visualize the progress of the
catheter and to perform the intervention. At distances of 20, 40 and 70 cm for an operator turning away
from the tube, which represents the most likely situation in routine practice, the left eye is always the
most exposed one. In addition, as shown in Table 13.1 (col. 3 to 5), the ratio between the dose to the
left eye and right eye increases with both angle and distance, even though when the angle changes from
45◦ to 60◦ away from the tube, the dose remains almost constant. In these latter cases, the dose to the
right eye is almost negligible, since it is mainly due to backscatter from the head (McVey et al., 2013).
H p(3, LE)/H p(3, RE)
away from the tube towards the tube
Angles (◦) 0 cm 20 cm 40 cm 70 cm 20 cm 40 cm 70 cm
0 1.0 1.2 1.3 1.5 1.2 1.3 1.5
10 1.0 1.2 1.5 2.3 1.0 1.2 1.4
30 1.1 1.6 2.8 5.4 1.1 1.1 1.2
45 1.3 3.6 6.6 13.1 1.0 1.2 1.1
60 2.2 4.3 6.0 12.6 0.8 0.9 1.0
Table 13.1: H p(3, LE)/H p(3, RE) ratios for away from the tube and for towards the tube for the PA
projection and when lead glasses are not worn. LE stands for Left Eye and RE for Right Eye
Figure 13.2 shows the normalized dose values with respect to the LE dose at 40 cm distance and for
0◦ rotation. Values correspond to the configuration facing away from the tube. This configuration yields
the highest dose to both eyes in the case of PA projection. It can be seen that increasing the rotation
of the head diminishes the dose to both eyes when the operator is standing at distances of more than
40 cm away from the X-ray tube. This was also verified by Koukorava et al. (2014). Rotations higher
than 45◦ entail a drop in dose of more than 50% for the left eye compared with the 0◦ rotation. The
relative lower dose between 0 cm and 20 cm compared with the dose at 40 cm can be explained by the
simulations performed both with and without the image intensifier. Eye lens dose with and without the
image intensifier is lower by a factor of 3 at 0 cm distance. This effect decreases when the distance
is increased and it is null for 40 and 70 cm distance of the operator from the source. Thus, it can
be confirmed that the image intensifier works as a shield when it is near the operator. In the present
simulations this effect can be seen for distances lower than 40 cm from the X-ray beam axis for the PA
projection.
Both eye lens dose values were found to increase by about 25% when tube voltage was increased from
90 kV to 110 kV with 3mm Al filtration for all tested situations and operator-field distances of 0, 40, 70
cm and 0◦ rotation. Table 13.2 highlights the influence of operator height on the left eye lens dose. It
shows the ratio between the left eye lens dose for three different phantom heights (158, 168 and 188 cm)
and the left eye lens dose of the reference phantom height (ref = 178 cm). The phantom height plays a
crucial role in diminishing the cumulative doses. Calculations show that eye lens dose decreases when
the vertical distance between the operator’s eyes and the patient increases. This effect is important
when the operator is close to the X-ray tube (0 and 20 cm): in this case the left eye dose can change
by a factor of 2 in the case of a 10 − cm shorter operator (168/ref case). This effect is mitigated by
increasing the lateral distance (e.g. from radial to femoral access). However, a taller operator (column
4) leads to doses to the left eye lens that are reduced by a factor of 2 at 0 and 20 cm distance; this
reduction is lower for 40 and 70 cm distances.
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Figure 13.2: Eye lens dose distribution for all distances normalized with respect to the left eye dose at
40 cm distance and 0◦ rotation for the PA projection, and for when lead glasses are not worn
Distance 158/ref 168/ref 188/ref
0 cm 3.2 2.0 0.5
20 cm 2.8 1.9 0.5
40 cm 1.9 1.4 0.6
70 cm 1.3 1.2 0.8
Table 13.2: LE dose ratios for different operator heights (158 cm, 168 cm and 188 cm) and a reference
height of 178 cm
13.2 Protection efficiency of lead glasses
MC results of H p(3) values with and without lead glasses (CF) for PA and LLAT irradiation are shown
in Table 13.3. Some relevant data from Koukorava et al. (Koukorava et al. (2014)) are also included for
comparison. It can be seen that, at 0◦, the protection effectiveness of the glasses for the left eye is higher
as distance increases, whilst it decreases for the right eye (as shown in Figure 13.2, without glasses the
right eye is the least exposed). Likewise, the protection effectiveness of lead glasses is generally increased
when the operator faces the X-ray tube as opposed to when looking away. This is due to the fact that
a larger amount of scattered radiation directly strikes the lens of the glasses. Similar observations were
found by Koukorava et al (Koukorava et al., 2014). Such a protective effect is reduced at 70 cm distance,
where no relevant difference is observed within CF at different angles.
If we consider the most likely operator positions, which are 0, 40 and 70 cm distance for rotation
angles up to 45◦, the correction factor for the most exposed eye (the left one), for 0.5 − mm−thick
wraparound-style lead glasses, ranges from 0.11 to 0.58. The lowest protection (0.58) belongs to the
femoral access configuration (70 cm) with 45◦ rotation away from the tube. Figure 13.2 shows that
this value corresponds to the lowest dose and thus reduction of the protective efficiency should be of no
concern.
Measured CF in real clinical conditions for types of lead glasses shown in Figure 12.1 are presented
in Table 12.14.
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CF
PA LLAT
LE RE LE RE Reference
0 cm 0◦ 0.51 0.52 – – Koukorava et al. (2014)
40 cm
0◦ 0.2 0.78 0.23 0.92 Koukorava et al. (2014)
30◦ towards 0.27 0.31 0.21 0.39 Present work
30◦ away 0.34 1.19 0.32 0.98 Present work
45◦ towards 0.32 0.22 0.29 0.29 Present work
45◦ away 0.41 0.88 0.40 0.79 Present work
60◦ towards 0.53 0.2 0.45 0.2 Present work
60◦ away 0.58 0.8 0.31 0.58 Present work
70 cm
0◦ 0.15 0.89 0.12 0.97 Koukorava et al. (2014)
30◦ towards 0.15 0.24 0.11 0.31 Present work
30◦ away 0.25 0.95 0.28 0.92 Present work
45◦ towards 0.15 0.16 0.11 0.18 Koukorava et al. (2014)
45◦ away 0.42 0.78 0.58 0.7 Koukorava et al. (2014)
60◦ towards 0.17 0.16 0.12 0.12 Present work
60◦ away 0.84 0.82 0.89 0.76 Present work
Table 13.3: Ratio of H p(3) values with and without lead glasses (CF) for PA and LLAT irradiation (data
from Kourokava et al. (Koukorava et al., 2014) are also included for comparison).
13.3 Results on the relation between H p(3) and H p(10)
measured on the thorax
Calculations were performed for PA projection considering rotation of the head, of 30◦ and 45◦, whereas
the rest of the body remains at 0◦. Simulations were repeated for the LLAT projection only for 0◦
rotation of the head and body (no rotation). Correction factors are determined as the ratio between the
dose at the left eye (LE) and at the left lateral sensor (LL) and the dose at middle thorax (MT) and left
thorax (LT), when the operator was wearing the protective apron, but not the lead glasses. Results are
shown in Table 13.4. In column 6 the H p(3) ratio between LL and LE is also presented. The LL sensor
overestimates the dose to the eye lens of approximately 30%. This overestimation is higher when the head
is rotated away from the tube and LE receives a lower amount of radiation than other configurations,
such as for 70 cm and 45◦ away.
Hp(3, LE)
Hp(10,MT )
Hp(3, LE)
Hp(10, LT )
Hp(3, LL)
Hp(3, LE)
Hp(3, LL)
Hp(10,MT )
Hp(3, LL)
Hp(10, LT )
PA
40 cm
0◦ 0.58 0.39 1.29 0.75 0.65
30◦ towards 0.44 0.39 1.22 0.54 0.48
30◦ away 0.52 0.46 1.29 0.68 0.59
45◦ towards 0.43 0.38 1.26 0.54 0.48
45◦ away 0.29 0.25 1.30 0.37 0.33
70 cm
0◦ 0.93 0.84 1.29 1.21 1.09
30◦ towards 1.00 0.91 1.16 1.17 1.05
30◦ away 0.77 0.70 1.40 1.08 0.98
45◦ towards 1.02 0.92 1.18 1.20 1.08
45◦ away 0.45 0.40 2.11 0.94 0.85
LLAT
40 cm 0◦ 0.95 0.82 1.34 1.27 1.10
70 cm 0◦ 1.25 1.30 1.34 1.68 1.75
Table 13.4: Ratio of H p(3) and H p(10) values measured at different positions. The H p(3, LL)/H p(3, LE)
ratio is also included. LE stands for Left Eye, MT for Middle Thorax, LT for Left Thorax, LL for Left
Lateral
Table 13.5 shows mean, minimum, maximum values for 40 and 70 cm distances together for the PA
projection. Mean all represents the average value obtained from all data from Table 13.4 disregarding
the direction of the rotation of the head, whereas mean away, mean towards and mean 0◦ are the values
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for rotation away from the tube, towards the tube and 0◦ respectively (averaged between 40 and 70 cm).
Hp(3, LE)
Hp(10,MT )
Hp(3, LE)
Hp(10, LT )
Hp(3, LL)
Hp(3, LE)
Hp(3, LL)
Hp(10,MT )
Hp(3, LL)
Hp(10, LT )
Mean all 0.64 0.56 1.3 0.85 0.76
Min 0.29 0.25 1.16 0.37 0.33
Max 1.02 0.92 2.11 1.21 1.09
Mean away 0.5 0.5 1.5 0.8 0.7
Mean towards 0.7 0.6 1.2 0.9 0.8
Mean 0◦ 0.8 0.6 1.3 1.0 0.9
sd 0.27 0.25 0.27 0.31 0.29
Table 13.5: Mean, minimum, maximum and standard deviation sd of H p(3) and H p(10) ratios measured
at different positions for PA projection
For the PA projection results show that H p(3, LE)/H p(10,MT ) ratios are higher than
H p(3, LE)/H p(10, LT ) as the left thorax is more exposed to scattered radiation than the middle thorax,
as the radiation strikes from the left side. For the configurations where the physician is looking away
from the tube, the H p(3)/H p(10) ratios are lower than for the configuration ’towards the tube’, as the
eyes are less exposed in the ’away from the tube’ case, whilst the thorax is equally exposed. The lowest
value of 0.29 corresponds to the configuration at 40 cm distance for 45◦ rotation away from the tube. In
this case, the physician is close to the field and the thorax is much more exposed than the head because
of the rotation. The higher the rotation of the head away from the tube, the lower is H p(3)/H p(10), as
the eye lens dose decreases. This effect is mitigated at 70 cm. For the configuration ’towards the tube’
and for 40 cm distance, H p(3)/H p(10) is independent from the rotation angle (for the studied cases).
The same can be stated for 70 cm. However, at this distance the exposure of the body to the field is
more homogeneous for this specific projection and eyes and thorax are equally exposed (ratios close to
unity while close to 0.5 for 40 cm). In order to extrapolate H p(3, LL), that is the eye lens equivalent
dose that might be measured by an eye lens dosemeter located at the left temple, a correction factor of
0.76 should be applied to H p(10, LT ), that is the dose measured by a whole body dosemeter positioned
on the lead apron. This correction factor is derived from the mean of all H p(3, LL)/H p(10, LT ) and it
ranges between 0.33 (40 cm, 45◦ away) and 1.09 (70 cm, 0◦). Thus, a large variation is observed for
these cases.
For the LLAT projection, the ratios increase significantly with respect to the PA projection. The
eyes are generally more exposed than the thorax, especially at 70 cm. A mean value of 1.43 is derived
from H p(3, LL)/H p(10, LT ) at 40 and 70 cm distance. This shows that, for the studied cases, the use of
different projections influences the values of H p(3)/H p(10), and highlights the difficulty of the application
of a proper correction factor.
Although it is not very frequent in real practice, PA calculations were repeated considering the rotation of
the whole body (head and thorax). Results are shown in Table 13.6. When both head and thorax rotate
away from the tube, the eye lens dose to the left eye H p(3, LE) overestimates the dose to the thorax at
10mm depth by a factor of 5 for MT and 3 for LT. These values are doubled for H p(3, LL)/H p(10,MT )
and H p(3, LL)/H p(10, LT ), as the H p(3, LL) is 50% higher than H p(3, LE) for these configurations.
Thus, in these cases, the radiation that reaches the thorax is highly attenuated by the body itself
and there is the possibility of incurring in a high underestimation of the eye lens dose estimate by
applying the H p(3)/H p(10) factor. In the scenarios where the operator is facing towards the tube,
H p(3, LE)/H p(10,MT ) and H p(3, LE)/H p(10, LT ) are equal to 0.7 and these ratios slightly increase
using the LL sensor (0.8).
Hp(3, LE)
Hp(10,MT )
Hp(3, LE)
Hp(10, LT )
Hp(3, LL)
Hp(3, LE)
Hp(3, LL)
Hp(10,MT )
Hp(3, LL)
Hp(10, LT )
Mean all 2.5 1.7 1.2 4.4 2.5
Mean away 5.3 3.2 1.5 11.4 6.0
Mean towards 0.7 0.7 1.2 0.8 0.8
Mean 0 0.8 0.6 1.3 1.0 0.9
sd 3.4 1.6 0.3 7.4 2.8
Table 13.6: Mean values and standard deviation sd of H p(3) and H p(10) ratios measured at different
positions for PA irradiation considering the rotation of the whole body
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Chapter 14
Summary of results and comparison
with earlier published data
The main results of this thesis are analyzed and compared with earlier published data. Achievements
and limitations are discussed and future studies are proposed.
14.1 Optimal positioning for maximum eye lens equivalent dose
assessment
The study on phantom has shown the fact that an eye lens dosemeter at the left lateral (LL) position
provides the best estimate of the eye lens equivalent dose at the most exposed eye (the left one for the
studied cases). On the other hand, a dosemeter located at the forehead or at the right temple subestimate
the dose at the left eye. In Domienik et al. study (Domienik et al., 2012) 10 TLDs were placed on a head
band between the left and the right temple of physicians working in IR suites. Their results show that
in 50% of the studied cases the TLD at the left temple (LL) registered the highest eye lens dose. The
dose measured at the different sites decreases as the distance of the TLD from the X-ray tube increases.
In none of the measured cases the maximum eye lens dose was found in one of the five TLDs between
the forehead and the right temple. These results obtained in clinical condition agree with measurements
performed on phantom and the pilot study performed in San Carlos University Hospital within the frame
of this thesis .
14.2 Use of active personal dosemeters
The use of active personal dosemeters could be of great help to increase awareness of workers while they
are being exposed and to optimize the procedures when an increased signal is observed. The comparison
of H p(10) measurements with UPC-WBD and with the electronic DoseAware detector in the preliminary
phantom studies provided a mean value of H p(10)DoseAware/H p(10)UPC−WBD equal to 1.02 (sd = 0.21).
The result was obtained from 24 measurements corresponding to typical interventional procedures and
it is in agreement with the value obtained in previous works done by our team: (1.11±0.10) (Sanchez
et al., 2014). It confirms that the DoseAware electronic device responds satisfactorily well to realistic
interventional cardiology scattered fields. The observed performance is better than the data pubished
by Struelens et al. (Struelens et al., 2011) who performed some tests on operators. In their work,
they reported a median value for the DoseAware of 0.61, obtained from a set of 5 measurements at one
hospital. Similar responses were found for other active personal dosemeters, the authors admitted that
the study could have some limitations associated with the low registered dose or with the shielding of
one dosemeter compared with another. To complete our study it would be interesting to undertake a
systematic campaign of measurements assigning both active and passive dosemeters to workers. This
additional work has just started within the framework of EURADOS WG12 and preliminary results are
promising and confirm our phantom data.
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14.3 Assessment of eye lens equivalent dose using a whole body
dosemeter situated on the lead apron
The most common and convenient procedure used at present for assessing eye lens equivalent dose is the
use of a second WBD situated on the apron on the chest or the collar. Many studies have been published
in recent years to analyze this procedure. Three major approaches or a combination of approaches
are followed to address this issue, namely, measurements with phantoms, measurements in clinics and
MC calculations. The three methodologies and, in particular, a combination of MC simulation and
experimental results are used in different parts of this study. MC simulations have proven to be useful
to study the individual influence of specific parameters, such as X-ray tube projection, operator position,
type of lead glasses, etc. However, calculations fail to realistically reproduce clinical practice. The
geometry of the patient and operator movements must be simplified compared with real clinical conditions.
On the other hand, data from clinical practice are obviously realistic, but suffer from great variability
of different parameters depending on patient, operator, difficulty of the procedure, adopted practice etc.
Thus, large differences in measurements are not only found among the various hospitals and operators
but also for the same operator.
To provide insight into the limitations and usefulness of the assessment of eye lens dose using a WBD
situated on the lead apron, several papers from the literature were selected and compared with our
data. Phantom and workers’ measurements and MC calculations will be compared separately. For the
comparison, preferably eye lens doses assessed as H p(3) measured close to the eye and H p(10) or H p(0.07)
measured at chest or collar level will be chosen since they are the most frequently preferred positions.
Measurements performed on other parts of the body, such as the shoulder or the extremities, will not
be considered in the discussion. section 11.4 showed that the left shoulder position presented a larger
variability than the chest or neck. When both H p(10) and H p(0.07) are reported, only H p(0.07) will be
considered. As is verified in this study, the difference between the two quantities for low energy photon
fields is not significant. Likewise, if the eye lens dose is assessed as H p(0.07), it will also be analyzed
provided that it corresponds to a measurement close to the eye (Behrens et al., 2012).
14.3.1 Relation between eye lens and whole body doses on phantom
Table 14.1 provides a summary of results corresponding to recently published correction factors from eye
lens dose measurements on phantoms. Correction factors CF are given in H eye/H thorax or H eye/H thyroid.
The operational quantities will be specified henceforth in the text. The number N of performed
irradiations and the type of projections or simulated procedures is also provided.
Author N of irradiations Projections/procedures
CF (mean ± sd)
H eye/H thorax H eye/H thyroid
This thesis Principi et al. (2015b) 8
PA 0.80±9% 1.14±6%
LLAT 0.56±7% 1.02±12%
PA,LLAT 0.74±8% 1.10±5%
Strocchi et al. (2016) 9
Vertebroplasty
0.71Perigangliar
Cerebral arteriography
Cemusova´ et al. (2016) 24
PA 0.76±5% 1.12±5%
LLAT 0.85±10% 1.13±9%
PA,LLAT,AP,RLAT 0.73±15% 0.93±15%
Farah et al. (2013) 48
CA/PTCA, RFA, PM, ICD 0.87±87% 3.36±41%
CA/PTCA, RFA 0.69±52% 3.98±41%
Table 14.1: Comparison of recently published data on the relation of the eye lens dose with whole body
dose measured at chest or neck level on phantoms
The best estimate of H p(3) measured at the left eye in our study is given by H p(10) or
H p(0.07) measured by a WBD at collar level. This is when the lowest spread of values is found
(sd = 5%). In Strocchi et al.’s work (Strocchi et al., 2016), several projections corresponding to
vertebroplasty, perigangliar and cerebral angiography procedures were simulated on the RANDO
phantom. Both eye lens dose and chest were given in units of H p(0.07) from TLD measurements. The
CF H p(0.07)eye/H p(0.07)chest averaged over all the simulated procedures was 0.71. In Cemusova´ et
al.’s study (Cemusova´ et al., 2016), eye lens dose was measured with an EYE-D dosemeter in terms
of H p(3), whilst H p(10) and H p(0.07) at chest and neck level were measured with a conventional
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TL-WBD. The anthropomorphic phantom representing the physician wore a thyroid collar and a
protective apron, thus WBD were located above the protection. Data were calculated for AP, PA,
LLAT and RLAT projections. The CFs obtained in these three studies indicate that, disregarding the
procedures/projections, a common factor of about 0.7 describe the dependence between eye lens dose
and thorax dose and around 1.1 between eye lens equivalent dose and thyroid equivalent dose. Within
2 sd, the three papers are consistent. The ELDO study Farah et al. (2013) included a large number
of measurements (48 irradiations) on anthropomorphic phantoms in typical interventional settings and
considered different tube projections and configurations, beam energies and filtration, operator positions
and access routes and used both mono-tube and biplane X-ray systems. No protection means were
employed. Results showed that eye lens equivalent dose correlated best with H p(10) measured on the left
side of the phantom at collar level. In Table 14.1 values for all procedures and specifically for CA/PTCA
and RFA with mono-tube are reported. The CF for the dose at the thorax of 0.87 for all procedures
show high standard deviation (87%). This variability is considerably reduced when only a type of
procedure is selected, i.e. CA/PTCA (CF = 0.69±52%). The CF for equivalent dose at neck proposed
by Farah et al. Farah et al. (2013) is much higher than CF from other studies. In Martin review from 17
different studies on the relation with H eye and H thyroid, the ratios of eye lens dose to whole body dose
were between 0.24 and 1.25. Table 14.1 proves that for specific set-ups (ex. PA) the spread between
results is small. However, when different positions are considered together, as it is the case in the ELDO
study, the spread in the results increases and will be closer to what can be found when monitoring workers.
14.3.2 Relation between eye lens and whole body doses on physicians
As was mentioned in Part IV, one of the main difficulties when analyzing eye lens monitoring in clinics
is the great variability of the results. One of the most important factor contributing to this variability of
the eye lens dose and to high spread of the CFs is the use of shields (eyewear, suspended screen). These
issues cannot be properly quantified by measurements on phantoms. A close follow up was organized and
detailed data provided for some of the procedures. When the radiation protection officer is present during
monitoring it is much easier to understand and justify some of the results. In Table 14.2, a summary of
our main results is presented. H p(3) and H p(0.07)thorax show good correlation for all hospitals. However,
mean H p(3)/H p(0.07) vary from 0.7 to 2.6. Considering all hospitals together, the correlation is still good
(0.7) but increases up to 0.9 when disregarding the Vall d’Hebron Hospital measurements. As indicated
in section 12.3, the proposed correction factor to assess H p(3) from H p(0.07) is derived from the slope
of the fitted equations. From Table 14.2, we recommend to use the following equation: H p(3) = 0.8 ·
H p(0.07)thorax
H p(3)out/H p(0.07)thorax
Hospital N of procedures Mean sd % Median Slope Figure 12.7 R2
Vall d’Hebron* 51 2.6 15 2.2 1.40 0.8
Navarra 49 1.6 35 1.1 0.85 0.9
Princesa 80 0.74 11 0.79 0.77 0.7
San Carlos 68 0.78 12 0.80 0.70 0.7
All 248 1.8 14 1.09 0.84 0.7
All except V.H. 197 1.08 21 0.84 0.77 0.9
Table 14.2: Number of procedures N, mean, standard deviation (%), median and R2 of the ratios between
H p(3) measured outside the glasses (H p(3)out) and H p(0.07) for physicians. *Only no pediatric-1st
position physicians
In Table 14.3, results from our study are compared with other authors’ works for physicians. The
square of the Pearson coefficient, when available, was used to measure the strength of the linear
relationship between H p(3) and H p(0.07) measured on the lead apron. When data on neck dose are
provided, they are also included. However, in this study, the thorax positioning was preferred because of
the acceptability by the workers to wear a dosemeter at the chest rather than at the collar.
Comparison here is more difficult and the information provided in the different papers is often not
comparable. Most of published data correspond to measurements performed with a WBD situated on
the neck, whereas our data correspond to measurements on the chest. For interventional cardiology,
doses at the thyroid or chest are higher than the eye lens doses, as we found in our study except for Vall
d’Hebron Hospital. For other interventional procedures and for pediatrics, the eye lens equivalent dose
is higher than the thyroid equivalent dose. In (Efstathopoulos et al., 2006), a ratio of 1.86 was found
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Author N of procedures Procedure
CF (mean ± sd)
H eye/H thorax H eye/H thyroid
Efstathopoulos et al. (2006)
43 IR
0.52 1.86
(only 1 physician followed)
Lie et al. (2008) IC 0.75
Kong et al. (2014) 31 IR (anaesthetists) 1.42 2.49
Thrapnasnioti et al. (2016) 35 physicians IC 0.64±0.43
Buls et al. (2002) 54 IR 1.22
Sulieman et al. (2008) IR 1.46
Table 14.3: H p(3)/H p(d) measured at different positions and through different campaigns
for electrophysiology operators using bilateral femoral access. CF suggested by Lie and Thrapnasnioti
are in agreement with values obtained from measurements on phantom of about 0.7 (Lie et al., 2008;
Thrapnasnioti et al., 2016). In Kong et al. work, when single procedures are followed, a CF of 1.42
is achieved for the dose at chest for anaesthetists assisting IR procedures (Kong et al., 2014). In their
study, a correlation coefficient of R2=0.64 is published. Furthermore, the relation between eye dose and
neck dose highlighted a large CF of 2.49 (R2=0.61). Buls et al. (Buls et al., 2002) and Sulieman et al.
(Sulieman et al., 2008) published correction factors H eye/H thyroid of 1.22 and 1.46 respectively, where in
all set-ups over-couch irradiation was predominant. In these cases, the upper part of the operator was the
most exposed. The spread of H p(3)out/H p(0.07)chest and H p(3)out/H p(0.07)thyroid ratios found in the
literature for measurements on physicians confirms the difficulties in assessing eye lens dose using a WBD
situated on the lead apron and the problems in finding a unique correction factor, valid for all clinical
conditions. Even when good correlation is found (Table 14.2), great variability among values is observed,
thus highlighting the possibility of causing large over- or under-estimation of eye lens dose depending on
the chosen correction factor. Mean and median H p(3)out/H p(0.07)chest for all nurses (Vall d’Hebron and
Navarra hospitals) is found to be 1.27 and 1.12 (with sd=6.4% and R2=0.9). Less variability is observed
than for physicians. Therefore, H p(0.07) measured on the apron, on the left side of the thorax, can be
considered as being a good estimator of eye lens dose for nurses.
14.3.3 Relation between eye lens and whole body doses with Monte Carlo
simulations
Clerinx et al. (Clerinx et al., 2008) performed 62 simulations, including eight different projections: AP,
PA, RLAT, LLAT and four 45◦ oblique. Simulations were performed for a distance lower than 50 cm from
the worker to the center of the patient entry field for most cases (53 out of 62), while for all other cases the
distance was 71 cm. The correlation between Heye and H p(0.07) measured at neck level (H p(0.07)neck)
was analyzed. For most cases, Heye/H p(0.07)neck is 0.73, calculated as the regression coefficient obtained
by least squares fitting. The square of the Pearson coefficient is 0.98. It follows that H p(0.07) measured
at the neck (above the thyroid collar if worn) overestimates the eye lens dose by approximately 25%.
Different ratios are observed for a specific projection. The largest Heye/H p(0.07)neck is found for the
RLAT projection. A value of 1.2 was calculated for the LLAT projection. It is important to emphasise
the fact that the number and type of simulated projections influence the value of the factor. For most
projections, H p(0.07)neck tends to overestimate the eye lens dose. They are also in good agreement with
the phantom results in Table 14.1. Based on the general agreement between different MC and phantom
studies, as well as with some of the clinical measurements, (Martin, 2011) and (IAEA, 2013), recommend
adopting a correction factor of 0.75 in practice for H p(0.07) measured at neck.
The results from Clerinx’s study cannot be quantitatively compared to our simulations, as in the case
of this thesis the relation of eye lens dose with the dose at thorax level was studied but not at the
neck. However, they are consistent. In fact, also in the present work, the highest Heye/H p(0.07)thorax
is found for the lateral projection. In the author’s opinion, MC simulation and phantom measurements
are very powerful methods, but they reproduce static scenarios and thus are always less accurate than
actual measurements. Considering the large spread of correction factors derived from the real monitoring
data (Table 14.2), a single correction should only be used for low exposed staff that are exposed to low
radiation levels, in order to confirm that more precise monitoring is not needed.
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14.4 Lead glasses efficiency
Protective lead glasses are often recommended in IC/IR procedures, especially in those cases where the
ceiling screen is not practical for clinical work. For an appropriate assessment of eye lens dose, ISO
15382 recommends wearing a dosemeter behind the protection (ISO, 2015). However, this is often not
very practical, and thus an alternative proposed option is to wear a dosemeter either on the outside or
next to the lead glasses, and then apply a correction factor (CF) to take into account the efficiency of
the eye wear. Part IV determines the efficiency of three types of lead glasses by MC simulation and
through the monitoring of several physicians. Since a clinical procedure involves different positions and
body orientations of the operator with respect to the radiation source, a mean CF is calculated from
MC results in Table 13.3. Two hypotheses are considered. Firstly, the mean value of all CFs for the
left eye is calculated including all distances and angles and the two projections, Postero-Anterior PA and
Left-Lateral LLAT. Secondly, and based on feedback from routine practice, the mean CF is obtained
by using only the most likely operator positions (i.e. 40 cm and 70 cm) and body orientations (0◦, 30◦
and 45◦ away from the tube). Following these hypotheses, mean, standard deviation, maximum and
minimum values of CF are presented in Table 14.4 in columns 2 and 3. For the first hypothesis, the mean
CF value is 0.33 (sd = 0.22). For the second hypothesis, it is 0.31 (sd = 0.15) which shows that both
results are consistent. Furthermore, the two results agree with findings from the work of Koukorava at
al. (column 4) (Koukorava et al., 2014). These data are also consistent with our experimental results for
the wraparound glasses (Table 14.4, column 5).
MC calculated CF Measured CF
This study This study Koukorava et al. (2014)
This study Magee et al. (2014) Moore et al. (1980) Thornton et al. (2010) Rooijen et al. (2014)
hyp.1 hyp.2 hyp.2
Mean 0.33 0.31 0.32 0.31 0.22 0.24 0.14 0.32
SD 0.22 0.15 0.18 0.10 0.05 0.07 0.04 0.24
Max 0.89 0.58 0.58 0.41 0.53 0.29 0.19 0.62
Min 0.11 0.12 0.12 0.21 0.15 0.14 0.10 0.12
Table 14.4: Mean, standard deviation, maximum, minimum values of CF obtained for wraparound glasses
with: Monte Carlo (MC) calculations, for hypotheses 1 and 2 (hyp.1: all MC, hyp.2: MC for 0, 30, 45◦
away from the tube), experimental measurements performed in this study and data from the literature
Other published experimental studies are also shown for comparison in Table 14.4, columns 6 to 9.
These were performed on anthropomorphic phantoms and for wraparound glasses (Magee et al., 2014;
Thornton et al., 2010; Rooijen et al., 2014; Moore et al., 1980). In these works, other types of glasses
were also studied but are not taken into account in this comparison. In Magee et al. (Magee et al., 2014)
three different scenarios were considered: the operator 30 cm from the source, 0◦ rotation; 68 cm from
the source and 0◦ rotation; 68 cm with the operator tilted towards the tube by an angle of 60◦. The
CF ranged between 0.15 and 0.53, with a mean value of 0.22. This result is similar to the range found
in the present study for measurements on operators in real clinical conditions. Furthermore, the highest
protection efficiency of lead glasses (0.15) is attributed to the configuration with the operator looking
towards the tube; this is in line with our MC value of 0.17 (PA projection) obtained for 70 cm and 60◦
rotation towards the tube. Furthermore, in the study by Moore et al. (Moore et al., 1980), a 3MR pelvic
phantom was used to generate the scattered radiation field, while a phantom head simulated the position
of the radiologist’s head. Three different geometric configurations were studied: rotation of the operator
of 0◦, 30◦ and 60◦ towards the tube. No details regarding the distances of the operator to the tube were
given, but as a patient pelvic phantom was used, radial/femoral access of the operator, i.e. about 55cm
distance from the source, could be assumed. Their CF values ranged from 0.14 to 0.29 with a mean value
of 0.24 obtained as an average of three geometric configurations. The authors showed that the larger the
rotation is, the lower the attenuation efficiency becomes.
Additionally, in Thornton et al. (Thornton et al., 2010) the scenarios simulated were jugular, radial
and femoral accesses; again no detailed information about the distances from the source was given. No
rotation of the head was considered. This study provides the smallest CF range (0.10 - 0.19) compared
with the other publications. The highest attenuation (0.1) is obtained for jugular access, as opposed to
the results of the present work, where a CF of 0.5 was obtained considering 0 cm distance of the operator
from the tube and no operator rotation (column 3, line 3). It is probably not overbold to consider that
the influence of the image intensifier position has an important role in this case, as this difference in the
two values could be due to the different relative positions of the eyes and the image intensifier in the two
studies. Thornton’s values for radial and femoral access of 0.19 and 0.11 agree with our MC results of
0.20 and 0.15, respectively.
Finally, Van Rooijen et al. (Rooijen et al., 2014) used two different geometrical configurations. Firstly,
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a 50− cm−distance was set between the source and the operator who was not tilted and had a height of
1.85m. Secondly, the distances were maintained, but the operator head was tilted 45◦ away from the tube.
The scattered radiation from the patient was produced by a PMMA slab phantom. Wraparound-type
glasses, named model 4 and 5 in the quoted paper, were considered. Such types of glasses are similar to
the MC model of this study. A mean CF of 0.32 (column 9) was obtained. This result is in agreement
with our experimental measurements and our mean Monte Carlo CF value (columns 1 to 4 in Table 14.4)
but remains larger than the other phantom measurements (columns 6 to 8). This difference may be due
to the geometrical configuration involving an operator rotation of 45◦ away from the tube. Indeed, as
previously mentioned, the efficiency of the lead glasses is reduced for head rotation away from the source
and the highest CF value corresponding to this set-up was about 0.62.
In addition, the studies by Moore et al. (Moore et al., 1980) and Van Rooijen et al. (Rooijen et al.,
2014) included few measurements on operators in clinical scenarios. Moore et al (Moore et al., 1980) only
provided one value with a corresponding measured CF of 0.19. This value is smaller than the average
CF value of 0.31 obtained in this study. Van Rooijen et al. (Rooijen et al., 2014) presented CF values
for wraparound glasses (model 5 in the original paper) ranging from 0.18 to 0.90, with a mean value of
0.48. This range is broader than our measurements (CF range 0.21 - 0.41), but still consistent with MC
values (0.15 - 0.84, for PA). However, as explained in their paper, Van Rooijen et al. (Rooijen et al.,
2014) indicated that the dose reduction for the left eye lens is probably underestimated because the
dosemeter was placed in a poorly shielded position. Based on this consideration, a mean CF of 0.48 for
the wraparound model, as proposed, may be too high.
In spite of the shortcomings of both MC and experimental measurements, Table 14.4 shows good
consistency between the two approaches, with CF mean values ranging from 0.14 to 0.33 (line 3). Based
on our MC calculations, our measurements and the data available in the literature, a correction factor
of 0.3 is recommended for radiological protection purposes for wraparound glasses. This CF value is
obtained by averaging all values from the first row of CFs in Table 14.4. However, it is important to
underline the fact that the number of collected data from our experimental campaigns is very limited
and should be increased. The recommended correction factor provides a first solution to assess eye lens
dose when lead glasses are worn and the dosemeter is situated in an unprotected position. This finding
is in agreement with the recommendation from ISO 15382 (ISO, 2015), which proposes a value between
0.2 and 0.3 as correction factor. However, for non-wraparound glasses, such as type 3c glasses with
smaller lenses, a more conservative CF value of 0.5 is recommended. Unfortunately, there are few clinical
data available to reinforce our proposal. Further measurements in clinical practice would improve our
knowledge.
14.5 Ceiling suspended screen attenuation
Phantom experiments highlight the efficiency of ceiling suspended screens to protect physicians. An
attenuation factor of 17 on the eye lens dose is found for the PA projection, twice the efficiency of the
lead glasses for the same conditions. The improper or miss-placement of the ceiling screen was considered
to be one of the main justifications for the variability of the dose of the first operator, and training on how
to use it one of the most effective tools for staff dose reduction. The protection provided by the screen
is quantified by comparing H p(3)/KAP measured for single procedures in Vall d’Hebron Hospital when
screen was used and when it was not. Physicians at first and second position are considered separately
in Table 14.5. For physicians at first position, mean H p(3)/KAP from unshielded procedures is 3.4 and
mean H p(3)/KAP for shielded procedures is 1.7. The attenuation factor associated with the use of the
suspended screen is approximately 2. The difference between the mean values is statistically significant (p
= 0.01, for α = 0.05), but the attenuation is much lower than it was found for phantoms. For physicians
at the second position, as expected, no statistical difference is observed associated with the use of the
ceiling shielding (see chapter 12).
In clinical practice, several parameters change for each specific procedure. Thus, factors other than
shielding may also contribute to the variation in H p(3)/KAP. The low attenuation during measurements
in hospitals, could be due to the fact that the screen was not always well placed to protect the upper
part of the body while using X-rays. In several studies, the contribution of the suspended screen to
the attenuation of the eye lens dose was quantified. Within the framework of the ORAMED project,
data from 34 hospitals were recollected, covering almost 1300 procedures. Results showed a reduction
factor of (1.6 - 2.3) for CA/PTCA procedures, calculated as the ratio between eye lens dose without the
shield and eye lens dose in presence of the shield (Vanhavere et al., 2011). The attenuation is enhanced
up to 7 when the tube is above the operating table (Carinou et al., 2011). Simulations campaign were
also conducted in order to determine the attenuation provided by the screen. Koukorava et al. in 2011
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Position/Shielding N Mean SD p (2-tailed)
H p(3)/KAP (µSv Gy
−1cm−2)
1st shield 17 1.69 0.82 0.01
1st no 2 3.41 0.56
2nd shield 2 0.49 0.06 0.86
2nd no shield 3 0.55 0.36
Table 14.5: Number N of procedures, mean H p(3)/KAP, standard deviation and statistical significance
p for shielded and unshielded procedures for physicians at first and second position
(Koukorava et al., 2011) assessed that the shield can reduce the eye lens dose a factor of 12 for PA
and LLAT projections. This value was obtained for a specific and ideal configuration. In 2014 a more
comprehensive study was carried out in order to obtain a more realistic result (Koukorava et al., 2014).
Different projections, positioning of the screen and operator’s distance from the X-ray source were taken
into account. A total number of 25 simulations were performed. Results showed that the attenuation
factor, averaged over the 25 simulation’s outputs, was 2.3. Carinou et al (Carinou et al., 2015) in their
review paper they summarized the influence of this protection reported in several studies. High variability
was acknowledged. Attenuation factors ranged from 1.3 to 33 times with the most frequent range being
between 3 and 11. However, the highest reported values of protection correspond to measurements on
phantom or MC simulations. Martin’s review (Martin, 2016) showed protection factors from 4 to 33.
Within the reported wide variability, for a practical approach to radiation protection, measurements on
clinical practice should be preferred thus an attenuation of the order of 2 - 4 should be considered. A
correct use of the ceiling suspended screen should be promoted within physicians.
14.6 Estimation of annual eye lens dose
The distribution of the estimated annual eye lens doses of physicians monitored in this study is shown in
Figure 14.1.
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Figure 14.1: Distribution of the estimated annual eye lens dose Hp(3) (mSv) for the 24 physicians who
participated in the measurement campaigns (Dark grey = physicians without lead glasses; light grey =
physicians with lead glasses)
Results show that the new ICRP recommended limit of 20 mSv y−1 for the eye lens can be easily
surpassed by physicians and only two physicians out of 24 do not exceed 3/10th of the limit. The European
Directive 2013/59 (EURATOM, 2014) states that category A workers are systematically monitored based
on individual measurements performed by a dosimetry service. In the case of the eye lens this is when
the eye lens equivalent dose is greater than 15 mSv. In most technical reports (IAEA, 2013; IRPA,
2017), given the uncertainty associated with the eye lens dose assessment, eye lens dose monitoring is
recommended above 6 mSv per year. The use of lead glasses, even though it substantially reduces H p(3),
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does not guarantee that the 20 mSv recommended annual limit would not be reached. Workload and
good working practice have a great influence on annual doses. In Zett-Lobos’ study (Zett-Lobos et al.,
2013) the projected annual exposure of the eye lens for an interventional cardiologist wearing 0.25 mmPb
equivalent glasses reached 33 mSv, despite the fact that the degree of attenuation of the dose at eye level
ranged from 40% to 58%. Similar feature were found in this study. However, if monitored physicians had
all wore appropriate lead glasses (CFgoggles = 0.3), the number of physicians exceeding 20 mSv would
have been 1 out of 24 instead of 10 out of 24.
Further analyses have been performed in order to compare annual eye lens equivalent dose obtained with
a dedicated eye lens dosemeter or using a corrected WBD measurement. Eye lens doses per procedure
obtained from H p(0.07)thorax measurements (H p(3)
Hp(0.07)
out /N) have been calculated as H p(0.07)thorax/N
(where N represents the number of performed procedures during the monitoring period) for each
physicians multiplied by the correction factor suggested in subsection 14.3.2:
• H p(3)out/H p(0.07)thorax = 0.8
The annual H p(3)
Hp(0.07)
out,y−1 is then calculated with the usual method by multiplying H p(3)
Hp(0.07)
out /N
by the number of procedures performed in one year. The relative differences RD between H p(3)out,y−1 ,
calculated from H p(3), and H p(3)
Hp(0.07)
out,y−1 , calculated from H p(0.07), are obtained as:
RD =
Hp(3)
Hp(0.07)
out,y−1 −Hp(3)out,y−1
Hp(3)out,y−1
(14.1)
When protective glasses are worn H p(3) calculated from H p(0.07)chest is obtained multiplying
H p(3)
Hp(0.07)
out,y−1 by an additional CFgoggles that takes into account the attenuation of the goggles, as
proposed in section 14.4:
• CFgoggles = H p(3)in/H p(3)out = 0.5 (if protective glasses type (c) are worn)
• CFgoggles = H p(3)in/H p(3)out = 0.3 (if protective glasses type (a) and (b) are worn)
RD is calculated in this case by the formula:
RD =
Hp(3)
Hp(0.07)
out,y−1 CFgoggles −Hp(3)in,y−1
Hp(3)in,y−1
(14.2)
where H p(3)in,y−1 is the measurement of an ELD located inside the protective lens of the glasses,
multiplied by the number of procedures performed in one year.
Furthermore, in last analysis, measured H p(3)in,y−1 are compared to H p(3)out,y−1 multiplied by the
corresponding CFgoggles for the lead glasses attenuation. The RD is calculated as:
RD =
Hp(3)out,y−1CFgoggles −Hp(3)in,y−1
Hp(3)in,y−1
(14.3)
In Figure 14.2 the RDs are represented.
The difference in which we incur by calculating H p(3) applying correction factors ranges from +1%
(for Pr 2 and Pr 5) to +106% (for Pr 4). The arrows indicate in which cases the difference implies that
the recommended limit of 20 mSv is exceeded by the estimation through H p(0.07) or H p(3)out but not by
H p(3) from direct measurements (yellow arrow - false positive), and when the 20 mSv are not surpassed
by the indirect estimation but they are by H p(3) measurements (red arrows - false negative). For all
data considered for the estimation of annual eye lens equivalent doses, we found:
• 2 false negative out of 6 for the physicians with goggles
• 3 false negative and 2 false positive out of 17 for the physicians who did not wear goggles.
In general, the estimate is better using Equation 14.3 than Equation 14.2, but the number of false
negative is the same. 7 cases out of 23 provide erroneous information as regards exceeding of the
recommended limit. In Farah study (Farah et al., 2014), the ELDO approach (Farah et al., 2013) was
applied to assess cumulative doses on 14 cardiologists. High uncertainties were associated to the estimate
of the eye lens equivalent dose and the authors suggested that an indirect approach to quantify H p(3)
should be used only to indicate which individuals are more likely to reach annual doses close to the 20
mSv. In this case, a dedicated eye lens dosemeter is required.
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Figure 14.2: Relative differences RD between measured H p(3) and H p(3) assessed from corrected
H p(0.07) and H p(3)out
14.7 Assessment of eye lens dose using the KAP indication in
the X-ray console
A review of eye lens dose data reported in the literature shows great variability (Martin, 2009) between
KAP and eye lens equivalent dose: a mean value of 0.79 was found, within the range 0.29 and 1.9, from
9 datasets of previous studies. This is in agreement with the rather large range obtained in this study.
Mean and median H p(3)/KAP of 1.24 and 1.11 µSv Gy
−1cm−2 are obtained respectively (sd = 73%).
These ratios are in agreement with the mean H p(0.07)eye/KAP from the ORAMED campaign of 1.0
µSv Gy−1cm−2 (Vanhavere et al., 2011) for CA/PTCA procedures, and with maximum value of 7.7.
The highest eye dose per unit KAP was found for PM/ICD with an average ratio H p(0.07)eye/KAP of
2 µSv Gy−1cm−2. A comparison with previous published data is given in Table 14.6. In our analysis,
for general assessment of eye lens equivalent dose using KAP, only physicians at the first position are
considered at the Vall d’Hebron Hospital to avoid increasing the variability of the measurements (row 5,
Table 14.5). The importance of separately considering first physicians from assisting physicians has been
underlined by other works, as doses received by physicians at second position can vary from 30 to 100%
of the dose received by the primary operator (Antic et al., 2013; Martin, 2016). In Antic et al.’s work
mean H p(3)/KAP of 0.94 µSv Gy
−1cm−2 was obtained by measurements on primary operators. This
value is lower for operators at the second position or nurses: in this case mean H p(3)/KAP is 0.33 µSv
Gy−1cm−2. A weak but significant (p < 0.01) correlation is found between the eye dose and the KAP
for both operators and nurses. A similar mean H p(3)/KAP of 0.86 µSv Gy
−1cm−2, within the range
(0.46 - 1.25), was suggested by Bor et al. study (Bor et al., 2009), carried out on 9 cardiologists. A
significantly lower H p(0.07)eye/KAP of 0.5 µSv Gy
−1cm−2 was obtained in Koukorava et al.’s study on
two cardiologists (Koukorava et al., 2011). The eye lens was measured by passive dosemeters calibrated
in terms of H p(0.07) and located on the side closest to the X-ray tube. The limited number of operators
who participated in the follow-up reduces the relevance of the study. Nevertheless, this value is within
the range of eye lens dose per unit DAP or KAP found in other works (Principi et al., 2015a; Bor et al.,
2009). Mean value for the Vall d’Hebron Hospital of 1.89 µSv Gy−1cm−2 highlights the fact that the use
of protection is not optimised. In particular, for pediatric interventions, for the same amount of KAP,
high H p(3) values are recorded, due to the proximity of the physician to the tube because of the small size
of the patient and the preferred use of biplane system to the monoplane. Vano et al. (Vano et al., 2008)
studied the relation between eye lens dose and patient dose for pediatric cardiologists. The eye lens dose
was assessed by means of active dosemeters located at the cardiologist’s eye position and three different
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examination protocols were performed with newborn, infant and child phantoms. A mean value of 7 µSv
Gy−1cm−2 was obtained and a strong correlation between the two quantities was observed (R2=0.99).
The same measurement protocol was implemented in Leyton et al.’s study (Leyton et al., 2014), but for
adult patients only. Eye lens dose was then obtained again by solid state dosemeters calibrated in terms
of H p(10). H p(10)eye/KAP is considerably lower than for pediatric patients, in fact a mean value of 1.35
is obtained (R2=0.99). Mean H p(0.07)eye/KAP of 0.5 µSv Gy
−1cm−2 and 0.86 µSv Gy−1cm−2 have
been suggested by Koukorava’s and Bor’s studies (Koukorava et al., 2011; Bor et al., 2009).
Author Eye lens equivalent dose/KAP
µSv Gy−1cm−2
Bor et al. (2009) Clinical 0.86 (0.46 - 1.25)
Koukorava et al. (2011) Clinical 0.5
Antic et al. (2013) Clinical
1.3±0.94 (CA, 1st)
0.36±0.18(CA, 2nd/nurse)
0.94±0.61(All, 1st)
0.33±0.26(All, 2nd)
This work - Vall d’Hebron 1st-2ndweek Clinical
3.41±0.56 (1st, no shield)
1.69±0.82 (1st, shield)
0.55±0.36 (2nd,no shield)
0.49±0.06 (2nd, shield)
0.18 (nurse)
This work - All (derived from slope in Figure 12.9 Clinical
1.67 (Vall d’Hebron-1st op.)
1.04 (Navarra)
0.62 (Princesa)
0.55 (San Carlos)
0.78 (All)
Vano et al. (2008) phantom, pediatric 7
Leyton et al. (2014) Phantom 1.35
Table 14.6: Eye lens dose per unit KAP measured by different measurement campaigns on clinical operator
or phantom (as specified)
A correction factor of about 1 µSv Gy−1cm−2 for first operator can be derived from the data of this
study and the literature review, if some measurements on very few operators (Koukorava et al. (2011))
and pediatric measurements (Vano et al. (2008))are disregarded, as they are very specific cases and entail
higher eye lens dose per unit KAP, as also demonstrated by this work. However, the influence of protective
equipment and the position of the operator depending on the catheter access position cannot be taken
into consideration by a conversion factor based on KAP values. H p(3)/KAP from the present study show
the fact that the relation between these two quantities depends on the use of shielding and the position of
the operator. Overall, as the use of protective tools introduces large variability, the possibility of deriving
eye lens dose from KAP can not be considered to be a trustworthy solution to eye lens dose monitoring
in the author’s opinion.
When all physicians are studied together, disregarding the hospital where they worked, mean and median
H p(3)out/KAP values of 0.97 and 0.84 µSv Gy
−1cm−2 were obtained, respectively, within the range 0.09
− 3.94 µSv Gy−1cm−2 (sd = 75%). When only data from physicians at the first position at the Vall
d’Hebron Hospital are included (as in the case of the study of the correlation, then daily data instead of
weekly data are used), mean and median H p(3)out/KAP of 1.24 and 1.11 µSv Gy
−1cm−2 are obtained,
respectively (sd = 73%). As regards the H p(3)out/KAP ratio for nurses the spread of data increases (sd
= 27%) and values range from 0.04 to 1.01 µSv Gy−1cm−2, with mean and median values of 0.46 and
0.19.
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Conclusions
This thesis is aimed at investigating possible solutions to introduce eye lens dose monitoring in a real
clinical scenario and to improve radiation protection for medical staff in IC/IR. The study was mainly
devoted to broadening the knowledge of the main issues related to eye lens dosimetry in IC/IR, i.e.
calibration, measurements, MC simulation, taking into account the multi-parametric dependence of eye
lens dose on several factors and its intrinsic variability. The main conclusions of this thesis are the
following.
1. This thesis has set up an easy-to-use eye lens dosemeter (UPC-ELD) and provides
the basis for its accurate calibration in terms of Hp(3) for photon radiation.
Calibration should be preferably performed on the 20 cm x 20 cm cylindrical phantom developed
during the ORAMED European project using H p(3) operational quantity. The UPC-ELD is shown
to fulfill the IEC 62387-1 requirements for energy and angular dependence for photon radiation
with a response between 0.71 and 1.67. Overall good performance is proven through its results in
the EURADOS 2014 eye lens intercomparison study.
Conversion coefficients from air kerma to equivalent dose at 3 mm depth hpK (3) for radiation
qualities RQR 2−9 and for angles of incidence from 0 to 180◦ are provided for the cylindrical
phantom, with an uncertainty of 2% (one standard deviation). This is the same uncertainty stated
in ISO 4037-3 for ISO 4037-1 qualities conversion coefficients. The set of coefficients were published
in Radiation Protection Dosimetry journal and used in the two intercomparisons organized up to
now by EURADOS for eye lens dosemeters. The study also highlights the fact that, although
MC calculations are considered to be the gold standard method for this type of calculations, the
interpolation method, when it is carefully chosen, provides satisfactory results.
2. This thesis highlights the risk of exceeding the new recommended eye lens dose limit
of 20 mSv per year.
Measurement campaigns performed at several Spanish hospitals showed that the actual annual
limit of 150 mSv for the eye lens equivalent dose was not exceeded by any of the monitored workers.
However, approximately 40% of the physicians exceed the new limit of 20 mSv. The annual eye
lens doses depend largely on workload and on the appropriate use of protection, but the results of
this study highlight the fact that there is a need to both introduce monitoring of the eye lens in
this field and also to make better use of existing protections. At one of the monitored hospitals, eye
lens dose fom nurses was clearly below the new limit, whereas at another hospital, the limit could
be surpassed. This observation reinforces the need to study exposure levels of all staff required to
work in close proximity to X-ray sources during interventional procedures.
3. This thesis provides guidance and recommendations for eye lens dose monitoring.
The measurement campaigns at several hospitals confirm that a dosemeter measuring H p(3) placed
close to the eye is the best method for an accurate assessment of eye lens dose and it should be
implemented whenever there is large workload. The correlation between the dose measured close
to the eye and the dose in other parts of the body or the patient dose (KAP), demonstrates the
fact that large uncertainties are associated with an eye lens dose assessment based on indirect
measurements. Results of the EURADOS 2014 intercomparison showed that nowadays dosimetry
services can provide users with appropriate dosemeters.
In spite of their limitations, it is shown that eye lens indirect monitoring methodologies can be very
useful in identifying the group of people who require a more specific monitoring programme. In
particular, at one of the monitored hospitals, nurses would not need specific eye lens monitoring.
In general, the relationship between H p(3) and H p(10) or H p(0.07) measured on the chest or collar
with an unprotected whole body dosemeter is more reproducible than the relationship between
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H p(3) and KAP, in particular in the case of nurses. Thus, if a specific eye lens dosemeter is not
used, at least an unprotected WBD should be required when participating in fluoroscopy guided
procedures. The proposed correction factor derived from this study is H p(3)out/H p(0.07)thorax =
0.8. These recommendations are in line with the latest IRPA guidance on implementation of eye
dose monitoring and eye protection of workers published at the beginning of 2017 (IRPA, 2017).
Eye lens monitoring when using lead glasses is a specific issue since the dosemeter should be
placed underneath the protection. However, this is often very cumbersome. This thesis proposes
a correction factor of 0.3 for wraparound glasses or a more conservative value of 0.5 when the
design of the glasses is unknown, in order to assess the eye lens dose when using eye protection and
the dosemeter is situated outside the glasses. The proposed correction factor has been based on
experimental measurements and MC calculations and it is in agreement with previous works (Magee
et al., 2014; Thornton et al., 2010; Rooijen et al., 2014; Moore et al., 1980) and recommendations
from ISO (2015).
4. This thesis provides practical recommendations to reduce eye lens dose for workers
exposed to X-rays in interventional cardiology and radiology.
Measurements on a phantom in a clinical scenario and MC calculations demonstrate that protection
such as the ceiling shield and lead glasses drastically reduce eye exposure. However, as shown in
the hospital campaigns, in practice the efficiency of protection is much lower. Thus, better training
in the use of protection and the selection of an appropriate design for glasses are recommended
to reduce the eye lens dose. To improve the use of ceiling shield and the workers’ awareness of
exposure, the use of electronic, direct reading dosemeters, such as the Doseaware, which were
tested and satisfactorily compared with passive dosemeters in this thesis, is recommended.
A detailed MC analysis has highlighted the influence of different parameters studied independently,
such as the operator position, height and orientation with respect to the source, on eye lens exposure
during an interventional procedure. To reduce eye lens exposure, placing the monitors away from
the primary X-ray field is recommended. A rotation of the head of 30◦ or 45◦ away from the tube
can reduce eye lens dose by approximately 50%, in particular at distances of 20cm and 40cm from
the X-ray source.
The conclusion of this thesis could be used to prepare a training course for improving radiation
protection of staff involved in IC/IR procedures.
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Appendix B
Uncertainty calculation for the
personal dose equivalent assessment
The uncertainty associated to the determination of H p(d) is calculated by applying the Guide to the
expression of Uncertainty in Measurement, GUM, (ISO/IEC, 2008) to Equation 6.1:
Hp(d) = (Lifi− < B >)Ncal εcal
εt
(B.1)
As decribed in chapter 10, the calibration factor Ncal is derived from calibration factors obtained for
reference qualities. In practice, in general the energy field is not known, thus, a sigle Ncal value is used
for each equivalent dose quantity. A mean value is used for H p(0.07) and H p(3), whereas for H p(10)
the calibration factor is assigned as a function of the ratio between the readings M(10) and M(0.07) as
shown in Figure 10.1.
To facilitate the application of the GUM, Equation B.1 can be written as:
Hp(d) = MQNcal(Hp(d))f(Q,α)f
(εcal
εt
)
(B.2)
Where:
• MQ = Lifi− < B > is the reading corrected for individual sensitivity and background. For
UPC-WBD and UPC-ELD, as there are two detectors for each quantity to be measured, a mean
value of the two is used 1.
• Ncal(Hp(d)) is the calibration factor defined in chapter 10.
• f(Q,α) is a function which takes into account the influence of the energy (Q) and the angular
response (α). It is set equal to 1 with an uncertainty associated to the variability of Ncal as a
function of Q and α.
• f
(εcal
εt
)
is a function which takes into account the stability of the efficiency of the dosemeters
between the date of calibration and the date of measurement. As mentioned in subsection 6.2.1,
during our study this function is set to one with a maximum variation of ±1%, thus with an
associated relative standard uncertainty of 1/
√
3% 2.
1In most cases, the best available estimate of a quantity that varies randomly and for which n independent observations
have been obtained under the same conditions of measurement is the arithmetic mean or average of the n observations.
The individual observations differ in value because of random variations in the influence quantities, or random effects. The
variability of the observed values, or more specifically, their dispersion about their mean is characterized by the experimental
standard deviation (s) of the observations. The number of observations n should be large enough to ensure that the mean
provides a reliable estimate of the expected value of the quantity. In our case, very often measurement is performed using
the reading of one or two dosemeters. In order to better estimate the associated uncertainty of the reading, the GUM
recommends using the information about the variability of the quantity obtained from a well-characterized measurement
under statistical control. This is, for example, in our case the set of readings obtained when the badge is irradiated in
known conditions, once corrected for individual sensibility. This procedure is called to use a ’pooled experimental standard
deviation’, sp. In our case sp is derived from the experimental standard deviation of the 300 detectors when irradiated with
137Cs at 3 mGy and is equal to 3.3% (k=1). If m detectors are used in one measurement the pooled uncertainty is equal
to sp/
√
m. In our case we compare the pooled uncertainty and the experimental standard deviation of the mean of the m
measurements: s/
√
m. The largest value is considered as the uncertainty associated to this quantity. This approach is used
for any set of TL readings, independently if they are used for calibration, background or dose measurement.
2According to GUM, for variables where it may be possible to estimate only bounds (upper and lower limits), it can be
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B.1 Uncertainty of the calibration factor N cal(Q,H p(d))
The uncertainty of the calibration factor for each reference quality Ncal(Q,Hp(d)) (Equation 10.1) is
obtained, according to GUM, as:
u(Ncal(Q,Hp(d)))
Ncal(Q,Hp(d))
=
√√√√[u(Hp(d)ref )
Hp(d)ref
]2
+
[
u(MQ)
MQ
]2
(B.3)
The uncertainty of the reference quantity H p(d)ref is provided by the calibration laboratory and it
is equal to 2.5% (k=1).
The uncertainty of MQ is equal to:
u(MQ) =
√
s2Lifi + s
2
<B> (B.4)
sLifi is the standard deviation derived from the distribution of the set of 300 detectors readings
corrected by the individual factor. If MQ is calculated using n detectors, sLifi/
√
n is the assigned
uncertainty. The numerical value of sLifi is 3.3 nC for a single detector. s<B> is the standard deviation
associated to the background correction. It is calculated as the standard deviation of the mean of the
corrected readings (corrected for individual sensitivity) of the background detectors. Equation B.3 is
used to obtain the uncertainties presented in Table 10.1 and a numerical example is shown in Table B.2.
B.2 Uncertainty of f (Q,α)
The uncertainty associated to the lack of knowledge of the radiation field f(Q,α) varies depending on
H p(d) and the hypothesis used to derive the value of Ncal.
B.2.1 Contribution of the radiation quality Q to the uncertainty u(f (Q,α))
For H p(3), a mean value of the calibration factors in the range of energies of interest is used. The
associated standard uncertainty is estimated considering that the maximum deviation within Ncal,max
and Ncal,min is (Ncal,max − Ncal,min) and that a constant probability distribution between these upper
and lower bounds can be hypothesized for Ncal(Hp(3)). Thus, a rectangular distribution can be assumed
and u(f(Q,α)) =
Ncal,max −Ncal,min
2
√
3
for H p(3) and for k=1. Numerically, this value is equal to 2.6%
(k=1).
Likewise, for H p(0.07) the u(f(Q,α)) is obtained assuming a rectangular distribution for Ncal(Hp(0.07))
and it is numerically equal to 2.3%.
For H p(10), Ncal(Hp(10)) is derived applying the equation Ncal(Hp(10)) = 20.36−14.56·M(10)/M(0.07)
obtained by a linear least squares fitting of the experimental values. The uncertainty associated to this
fitting is 0.8% for k=1.
B.2.2 Contribution of the incident direction α to the uncertainty u(f (Q,α))
The uncertainty related to the angular response is associated to the error performed when Ncal(0
◦)
is chosen instead of Ncal(α). The angular response for the UPC-ELD and the EYE-D is shown in
Table 10.2. The deviation observed for angular deflections of 45◦ and 75◦ are combined and considered
equal to the uncertainty associated to this parameter. Numerically, it is equal to 3.3% (k=1). For H p(10)
and H p(0.07), the angular response has not been studied in the framework of this thesis. According to
the personal dosimetry service of INTE-UPC it is equal to 3.3%.
The uncertainty associated to both the energy and the angular response u(f(Q,α))/f(Q,α) is obtained
combining quadratically the uncertainty of each parameter.
assumed that ’the probability that the variable lies within the interval a(min) to a(max) for all practical purposes is equal to
one and the probability that the variable lies outside this interval is essentially zero’. One can only assume that it is equally
probable for the variable to lie anywhere within it (a uniform or rectangular distribution is assumed). Then, the expected
value of the variable is the midpoint of the interval with an associated uncertainty equal to u = [a(max) − a(min)]/2√3.
Such hypothesis is considered for the stability of the batch, and also when a single calibration factor is used for any field.
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B.3 Uncertainty of the calibration factor N cal
The uncertainty of the calibration factor Ncal for each reference quality in an unknown field can be
estimated as the combined uncertainty of Ncal(Q,Hp(d)) (section B.1) and the uncertainty of f(Q,α)
(section B.2).
Equation B.5 has been used to obtain the uncertainties presented in subsection 10.1.1 for Ncal(Hp(d))
and a numerical example is shown in Table B.4.
u(Ncal(Hp(d)))
Ncal(Hp(d))
=
√√√√[u(Ncal(Q,Hp(d)))
Ncal(Q,Hp(d))
]2
+
[
u(f(Q,α))
f(Q,α)
]2
(B.5)
B.4 Practical example of the assessment of the uncertainty
associated to H p(d)
A numerical example is provided to illustrate the uncertainty calibration budget. The data can change
slightly for each measurement. Relative uncertainty u(Ncal(Q,Hp(d)))/Ncal(Q,Hp(d)) in Table B.2 has
been calculated considering the experimental data shown in Table B.1. u(f(Q,α))/f(Q,α) obtained as
the combined uncertainty of the energy and angular response is shown in Table B.3. The uncertainty
associated to Ncal is calculated in Table B.4. The assessment of the combined uncertainty associated to
H p(d) is given in Table B.5. All uncertainty values are given for k=1.
The relative expanded uncertainty U(H p(d))/H p(d) is obtained multiplying u(H p(d))/H p(d) by a
coverage factor k=2 (Table B.6).
Table B.1: Example of experimental data and associated uncertainties
Variable Mean reading N Standard deviation u(MQ) u(MQ)/MQ
nC (detectors) of the mean (nC) (nC) (%)
Readings corresponding to an individual monitoring campaign 100 2 2.33
2.33 2.48%
Background Readings for an individual monitoring campaign 6 6 0.08
Readings corresponding for energy calibration 200 6 1.69
1.69 0.85%
Background Readings for energy calibration 0.6 10 0.006
Table B.2: u(Ncal(Q,Hp(d)))/Ncal(Q,Hp(d))
Variable Relative uncertainty (%)
u(H p(d)ref )/H p(d)ref 2.50%
u(MQ)/MQ (for energy calibration) 0.85%
Combined uncertainty: u(N cal(Q,H p(d)))/N cal(Q,H p(d)) 2.64%
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Table B.3: u(f(Q,α))/f(Q,α)
Variable H p(3) H p(0.07) H p(10)
Energy response 2.60% 2.30% 0.80%
Angular response 3.30% 3.30% 3.30%
Combined uncertainty: u(f (Q,α))/f (Q,α) 4.20% 4.01% 3.40%
Table B.4: u(Ncal(Hp(d)))/Ncal(Hp(d))
Variable H p(3)UPC−ELD H p(0.07) H p(10)
u(Ncal(Q,Hp(d)))/Ncal(Q,Hp(d)) 2.64% 2.64% 2.64%
u(f(Q,α))/f(Q,α) 4.20% 4.01% 3.40%
Combined uncertainty: u(N cal(H p(d)))/N cal(H p(d))(k=1) 5.0% 4.8% 4.3%
Table B.5: Assessment of the combined uncertainty associated to H p(d) (k=1)
Variable H p(3) H p(0.07) H p(10)
u(MQ)/MQ 2.48% 2.48% 2.48%
u(Ncal(Q,Hp(d)))/Ncal(Q,Hp(d)) 2.64% 2.64% 2.64%
u(f(Q,α))/f(Q,α) 4.20% 4.01% 3.40%
u(f
(εcal
εt
)
)/f
(εcal
εt
)
0.58% 0.58% 0.58%
Combined uncertainty: u(H p(d))/H p(d) k=1 5.6% 5.4% 5.0%
Table B.6: Expanded uncertainty associated to H p(d) (k=2)
Variable H p(3) H p(0.07) H p(10)
Expanded uncertainty: U(H p(d))/H p(d) k=2 11% 11% 10%
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